data_2k32_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k32 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.692 0.282 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 . . . . . 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.502 -0.899 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 . . . . . 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 119.79 -0.148 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 119.508 -0.282 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.492 ' H ' HG11 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.567 0.222 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.45 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.474 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.437 0.16 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.469 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.469 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD2' HG21 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 . . . . . 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.415 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.472 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.412 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 2' ' ' VAL 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 119.932 -0.08 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.64 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.823 1.649 . . . . 0.0 111.112 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -71.02 28.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 37.1 -85.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.714 3.605 . . . . 0.0 116.259 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 8.0 4.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.27 89.99 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.132 0.967 . . . . 0.0 110.302 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 m -79.64 -2.21 41.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.78 2.032 . . . . 0.0 114.364 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -54.46 -38.86 66.87 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.76 -24.58 56.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.13 -25.77 14.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.866 1.667 . . . . 0.0 113.646 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.78 -42.15 91.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.704 2.002 . . . . 0.0 114.536 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -60.24 -44.05 95.58 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.3 p -59.23 -50.4 74.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -68.34 -35.47 77.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 -37.69 88.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 0.0 112.99 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.3 -56.9 6.98 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.981 0.913 . . . . 0.0 112.588 169.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -31.51 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -163.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -61.52 -19.44 62.11 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -50.11 -29.23 8.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.345 1.458 . . . . 0.0 114.679 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -77.66 -19.69 54.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.11 -172.77 4.33 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.48 -18.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.006 1.722 . . . . 0.0 111.763 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -57.38 135.46 56.54 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.067 1.347 . . . . 0.0 112.317 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.36 -6.38 0.99 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -168.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.99 -12.98 10.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.312 1.045 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -98.64 -40.98 7.93 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.316 2.246 . . . . 0.0 112.426 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.68 3.83 0.93 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.228 2.211 . . . . 0.0 116.761 -172.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.0 -19.4 52.22 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -167.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -59.9 -27.62 66.88 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.523 -1.36 . . . . 0.0 113.284 169.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.0 m -75.01 -16.92 60.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.5 -34.81 8.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 112.836 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.18 7.27 1.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m 46.23 -138.43 0.58 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.726 1.611 . . . . 0.0 111.506 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -77.1 55.38 1.15 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.854 1.662 . . . . 0.0 111.11 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 63.03 46.06 4.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 113.769 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -100.68 157.07 16.96 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -63.47 139.64 58.79 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.73 -59.75 4.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.098 1.759 . . . . 0.0 112.245 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -139.89 154.7 70.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.19 1.396 . . . . 0.0 111.056 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.2 -9.53 13.94 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.927 2.418 . . . . 0.0 114.715 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.9 pt -65.8 -23.61 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.37 1.468 . . . . 0.0 113.381 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -73.86 5.79 3.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.717 1.607 . . . . 0.0 114.264 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -140.86 -28.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.038 1.335 . . . . 0.0 114.506 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -150.76 30.04 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.284 0.947 . . . . 0.0 113.465 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.83 92.66 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 120.672 -1.267 . . . . 0.0 115.216 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 p -165.56 -35.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -139.78 3.43 2.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.065 1.346 . . . . 0.0 113.675 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -68.43 1.76 2.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.165 2.186 . . . . 0.0 115.076 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -60.81 -11.52 7.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.893 2.077 . . . . 0.0 113.873 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -116.77 16.35 15.31 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.705 2.002 . . . . 0.0 112.506 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -130.76 -7.89 4.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.309 2.244 . . . . 0.0 112.707 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.8 t60 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.264 1.826 . . . . 0.0 112.312 -169.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.82 146.4 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 126.867 2.067 . . . . 0.0 110.307 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -64.78 -7.37 10.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.36 42.33 17.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.088 2.155 . . . . 0.0 112.905 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.22 5.74 10.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -168.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.15 -58.53 5.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.289 1.036 . . . . 0.0 113.079 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -69.58 -25.35 63.94 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.42 -30.92 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.968 0.907 . . . . 0.0 112.302 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.25 -50.04 6.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.061 0.544 . . . . 0.0 111.453 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -69.89 -40.35 75.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -70.67 -39.23 73.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.321 -0.862 . . . . 0.0 111.065 172.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -68.11 -43.76 77.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.103 -169.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -14.88 33.55 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -57.08 -17.69 11.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.042 1.737 . . . . 0.0 114.114 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.62 12.44 1.7 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.414 1.486 . . . . 0.0 113.897 172.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -146.67 177.82 8.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.466 1.506 . . . . 0.0 112.933 -169.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -54.84 162.4 1.26 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.95 1.7 . . . . 0.0 113.597 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.6 p -149.12 164.88 33.41 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.4 -19.78 66.09 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.48 0.712 . . . . 0.0 112.838 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 m -78.96 -6.73 57.0 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.98 -20.0 61.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.35 160.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.729 2.012 . . . . 0.0 110.669 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.8 m -44.01 135.82 4.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.581 1.552 . . . . 0.0 113.57 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.19 0.71 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.899 2.48 . . . . 0.0 116.133 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -113.68 -24.73 9.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.379 1.872 . . . . 0.0 112.6 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -98.92 -37.37 9.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 113.276 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -8.75 6.63 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.74 -22.93 62.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -168.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -59.61 -26.07 65.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -85.67 -14.96 43.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.012 1.325 . . . . 0.0 113.592 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -102.3 -29.08 11.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.32 1.848 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.3 21.47 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -168.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -138.01 -175.72 4.19 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.696 -1.252 . . . . 0.0 111.992 172.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' HG22 ' A' ' 64' ' ' THR . 36.5 mt -118.6 24.59 10.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.725 2.01 . . . . 0.0 112.563 -166.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.333 5.7 p-10 47.77 36.34 5.66 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.357 1.463 . . . . 0.0 114.785 -172.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -81.44 155.84 25.66 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.38 -0.825 . . . . 0.0 113.104 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.71 -13.35 62.25 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 mt 52.75 -164.47 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.538 1.535 . . . . 0.0 111.76 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.05 156.5 87.64 Favored Pre-proline 0 CA--C 1.552 1.047 0 O-C-N 120.945 -1.097 . . . . 0.0 108.571 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.53 -16.43 30.57 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.223 1.949 . . . . 0.0 114.981 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 pt -63.92 -6.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.173 2.189 . . . . 0.0 115.227 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -117.62 4.53 12.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.27 1.828 . . . . 0.0 112.69 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.75 -14.34 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.946 1.298 . . . . 0.0 114.367 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -153.09 173.02 16.0 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 119.552 1.069 . . . . 0.0 112.263 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.01 -173.9 38.44 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.742 1.163 . . . . 0.0 113.941 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -145.25 153.05 40.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.827 1.251 . . . . 0.0 111.499 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -156.74 154.76 30.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.676 1.59 . . . . 0.0 111.452 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -152.44 138.34 18.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.484 1.514 . . . . 0.0 111.306 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -146.63 0.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.664 1.585 . . . . 0.0 112.968 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -70.44 161.63 30.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.373 2.269 . . . . 0.0 114.315 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -73.67 4.79 4.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.209 1.804 . . . . 0.0 114.634 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.002 2.121 . . . . 0.0 111.692 -170.194 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.45 0.167 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 156.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.548 1.939 . . . . 0.0 111.582 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.69 -52.47 65.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.65 161.66 1.7 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.412 2.285 . . . . 0.0 109.025 -167.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.415 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -139.63 12.63 2.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.78 66.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m -96.9 -2.99 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 32.9 ttpt -62.27 -24.62 67.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -119.48 -27.96 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.699 1.6 . . . . 0.0 112.286 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.4 -5.92 45.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -58.63 -15.45 11.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -58.83 -37.57 76.74 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -167.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -72.45 -35.06 68.18 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.549 1.14 . . . . 0.0 112.968 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -68.56 -31.16 70.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.405 1.482 . . . . 0.0 112.326 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -22.9 47.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.399 1.479 . . . . 0.0 114.333 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.76 -21.08 39.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.331 1.452 . . . . 0.0 114.346 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 9.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -75.96 2.63 12.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.95 1.7 . . . . 0.0 114.668 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -62.8 -17.82 61.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 114.265 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.1 p -62.83 -25.51 68.29 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.752 -1.217 . . . . 0.0 113.627 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.33 5.73 37.49 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.661 2.384 . . . . 0.0 112.564 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp 73.46 -59.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.741 2.817 . . . . 0.0 110.05 -169.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 56' ' ' LYS . 4.4 m -167.36 144.52 4.51 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.783 2.033 . . . . 0.0 110.016 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.3 7.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.09 2.156 . . . . 0.0 115.578 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' H ' ' C ' ' A' ' 54' ' ' SER . 72.2 mmtt -129.02 -15.59 4.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.95 2.1 . . . . 0.0 113.23 -175.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.76 -45.16 6.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 112.355 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -31.89 64.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.906 1.282 . . . . 0.0 114.285 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.2 -13.75 56.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.586 1.555 . . . . 0.0 113.95 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.2 p -57.89 -21.93 45.7 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -103.11 -12.67 17.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.293 1.437 . . . . 0.0 114.273 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.26 -55.18 2.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 0.0 113.061 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -175.99 67.34 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.455 2.302 . . . . 0.0 109.502 -168.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -50.31 129.78 22.09 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.042 1.337 . . . . 0.0 111.772 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt 43.69 39.31 2.38 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.039 1.336 . . . . 0.0 113.471 -173.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.66 22.09 12.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.611 1.564 . . . . 0.0 113.317 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -87.56 149.75 24.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.74 105.64 11.18 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.01 162.95 6.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.396 0.678 . . . . 0.0 111.32 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.8 149.07 55.39 Favored Pre-proline 0 CA--C 1.553 1.081 0 O-C-N 121.523 -0.735 . . . . 0.0 110.817 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.97 0.81 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.391 2.727 . . . . 0.0 114.008 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.5 pt -72.13 -9.35 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.084 2.154 . . . . 0.0 115.303 -169.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -61.71 -14.69 34.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.105 1.362 . . . . 0.0 114.661 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.97 -3.73 24.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.872 1.269 . . . . 0.0 114.387 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.04 -170.21 3.53 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.601 1.16 . . . . 0.0 111.795 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.41 5.71 0.03 OUTLIER Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.184 1.373 . . . . 0.0 114.855 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -83.73 18.05 2.09 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.153 1.476 . . . . 0.0 113.892 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -64.51 152.63 41.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.796 1.638 . . . . 0.0 113.111 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -126.41 1.68 6.98 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 58.96 -8.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 170.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -122.23 -7.53 8.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.896 1.678 . . . . 0.0 112.897 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -132.05 14.53 4.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.388 1.875 . . . . 0.0 112.509 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.699 2.4 . . . . 0.0 110.568 -175.686 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.373 0.13 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.58 153.2 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.767 1.627 . . . . 0.0 112.172 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -58.49 -41.64 85.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.34 170.36 10.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.188 1.795 . . . . 0.0 111.375 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.15 18.2 6.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.13 -52.83 64.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.827 0.851 . . . . 0.0 112.053 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -64.62 -30.06 71.08 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.73 1.212 . . . . 0.0 113.222 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 31.3 ttpt -66.89 -32.48 73.78 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.969 -0.457 . . . . 0.0 111.737 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -80.41 -35.27 35.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 171.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -98.38 -40.28 8.38 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -92.4 -51.42 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.75 0.82 . . . . 0.0 111.952 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -69.72 -21.51 63.47 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -65.74 -47.51 75.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 111.962 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -67.52 -36.54 81.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.15 1.38 . . . . 0.0 112.384 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.77 -20.47 50.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 114.152 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.18 -24.36 64.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.088 1.355 . . . . 0.0 113.891 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.01 11.28 0.55 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -167.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 t -146.91 163.82 34.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 112.404 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -72.69 -0.21 12.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.859 1.663 . . . . 0.0 113.573 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.1 p -52.95 -28.09 21.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.857 1.663 . . . . 0.0 115.215 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -12.97 6.38 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.0 mm -125.4 -10.95 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 126.945 2.098 . . . . 0.0 111.6 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.5 m -56.73 118.52 4.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.895 1.278 . . . . 0.0 112.296 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -54.37 -6.15 0.1 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -124.3 -4.94 7.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.368 1.867 . . . . 0.0 113.38 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.88 -34.24 5.83 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.406 1.482 . . . . 0.0 113.946 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -1.48 0.48 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.52 1.928 . . . . 0.0 116.005 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.38 -29.66 64.25 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.758 -1.214 . . . . 0.0 111.14 167.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.8 p -59.09 -18.35 34.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.646 1.578 . . . . 0.0 114.972 168.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -102.78 -33.19 9.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.066 2.147 . . . . 0.0 113.285 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.16 -35.07 79.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.7 1.2 . . . . 0.0 113.156 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.39 70.87 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.419 1.888 . . . . 0.0 108.725 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -35.87 114.51 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.316 2.247 . . . . 0.0 115.039 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.4 mt 41.36 27.15 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t0 46.76 45.58 14.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.587 1.555 . . . . 0.0 113.671 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -73.18 145.39 46.35 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 121.337 -0.852 . . . . 0.0 112.798 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.66 132.75 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.46 -69.11 0.35 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.099 0.96 . . . . 0.0 111.307 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.55 168.24 14.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.715 2.006 . . . . 0.0 110.139 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.07 22.23 0.88 Allowed 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.003 3.135 . . . . 0.0 112.769 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.5 pt -145.84 174.51 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 129.865 3.266 . . . . 0.0 108.584 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 63.27 -22.62 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.338 2.255 . . . . 0.0 116.285 -172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.02 151.08 12.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.909 1.684 . . . . 0.0 113.158 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -100.35 117.44 34.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.979 0.912 . . . . 0.0 111.371 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.9 167.76 19.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.171 1.367 . . . . 0.0 113.435 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.2 p -75.85 -33.95 60.03 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.945 0.898 . . . . 0.0 113.22 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 47.01 30.81 1.35 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.059 2.144 . . . . 0.0 114.96 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -152.88 163.26 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.656 1.183 . . . . 0.0 112.458 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.51 -34.18 0.58 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.745 1.218 . . . . 0.0 114.134 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -80.87 56.76 2.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.818 1.247 . . . . 0.0 111.939 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -68.87 154.64 41.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.239 1.416 . . . . 0.0 113.365 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.383 1.873 . . . . 0.0 112.084 -179.06 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.03 148.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.412 1.885 . . . . 0.0 110.695 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -73.21 6.66 2.66 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 56.86 93.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.232 1.813 . . . . 0.0 113.03 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.457 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -59.15 4.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.818 2.847 . . . . 0.0 118.042 -169.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.4 62.7 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.997 1.319 . . . . 0.0 113.885 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -83.41 -9.64 58.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 35.9 ttpt -63.07 -44.58 95.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.066 0.848 . . . . 0.0 113.121 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 112.35 173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -74.77 -39.8 61.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.559 1.144 . . . . 0.0 112.391 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -67.61 -46.2 73.25 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.545 1.138 . . . . 0.0 112.447 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.11 -29.08 70.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.4 m -57.35 -23.41 48.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -70.16 -20.37 63.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.989 1.316 . . . . 0.0 114.16 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 68.47 2.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.195 1.398 . . . . 0.0 113.048 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -131.98 153.98 49.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.477 1.911 . . . . 0.0 111.38 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 23.44 -93.92 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.671 2.788 . . . . 0.0 116.828 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -70.71 -20.86 62.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -99.32 -34.5 10.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.089 1.756 . . . . 0.0 112.564 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -64.84 -20.87 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.076 0.853 . . . . 0.0 113.183 169.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -6.76 8.72 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.365 1.466 . . . . 0.0 114.073 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt 108.66 118.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 1 C-N-CA 132.016 4.126 . . . . 0.0 109.815 169.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -139.34 137.53 35.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.096 1.758 . . . . 0.0 110.414 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -58.93 -4.43 0.47 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -123.57 -6.12 8.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.235 2.214 . . . . 0.0 113.428 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.13 -33.37 6.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.407 1.883 . . . . 0.0 113.999 171.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -3.21 4.89 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -169.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -60.02 -22.96 63.28 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.944 -1.098 . . . . 0.0 113.289 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -62.19 -20.58 64.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.994 1.318 . . . . 0.0 114.365 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.2 m -102.88 -20.51 14.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.394 1.478 . . . . 0.0 113.616 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.7 mt -76.13 -22.31 55.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.839 1.255 . . . . 0.0 114.181 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.73 173.49 11.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.37 1.068 . . . . 0.0 113.761 -168.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -140.46 138.15 34.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.759 1.624 . . . . 0.0 110.121 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt 42.78 36.4 0.85 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.665 1.986 . . . . 0.0 113.843 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.8 p-10 46.23 28.62 0.7 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.801 2.04 . . . . 0.0 115.693 -171.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -91.18 160.11 15.72 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -77.03 153.12 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -133.95 -173.62 3.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.943 2.097 . . . . 0.0 109.827 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.36 155.63 6.84 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 121.239 -0.913 . . . . 0.0 111.129 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.25 5.57 5.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.38 2.72 . . . . 0.0 115.121 -167.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.87 -1.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 128.295 2.638 . . . . 0.0 115.011 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.45 -0.6 11.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.711 2.004 . . . . 0.0 113.053 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.11 179.18 3.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.466 1.106 . . . . 0.0 111.608 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.59 108.31 0.54 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.099 0.96 . . . . 0.0 112.597 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.77 -167.1 38.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.348 1.452 . . . . 0.0 112.332 -171.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.9 m -139.02 130.57 27.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 111.654 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -155.08 158.88 39.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.179 1.792 . . . . 0.0 109.954 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -87.76 -15.63 36.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.565 1.146 . . . . 0.0 113.707 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.3 m80 60.55 -16.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.404 2.682 . . . . 0.0 116.893 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -135.08 6.86 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.405 1.882 . . . . 0.0 113.095 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -153.18 162.91 40.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 110.1 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.374 1.47 . . . . 0.0 112.227 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.661 0.267 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.97 138.7 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.554 1.542 . . . . 0.0 110.768 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.33 52.46 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.14 -46.93 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.229 2.211 . . . . 0.0 114.296 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.404 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 7.9 pt20 -150.83 20.01 0.79 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.86 -46.48 78.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.178 0.899 . . . . 0.0 111.358 171.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 m -62.01 -27.92 69.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 24.8 ttpt -64.65 -23.36 67.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.642 1.177 . . . . 0.0 112.48 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.02 -46.16 7.26 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.44 1.096 . . . . 0.0 111.144 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.73 -32.89 74.68 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -65.48 -49.48 68.89 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -166.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 p -79.67 -36.38 37.75 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.056 1.342 . . . . 0.0 112.942 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -37.87 85.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.028 0.931 . . . . 0.0 112.858 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.22 -9.02 59.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.264 1.426 . . . . 0.0 114.233 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.83 -48.61 80.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.1 1.36 . . . . 0.0 113.857 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -11.83 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -163.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -129.04 -52.17 1.21 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -99.38 15.7 25.45 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 p -64.39 -15.04 59.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.056 1.343 . . . . 0.0 113.741 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.11 -17.52 27.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.971 1.708 . . . . 0.0 115.429 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.1 tp -132.83 123.45 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.359 0.982 . . . . 0.0 112.499 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 m -56.2 140.88 42.97 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.484 1.514 . . . . 0.0 114.254 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -60.47 -6.49 1.61 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.947 2.099 . . . . 0.0 116.072 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -125.87 5.25 7.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.978 0.911 . . . . 0.0 112.946 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -108.03 -43.76 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.719 1.608 . . . . 0.0 112.739 168.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -59.81 -27.36 66.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.74 -17.61 64.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 0.0 114.074 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.1 m -60.68 -19.92 59.72 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.14 -0.975 . . . . 0.0 113.28 169.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -89.54 -12.44 39.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.806 1.242 . . . . 0.0 113.708 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.6 mt -102.2 -21.81 14.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.315 1.846 . . . . 0.0 113.947 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 154.83 37.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.5 m -66.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.801 1.24 . . . . 0.0 113.888 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -149.57 -59.65 0.21 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.732 3.213 . . . . 0.0 108.288 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -158.98 27.97 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.883 3.273 . . . . 0.0 111.248 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -121.07 160.54 23.44 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.844 1.258 . . . . 0.0 113.711 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.4 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.67 126.1 30.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 74.0 mt -71.22 -61.48 1.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.389 0.675 . . . . 0.0 111.274 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -140.14 159.25 64.81 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.487 1.515 . . . . 0.0 110.161 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.06 -6.39 8.43 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.964 2.443 . . . . 0.0 114.577 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.0 -27.91 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.446 1.498 . . . . 0.0 113.307 174.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -76.03 -13.67 60.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.188 1.795 . . . . 0.0 112.833 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.84 23.24 10.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.805 1.642 . . . . 0.0 113.702 -169.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 100.13 -7.88 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 130.037 3.335 . . . . 0.0 113.934 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.3 -42.0 97.98 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 114.585 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t 57.45 -52.82 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.965 2.906 . . . . 0.0 117.206 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -159.0 164.87 35.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 111.574 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -70.02 -35.72 74.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.288 1.035 . . . . 0.0 112.804 171.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -158.52 160.42 36.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.869 2.067 . . . . 0.0 110.476 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -62.57 160.31 14.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.282 1.033 . . . . 0.0 112.876 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -147.51 166.9 25.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 112.444 -169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.9 m80 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.793 1.637 . . . . 0.0 112.261 -169.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.842 -0.058 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.65 147.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.424 0.69 . . . . 0.0 110.32 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -73.06 3.59 5.3 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 -53.41 0.1 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 129.328 3.051 . . . . 0.0 117.122 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.09 8.34 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.02 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.906 -1.121 . . . . 0.0 113.321 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -75.93 -8.77 57.72 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -63.3 -21.75 66.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.87 1.268 . . . . 0.0 114.401 -171.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -118.77 -26.5 6.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.527 1.131 . . . . 0.0 112.936 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -23.2 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 113.375 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -52.7 -33.48 47.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.715 1.206 . . . . 0.0 114.017 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 -60.22 -38.91 84.81 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -168.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 m -83.92 -21.03 31.99 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -62.44 -31.52 72.25 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.48 1.037 . . . . 0.0 112.542 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 -4.02 21.05 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.338 1.455 . . . . 0.0 114.331 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -121.27 -53.07 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.358 1.463 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.46 156.87 16.67 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -163.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.4 m -58.12 105.63 0.29 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.558 1.943 . . . . 0.0 113.643 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -67.74 -7.2 25.39 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 p -56.61 -20.85 23.16 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.278 -0.889 . . . . 0.0 113.243 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.19 59.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.66 158.76 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.552 1.541 . . . . 0.0 109.442 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -49.98 139.06 14.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.769 1.627 . . . . 0.0 114.177 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -61.5 -5.32 1.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.425 2.29 . . . . 0.0 116.826 -171.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -124.32 -3.92 7.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.34 1.856 . . . . 0.0 113.114 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -98.84 -40.37 8.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 112.482 168.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -3.72 9.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -169.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.77 -25.73 60.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 t -57.74 -26.55 61.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.774 1.229 . . . . 0.0 113.181 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.7 m -103.44 -5.0 23.31 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.46 -9.65 54.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.8 1.24 . . . . 0.0 113.443 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.48 -163.11 1.36 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.974 1.309 . . . . 0.0 112.056 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -174.16 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.346 1.859 . . . . 0.0 111.627 -176.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -48.94 -33.79 11.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -171.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -174.65 33.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.333 2.653 . . . . 0.0 111.946 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -122.7 165.05 17.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -67.9 132.32 47.13 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.6 mt -74.2 171.5 13.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 111.623 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -59.89 146.26 82.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.66 -0.65 . . . . 0.0 111.368 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.41 -6.43 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.946 2.43 . . . . 0.0 114.447 -167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.3 pt -63.12 -18.39 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.43 2.292 . . . . 0.0 113.862 170.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 -15.91 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -11.01 30.14 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.68 26.41 1.27 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.55 0.74 . . . . 0.0 112.435 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.01 177.98 53.88 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.576 1.084 . . . . 0.0 114.502 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.3 t -150.6 164.72 35.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.775 1.23 . . . . 0.0 112.132 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -67.84 -17.91 64.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.632 1.573 . . . . 0.0 114.362 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -151.34 177.69 10.01 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.556 1.542 . . . . 0.0 112.26 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.22 -7.47 4.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -158.63 -37.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -155.22 154.07 31.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 111.652 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.159 1.783 . . . . 0.0 112.274 -177.915 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.631 0.253 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.492 HG11 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -141.89 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.88 1.672 . . . . 0.0 110.604 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -66.17 -9.3 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.61 5.96 0.75 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.973 2.509 . . . . 0.0 114.889 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.329 6.0 pt20 42.83 30.3 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.558 2.343 . . . . 0.0 117.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.32 77.77 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.974 -1.078 . . . . 0.0 112.482 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 -26.77 65.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.963 1.305 . . . . 0.0 114.068 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.63 -15.88 32.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.78 -46.18 3.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.799 1.24 . . . . 0.0 110.816 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.44 -30.18 69.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -169.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -76.26 -39.07 55.3 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.429 -0.794 . . . . 0.0 112.814 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -57.01 -41.02 77.76 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -164.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.9 p -57.41 -25.93 60.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -99.36 -8.62 24.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.285 1.834 . . . . 0.0 114.045 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.63 39.19 1.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.807 1.243 . . . . 0.0 113.298 -169.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.66 155.83 25.16 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.068 0.947 . . . . 0.0 112.34 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 40.0 63.93 0.98 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.282 2.233 . . . . 0.0 116.27 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -151.25 154.96 37.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.724 0.81 . . . . 0.0 112.026 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.27 -30.57 68.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.125 0.97 . . . . 0.0 112.305 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 m -72.0 -4.05 26.35 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.512 1.525 . . . . 0.0 114.681 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.03 75.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -132.74 -5.44 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.3 m 55.39 106.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.345 2.258 . . . . 0.0 114.372 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.1 -6.31 0.36 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.224 2.21 . . . . 0.0 116.745 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -121.95 2.96 9.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.848 1.259 . . . . 0.0 112.62 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.66 -40.99 3.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.361 1.865 . . . . 0.0 113.153 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -58.32 -22.8 54.46 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.93 -16.83 46.69 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -60.6 -14.73 22.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.625 1.17 . . . . 0.0 114.144 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -103.28 -8.9 19.96 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.49 -31.75 11.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.999 1.32 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.38 6.3 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.415 1.486 . . . . 0.0 113.62 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.9 -163.95 1.91 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.688 1.995 . . . . 0.0 109.78 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.9 mt -124.89 36.59 4.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.856 2.062 . . . . 0.0 110.973 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.347 3.1 p30 51.11 29.73 4.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.381 1.872 . . . . 0.0 114.684 -168.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -79.65 154.68 28.49 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.492 ' H ' HG11 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -68.69 154.93 41.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.07 173.62 10.56 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.318 2.247 . . . . 0.0 108.832 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -56.16 147.12 47.63 Favored Pre-proline 0 CA--C 1.551 0.99 0 O-C-N 121.548 -0.72 . . . . 0.0 110.634 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.6 28.12 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.199 3.933 . . . . 0.0 113.21 -167.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.13 -0.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 127.49 2.316 . . . . 0.0 113.857 -168.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.04 132.67 54.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.329 -0.857 . . . . 0.0 112.238 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.05 173.57 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.25 1.42 . . . . 0.0 113.374 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.19 -31.34 62.62 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.91 40.03 0.11 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.086 0.85 . . . . 0.0 114.597 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.6 m -142.69 21.65 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.796 1.238 . . . . 0.0 113.518 -169.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -60.01 -41.7 92.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.18 1.792 . . . . 0.0 115.635 -168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -161.91 -33.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -62.8 -11.45 17.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.5 1.92 . . . . 0.0 115.96 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -74.42 -12.53 60.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 55.58 24.57 7.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.83 2.052 . . . . 0.0 114.755 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.364 1.866 . . . . 0.0 113.028 176.471 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.958 0.409 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.98 148.86 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.788 1.635 . . . . 0.0 111.377 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -71.11 41.12 0.06 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 61.34 8.77 2.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.77 2.428 . . . . 0.0 115.484 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.269 3.1 pt20 49.52 19.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.6 68.08 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 m -95.2 -23.61 17.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -64.26 -20.9 66.37 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.68 -5.82 18.32 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -107.79 -28.78 9.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.953 1.301 . . . . 0.0 113.568 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -68.38 -33.56 74.48 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.668 1.187 . . . . 0.0 114.072 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -62.71 -37.84 88.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -167.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -93.78 -31.73 14.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.689 1.596 . . . . 0.0 113.379 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -55.76 -36.23 67.1 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.99 1.316 . . . . 0.0 113.223 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.52 37.3 2.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.578 1.551 . . . . 0.0 112.481 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 125.09 19.58 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.98 1.712 . . . . 0.0 112.765 -174.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . 0.267 0.0 OUTLIER 62.55 4.4 1.35 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 165.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -52.25 -40.25 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.499 1.52 . . . . 0.0 114.606 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -99.84 -67.36 0.85 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.708 0.803 . . . . 0.0 110.981 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 p -133.35 -64.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.85 1.26 . . . . 0.0 112.822 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.61 -44.82 5.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.573 1.549 . . . . 0.0 112.802 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.8 mt -153.65 151.15 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.53 2.332 . . . . 0.0 107.008 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.7 m -55.03 144.7 22.59 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.912 1.233 . . . . 0.0 113.635 171.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.34 -1.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.254 2.621 . . . . 0.0 116.51 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -112.74 -26.66 8.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.352 1.861 . . . . 0.0 112.021 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -98.8 -30.75 12.23 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.273 1.829 . . . . 0.0 115.066 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 11.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.266 2.626 . . . . 0.0 117.31 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -45.12 -25.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.177 2.591 . . . . 0.0 115.386 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -50.78 -27.78 7.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.053 1.341 . . . . 0.0 113.924 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -95.69 -23.03 17.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.79 1.636 . . . . 0.0 113.95 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.3 mt -74.91 -34.4 62.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.051 1.341 . . . . 0.0 112.562 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.45 86.68 2.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.668 1.987 . . . . 0.0 108.172 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -48.47 123.64 6.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.44 1.496 . . . . 0.0 112.705 -168.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt 44.98 30.36 0.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.759 2.024 . . . . 0.0 114.818 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.308 4.0 p-10 46.39 32.34 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.876 2.07 . . . . 0.0 114.859 -170.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -82.36 154.45 25.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.45 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.45 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -71.13 165.67 23.06 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.3 mt -114.24 -174.1 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.742 1.617 . . . . 0.0 110.465 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -57.57 147.03 62.35 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.61 -7.36 16.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.487 2.791 . . . . 0.0 115.22 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 27.7 pt -65.15 -18.39 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.307 2.243 . . . . 0.0 114.221 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.92 -33.05 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.57 -11.9 56.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.27 28.28 0.74 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.51 -178.99 41.07 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.469 1.033 . . . . 0.0 114.408 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 m -140.22 30.25 1.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.964 1.706 . . . . 0.0 111.789 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -129.04 34.37 4.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.955 2.102 . . . . 0.0 111.869 -169.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -46.94 -46.43 21.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.708 2.403 . . . . 0.0 113.924 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -161.73 -178.83 6.78 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.554 1.942 . . . . 0.0 111.007 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.9 50.32 1.84 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.939 2.096 . . . . 0.0 110.639 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -56.11 -23.83 36.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 70.4 t60 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.585 1.554 . . . . 0.0 111.73 -178.367 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.534 -0.172 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.6 148.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 126.73 2.012 . . . . 0.0 109.929 -174.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -71.95 44.98 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 62.81 157.3 0.06 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.565 2.746 . . . . 0.0 115.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.447 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.26 12.05 4.77 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -169.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.45 -57.39 10.02 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 m -64.39 -21.43 66.63 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.932 -1.105 . . . . 0.0 113.872 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.6 ttpt -62.13 -22.3 65.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.457 1.103 . . . . 0.0 112.658 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.66 -32.87 6.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.211 1.004 . . . . 0.0 112.91 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.33 -28.03 64.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -74.62 -40.69 61.39 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.137 -0.977 . . . . 0.0 111.62 168.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -54.59 -36.01 63.97 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -166.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -63.09 -12.67 28.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.42 -10.72 58.93 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.634 1.106 . . . . 0.0 113.782 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.16 46.19 0.39 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.999 1.72 . . . . 0.0 114.708 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.44 -37.87 73.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.939 1.296 . . . . 0.0 114.147 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.42 -9.35 0.27 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 p -70.07 -13.37 62.18 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.611 1.565 . . . . 0.0 114.366 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.4 ' HA ' ' CG ' ' A' ' 58' ' ' TYR . 52.2 mt-30 -58.61 -28.61 65.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.0 m -72.61 -5.2 35.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.625 1.57 . . . . 0.0 114.824 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.3 68.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.5 mt -144.08 -65.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.036 1.334 . . . . 0.0 108.677 -170.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -168.09 150.78 5.57 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.878 2.471 . . . . 0.0 108.434 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.46 -6.28 2.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.706 1.603 . . . . 0.0 114.891 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -114.31 -1.24 13.61 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 112.464 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -120.99 -39.37 2.72 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.355 1.862 . . . . 0.0 114.773 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.4 ' CG ' ' HA ' ' A' ' 50' ' ' GLN . 19.1 p90 -51.21 -34.34 31.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.05 -25.83 67.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.518 1.127 . . . . 0.0 113.406 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -63.11 -18.52 63.51 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.9 m -92.49 -10.96 35.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.954 1.301 . . . . 0.0 113.292 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -100.84 -37.33 8.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.455 1.502 . . . . 0.0 112.778 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.48 179.53 9.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.439 1.496 . . . . 0.0 111.843 -172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.92 172.4 12.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.618 1.167 . . . . 0.0 111.704 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -77.76 2.49 16.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.839 1.656 . . . . 0.0 114.801 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.0 t0 58.02 50.58 9.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.995 1.318 . . . . 0.0 113.218 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -79.18 149.88 31.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.57 126.46 31.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.54 -175.66 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.029 1.732 . . . . 0.0 111.689 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -56.1 156.26 10.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 121.507 -0.745 . . . . 0.0 111.248 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -82.54 7.87 4.89 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 114.676 -168.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 pt -61.2 -22.44 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.77 2.028 . . . . 0.0 114.747 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -80.74 53.11 1.83 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.914 2.086 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.84 50.75 18.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.804 2.042 . . . . 0.0 114.898 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -133.34 -24.31 1.83 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.26 42.83 0.08 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 126.798 2.142 . . . . 0.0 110.968 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 p -71.58 1.44 6.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.612 2.365 . . . . 0.0 116.342 -169.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.17 158.89 43.9 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.961 1.304 . . . . 0.0 112.286 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 t60 48.05 36.84 6.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.275 1.83 . . . . 0.0 113.804 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -124.5 -11.05 7.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.276 1.83 . . . . 0.0 113.505 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -145.67 38.26 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.965 2.106 . . . . 0.0 109.791 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -137.7 144.6 41.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.621 1.568 . . . . 0.0 112.006 -167.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 125.949 1.7 . . . . 0.0 111.796 177.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.705 0.288 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.3 t -85.62 152.1 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.005 2.122 . . . . 0.0 112.138 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.71 -19.25 62.08 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.7 t70 58.34 -34.32 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 130.262 3.425 . . . . 0.0 117.175 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -155.52 24.19 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -167.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.01 74.18 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.744 -1.223 . . . . 0.0 112.736 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -97.58 -27.51 14.37 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -66.31 -16.26 63.89 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.485 1.114 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -94.71 -37.33 11.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.6 -0.688 . . . . 0.0 111.798 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -33.26 75.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.618 1.167 . . . . 0.0 113.959 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.19 -8.76 59.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -55.42 -43.16 75.05 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -165.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.5 m -80.29 -25.04 39.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.076 0.95 . . . . 0.0 113.224 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -73.84 -15.8 61.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.29 -7.19 8.6 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.63 176.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.955 1.302 . . . . 0.0 112.95 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -27.76 -46.6 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 129.038 2.935 . . . . 0.0 117.247 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -65.14 -10.99 35.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -55.45 -14.4 1.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.308 1.843 . . . . 0.0 114.761 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -54.79 -28.84 52.0 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.514 -1.366 . . . . 0.0 114.588 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.84 -19.99 47.07 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mt 69.54 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 129.678 3.191 . . . . 0.0 109.461 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 m -60.53 155.39 18.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.985 1.314 . . . . 0.0 112.964 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.83 -6.84 2.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -124.62 8.05 8.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.087 0.955 . . . . 0.0 111.989 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -110.91 -44.74 3.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.934 2.093 . . . . 0.0 112.538 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -23.72 66.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.054 1.342 . . . . 0.0 113.98 -173.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.7 -10.97 57.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.305 1.442 . . . . 0.0 113.676 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.2 p -61.19 -21.8 64.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.413 1.006 . . . . 0.0 113.246 169.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -82.8 -18.55 40.16 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.232 1.013 . . . . 0.0 113.548 170.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.45 -28.93 11.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.379 1.872 . . . . 0.0 113.972 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.52 174.31 11.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.734 1.614 . . . . 0.0 112.816 -168.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -172.21 4.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.829 1.652 . . . . 0.0 113.043 -169.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.3 mt -71.72 54.56 0.25 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.583 2.353 . . . . 0.0 113.856 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 60.52 36.14 20.05 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.083 1.753 . . . . 0.0 112.619 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -79.96 147.59 31.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.457 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.447 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.447 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.24 139.69 54.46 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.05 -71.2 0.44 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.765 0.826 . . . . 0.0 109.846 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -136.22 157.95 74.58 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.16 1.384 . . . . 0.0 109.243 166.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.9 29.97 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.067 3.178 . . . . 0.0 113.4 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.1 pt -138.69 0.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.893 2.077 . . . . 0.0 113.999 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -63.13 114.63 3.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.136 0.974 . . . . 0.0 111.848 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -156.02 175.13 14.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.237 1.815 . . . . 0.0 112.087 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -134.05 144.52 48.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 111.85 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.66 -169.1 42.25 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.561 1.077 . . . . 0.0 113.443 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.8 p -146.31 162.05 38.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.253 1.421 . . . . 0.0 112.232 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -132.72 -16.78 2.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.241 1.416 . . . . 0.0 113.941 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -149.78 159.1 44.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.861 1.664 . . . . 0.0 110.703 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -134.93 23.95 3.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.864 1.266 . . . . 0.0 112.87 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 66.2 8.06 5.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.595 2.358 . . . . 0.0 116.157 171.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -70.39 159.29 34.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.807 1.243 . . . . 0.0 112.231 169.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.248 1.819 . . . . 0.0 111.598 179.402 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.475 0.178 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.1 t -85.75 145.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.358 0.663 . . . . 0.0 110.599 170.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -61.14 -41.13 96.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.43 168.0 13.36 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.609 1.964 . . . . 0.0 111.305 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.426 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -135.44 16.53 3.4 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.01 92.63 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -90.42 -6.48 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.612 1.165 . . . . 0.0 113.745 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.7 ttpt -64.28 -41.39 96.91 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.213 0.915 . . . . 0.0 113.055 -169.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.22 -34.14 56.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -78.81 -40.18 33.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.8 -36.09 57.18 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -59.18 -29.08 67.2 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -58.37 -24.22 59.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.059 1.344 . . . . 0.0 113.746 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.54 -22.73 56.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 113.84 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -20.85 47.53 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.96 -33.07 74.98 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -158.77 -11.96 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -166.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.4 m -134.64 -28.22 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -169.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.6 -23.42 67.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.989 -1.069 . . . . 0.0 113.014 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.6 p -69.2 -10.25 56.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.487 1.915 . . . . 0.0 114.8 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.82 -161.53 0.17 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.243 0.929 . . . . 0.0 112.404 174.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mt -131.16 18.69 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.971 1.309 . . . . 0.0 111.86 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.8 m -60.75 143.15 55.05 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.639 -1.288 . . . . 0.0 110.901 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -58.55 -6.81 0.77 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -126.67 0.28 6.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.066 0.947 . . . . 0.0 112.95 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -105.69 -44.63 4.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.321 . . . . 0.0 111.329 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.28 -25.16 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.314 1.445 . . . . 0.0 114.85 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.48 -1.26 26.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.3 p -55.79 -25.89 43.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.5 p -102.92 -9.94 19.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.704 1.602 . . . . 0.0 114.32 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.83 -23.45 18.13 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.742 1.617 . . . . 0.0 112.748 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.49 179.98 6.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.423 1.489 . . . . 0.0 112.817 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.3 p -130.51 178.64 6.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.76 1.624 . . . . 0.0 112.11 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.92 58.13 2.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.195 2.198 . . . . 0.0 112.669 -172.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 58.87 35.31 24.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.165 1.386 . . . . 0.0 113.75 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -90.04 155.79 18.83 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.467 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.474 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.1 142.45 42.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.04 168.64 3.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.989 0.9 . . . . 0.0 112.736 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -63.2 156.01 70.96 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -97.38 14.53 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.878 3.719 . . . . 0.0 113.569 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 pt -66.07 -15.1 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.044 1.738 . . . . 0.0 114.169 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -78.82 45.38 0.6 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.254 2.222 . . . . 0.0 112.344 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 51.85 46.92 25.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 114.088 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.42 1.34 3.43 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.01 -23.84 0.16 Allowed Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.826 1.091 . . . . 0.0 115.826 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -133.65 47.21 2.48 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.998 1.399 . . . . 0.0 112.869 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -144.79 148.69 34.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.181 1.392 . . . . 0.0 110.992 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -156.81 176.58 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.756 1.622 . . . . 0.0 111.039 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -141.87 133.18 26.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.227 1.011 . . . . 0.0 111.669 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -153.85 9.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -126.34 2.26 7.03 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.818 1.247 . . . . 0.0 112.274 174.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.628 0.252 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -91.45 151.08 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.371 1.869 . . . . 0.0 111.953 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -70.57 35.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.5 t0 50.5 95.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 129.218 3.007 . . . . 0.0 114.864 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -67.88 3.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.31 -38.65 13.12 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 120.387 1.448 . . . . 0.0 114.402 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -71.02 -25.15 62.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -65.57 -32.99 74.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.737 1.153 . . . . 0.0 112.499 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.06 -25.58 68.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 113.356 170.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -107.31 -10.43 15.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.646 1.578 . . . . 0.0 114.148 -171.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -60.29 -19.57 55.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -54.53 -27.54 39.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -166.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.6 p -59.95 -36.67 77.59 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.099 0.96 . . . . 0.0 113.452 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.56 -22.62 67.02 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.882 1.673 . . . . 0.0 113.295 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.32 -7.59 50.37 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.82 -44.62 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.788 1.635 . . . . 0.0 113.089 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -159.63 165.77 32.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.112 1.365 . . . . 0.0 111.569 -168.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m 53.17 26.34 4.96 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.21 -12.72 54.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.21 1.404 . . . . 0.0 113.596 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -55.36 -20.25 11.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.65 1.98 . . . . 0.0 115.898 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.38 66.21 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 mm 64.89 -67.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 128.768 2.827 . . . . 0.0 113.031 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 m 60.07 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 112.903 -168.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -54.76 2.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 130.399 3.48 . . . . 0.0 118.185 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -124.75 -14.57 6.71 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.28 2.632 . . . . 0.0 113.016 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.76 -34.06 6.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.86 2.064 . . . . 0.0 113.44 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -58.24 -31.13 67.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.64 124.57 7.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.924 0.89 . . . . 0.0 112.233 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m -70.54 -16.42 62.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 m -103.53 -38.84 6.98 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.715 1.206 . . . . 0.0 112.336 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -16.9 63.0 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.076 1.35 . . . . 0.0 114.398 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.68 147.23 32.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.05 1.34 . . . . 0.0 111.28 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -178.09 2.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.679 1.592 . . . . 0.0 112.603 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' H ' ' CD2' ' A' ' 65' ' ' LEU 0.263 0.2 OUTLIER -60.97 49.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.986 2.914 . . . . 0.0 115.514 167.633 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.36 0.4 OUTLIER 47.24 35.01 3.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.314 3.046 . . . . 0.0 118.15 177.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -97.1 159.99 14.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.73 135.79 56.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.49 -67.06 0.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.175 0.99 . . . . 0.0 111.873 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -139.15 157.07 71.81 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.274 1.43 . . . . 0.0 109.99 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -86.58 4.82 6.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.602 2.868 . . . . 0.0 113.692 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 pt -91.0 6.9 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 127.223 2.209 . . . . 0.0 113.295 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -101.94 27.7 6.33 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.925 2.09 . . . . 0.0 111.835 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.14 159.33 44.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.469 2.307 . . . . 0.0 110.988 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.9 t70 60.99 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.686 2.794 . . . . 0.0 118.058 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.59 -174.2 43.74 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.473 -1.392 . . . . 0.0 114.112 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 m -132.22 5.74 4.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.742 1.217 . . . . 0.0 114.252 -171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -147.02 69.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.655 1.582 . . . . 0.0 110.098 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -61.44 -26.79 68.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -172.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -152.47 157.64 41.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.484 . . . . 0.0 111.286 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -75.17 174.55 9.29 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -135.8 11.32 3.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.884 1.274 . . . . 0.0 113.748 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.119 1.768 . . . . 0.0 113.445 179.667 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.15 149.91 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.026 1.73 . . . . 0.0 111.393 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -64.67 -42.12 95.59 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -156.02 -6.05 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.477 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 52.26 13.45 0.28 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -46.35 89.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.368 0.986 . . . . 0.0 113.08 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 m -75.24 -17.0 60.42 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 38.8 ttpt -62.76 -35.81 81.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.534 1.061 . . . . 0.0 112.469 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.19 0.996 . . . . 0.0 113.525 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -107.42 -40.22 5.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -92.91 -38.76 11.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 113.963 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -62.86 -22.01 66.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -166.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -69.78 -15.0 63.05 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.02 -39.18 8.66 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.687 1.195 . . . . 0.0 112.345 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.86 59.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.414 1.086 . . . . 0.0 113.631 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.254 4.3 mm? 60.62 159.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.887 2.875 . . . . 0.0 114.895 -167.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -74.16 -43.3 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.477 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.7 p -71.63 146.01 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -64.61 -30.01 71.02 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.49 -0.756 . . . . 0.0 112.456 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.1 m -69.22 -12.83 62.01 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.49 65.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.58 135.72 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.273 1.429 . . . . 0.0 109.617 -167.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.6 m -77.48 163.16 26.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -58.97 -6.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.891 2.076 . . . . 0.0 116.591 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -124.51 -1.62 8.02 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.549 -0.719 . . . . 0.0 112.297 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -98.24 -40.76 8.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.691 1.996 . . . . 0.0 112.396 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -63.81 -8.9 12.12 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.97 -22.72 60.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.817 -1.177 . . . . 0.0 112.644 168.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.5 m -67.18 -49.09 65.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.515 -0.741 . . . . 0.0 110.688 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 m -60.9 -34.22 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.43 1.492 . . . . 0.0 113.544 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.69 -15.25 61.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.302 1.841 . . . . 0.0 114.317 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.52 39.74 1.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 -168.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 t -147.49 -174.75 4.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.894 1.678 . . . . 0.0 110.909 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.0 mt 55.76 25.03 7.87 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.572 1.078 . . . . 0.0 112.589 -170.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.255 3.5 t0 58.91 36.65 24.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.531 2.332 . . . . 0.0 114.113 -169.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.37 144.18 48.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.415 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.469 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.469 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -75.72 152.04 37.53 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.88 -62.6 1.0 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.217 1.407 . . . . 0.0 108.606 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -133.25 162.96 54.49 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 126.411 1.884 . . . . 0.0 107.822 165.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.98 13.15 2.79 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.722 2.948 . . . . 0.0 113.704 -173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.8 pt -141.9 21.28 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.458 2.303 . . . . 0.0 111.358 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -11.53 56.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.492 -1.38 . . . . 0.0 114.389 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.15 68.19 3.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.385 1.088 . . . . 0.0 111.331 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.35 126.69 28.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 0.0 112.431 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.21 -12.37 61.94 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.82 1.2 . . . . 0.0 113.872 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -105.08 15.03 28.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.079 1.352 . . . . 0.0 113.095 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -155.11 -179.47 8.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.84 2.056 . . . . 0.0 110.912 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -142.9 157.08 44.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.873 1.269 . . . . 0.0 111.331 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.82 172.32 18.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.665 1.586 . . . . 0.0 111.292 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -65.47 -19.86 66.11 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.899 -1.126 . . . . 0.0 113.936 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 56.03 36.33 27.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.623 1.969 . . . . 0.0 113.731 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.064 2.146 . . . . 0.0 111.787 179.118 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.423 ' HA ' ' HB ' ' A' ' 100' ' ' THR . 1.7 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.94 110.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.406 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.436 HG21 ' CD2' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -74.64 38.75 0.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t0 50.86 107.01 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 129.294 3.038 . . . . 0.0 115.881 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.456 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.09 17.65 6.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.352 1.861 . . . . 0.0 113.68 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.34 82.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -78.16 -14.32 59.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.8 ttpt -63.84 -44.48 93.07 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.014 0.925 . . . . 0.0 112.3 -171.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.84 -46.84 56.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.203 0.601 . . . . 0.0 111.301 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.11 -32.87 74.58 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -72.07 -55.66 6.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.654 0.781 . . . . 0.0 111.273 169.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -67.92 -29.81 68.97 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -167.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.5 p -50.87 -34.16 26.98 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.064 1.346 . . . . 0.0 113.875 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -73.67 -9.09 58.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.22 1.808 . . . . 0.0 114.855 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 15.21 1.57 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.9 mt -54.74 152.77 6.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.059 0.943 . . . . 0.0 113.347 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 62.17 -23.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -66.42 149.23 50.72 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.699 1.136 . . . . 0.0 112.214 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -57.45 -26.63 61.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.039 0.936 . . . . 0.0 113.457 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 p -59.4 -56.16 25.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.669 1.188 . . . . 0.0 112.47 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.13 63.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.0 -6.8 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.454 1.901 . . . . 0.0 111.912 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -60.46 146.09 45.94 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.683 -1.26 . . . . 0.0 112.055 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.43 ' HA ' ' CD2' ' A' ' 58' ' ' TYR 0.328 2.5 tt0 -62.38 -5.94 2.87 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -170.598 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -105.25 -13.93 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.79 -1.819 . . . . 0.0 113.603 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -98.45 -33.11 11.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.101 1.761 . . . . 0.0 114.057 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.43 ' CD2' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -66.12 1.59 1.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 118.416 2.747 . . . . 0.0 118.416 -167.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.5 -33.4 65.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -67.02 -12.93 61.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -102.62 -5.6 23.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.5 1.52 . . . . 0.0 113.431 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.01 -6.28 57.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.819 1.648 . . . . 0.0 113.434 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 171.25 17.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.247 1.419 . . . . 0.0 112.603 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.63 -177.26 0.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.244 1.817 . . . . 0.0 112.315 175.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' H ' HG22 ' A' ' 64' ' ' THR . 59.4 mt -64.97 21.66 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 128.222 2.609 . . . . 0.0 115.427 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.2 p30 48.66 31.25 2.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.606 2.363 . . . . 0.0 116.198 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -77.62 161.75 27.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD2' HG21 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 1' ' ' ASP . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.11 144.55 53.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.59 -72.57 0.26 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.074 1.35 . . . . 0.0 111.819 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -135.69 157.56 75.97 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.219 1.408 . . . . 0.0 111.121 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.96 0.37 9.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.415 2.743 . . . . 0.0 114.46 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 pt -72.79 -2.55 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.305 1.842 . . . . 0.0 114.215 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -121.11 -47.2 2.28 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.286 1.834 . . . . 0.0 111.138 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.87 143.57 8.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 108.807 170.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -84.07 50.03 1.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.704 -1.247 . . . . 0.0 112.435 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.98 32.89 56.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.354 0.978 . . . . 0.0 113.236 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.4 t -156.92 168.45 27.45 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 110.514 -168.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -67.64 -4.47 12.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.538 1.135 . . . . 0.0 113.556 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -139.94 172.73 12.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.18 2.192 . . . . 0.0 111.368 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -78.41 18.32 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.285 1.834 . . . . 0.0 113.799 172.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -146.97 159.42 43.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.223 1.809 . . . . 0.0 110.902 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -73.54 -4.86 36.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.594 1.558 . . . . 0.0 114.756 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.772 1.629 . . . . 0.0 112.713 -175.795 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -136.63 141.03 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.843 1.657 . . . . 0.0 110.665 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.505 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.78 -43.29 99.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.75 173.36 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.674 2.389 . . . . 0.0 110.719 -176.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.83 16.77 3.3 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.7 73.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.616 -0.678 . . . . 0.0 111.279 169.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.8 m -93.95 -5.43 47.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.132 1.373 . . . . 0.0 114.301 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -64.19 -17.71 63.79 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.073 1.306 . . . . 0.0 113.937 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.11 -40.14 6.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.25 1.02 . . . . 0.0 111.896 167.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -74.98 -19.53 60.06 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -170.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -54.88 -28.07 47.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.262 1.425 . . . . 0.0 114.413 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -57.63 -40.88 80.23 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 m -72.33 -27.11 62.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.51 -36.12 81.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -7.1 59.65 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 mt -74.38 134.28 42.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -12.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 N-CA-C 122.411 4.226 . . . . 0.0 122.411 161.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -147.07 -174.9 4.62 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.919 1.69 . . . . 0.0 112.694 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.55 -22.57 8.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.025 2.13 . . . . 0.0 114.661 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.4 m -52.72 -25.17 10.29 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.76 64.67 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.35 -13.56 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 m -58.18 128.55 37.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.69 -6.35 1.15 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -168.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -117.76 -1.71 11.52 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.164 1.386 . . . . 0.0 113.238 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.55 -30.76 3.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 114.434 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 2.53 0.21 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.87 -28.04 63.81 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 m -60.53 -33.71 73.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.635 0.774 . . . . 0.0 112.977 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -81.07 -30.23 34.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.543 1.537 . . . . 0.0 112.96 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.67 -40.3 63.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.64 1.176 . . . . 0.0 112.965 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.14 87.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.304 1.441 . . . . 0.0 111.405 -169.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 m -52.71 129.57 30.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.017 0.927 . . . . 0.0 110.769 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt 39.53 38.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.448 1.899 . . . . 0.0 114.327 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.43 27.25 16.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.347 1.459 . . . . 0.0 113.714 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -92.29 153.56 19.16 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.471 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.415 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -87.97 138.37 31.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.99 -174.39 3.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.248 2.219 . . . . 0.0 109.602 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -55.34 155.65 9.31 Favored Pre-proline 0 CA--C 1.557 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 112.039 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.04 10.27 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.646 2.897 . . . . 0.0 114.719 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 pt -62.06 -14.98 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.132 1.773 . . . . 0.0 114.622 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.505 ' CE1' ' HE3' ' A' ' 22' ' ' LYS . 28.7 m-85 -89.83 5.39 46.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.816 2.046 . . . . 0.0 113.674 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.63 15.7 8.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.878 1.671 . . . . 0.0 114.131 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -154.7 162.21 41.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 0.0 112.066 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.72 22.06 0.1 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.76 2.124 . . . . 0.0 113.015 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.5 m -61.62 -19.39 62.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.59 1.556 . . . . 0.0 114.639 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -0.34 56.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.653 1.981 . . . . 0.0 114.114 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.9 m80 50.08 29.14 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.337 1.855 . . . . 0.0 113.768 -172.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.6 t60 56.45 18.53 3.54 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.05 2.14 . . . . 0.0 115.587 -173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.04 161.29 31.38 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.152 -0.968 . . . . 0.0 112.048 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -147.72 168.83 21.09 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.304 1.441 . . . . 0.0 111.186 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.596 1.558 . . . . 0.0 112.261 -171.481 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.54 149.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.005 1.275 . . . . 0.0 113.576 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -58.65 -26.49 63.83 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 167.92 141.6 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 128.229 2.611 . . . . 0.0 109.389 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -67.93 145.31 54.68 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -170.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.46 -66.32 1.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 165.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 m -61.86 -26.56 68.21 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.834 -1.166 . . . . 0.0 113.845 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -66.87 -24.75 66.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 111.967 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.86 -49.23 6.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.676 1.19 . . . . 0.0 110.016 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.26 -35.34 79.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -167.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -57.61 -38.49 75.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.884 0.766 . . . . 0.0 112.186 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -74.36 -32.07 62.63 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.917 -172.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.4 m -62.03 -32.8 73.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.454 1.102 . . . . 0.0 113.453 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.62 -24.63 49.38 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.641 1.176 . . . . 0.0 114.164 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -10.69 59.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.853 1.261 . . . . 0.0 114.327 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.89 -49.38 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.508 1.523 . . . . 0.0 113.825 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -160.77 159.67 30.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.309 1.043 . . . . 0.0 113.122 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -108.23 -7.45 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.651 1.181 . . . . 0.0 113.493 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -60.3 -23.02 63.84 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 0.0 113.658 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 m -56.77 -16.89 7.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.501 1.52 . . . . 0.0 114.09 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.88 18.13 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -94.82 -16.35 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.25 1.82 . . . . 0.0 112.035 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -62.51 140.34 58.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.49 1.116 . . . . 0.0 112.794 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.62 -6.01 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -168.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -130.65 1.42 4.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.787 1.635 . . . . 0.0 113.311 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.92 -37.37 5.13 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.263 2.225 . . . . 0.0 112.71 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.46 -17.76 60.23 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.05 7.45 33.96 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 114.021 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.9 m -57.01 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.522 -1.361 . . . . 0.0 113.072 171.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -73.32 -20.17 60.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 114.333 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.4 mt -102.34 -30.61 10.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.223 1.809 . . . . 0.0 113.413 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 6.75 2.61 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m 59.11 -71.31 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.322 2.649 . . . . 0.0 115.534 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -144.48 8.51 1.35 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.773 2.829 . . . . 0.0 113.011 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.2 44.85 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.333 1.453 . . . . 0.0 113.359 -174.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -77.92 151.63 33.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -101.55 110.9 22.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.59 174.63 1.28 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.043 1.737 . . . . 0.0 112.904 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -55.28 158.59 5.17 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.415 1.086 . . . . 0.0 112.305 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.86 5.47 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.533 2.822 . . . . 0.0 115.525 -168.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.4 pt -101.62 -2.5 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.133 2.173 . . . . 0.0 112.922 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -134.63 -21.69 1.72 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.092 1.757 . . . . 0.0 113.343 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.86 165.9 34.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.976 1.71 . . . . 0.0 111.232 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.17 -27.72 9.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.67 -166.91 25.99 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.68 1.134 . . . . 0.0 115.411 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.1 m -69.38 147.01 51.62 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.484 -1.01 . . . . 0.0 109.601 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -135.57 178.52 6.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -170.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -141.06 166.16 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.366 1.867 . . . . 0.0 110.932 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -58.98 -23.24 61.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.539 1.536 . . . . 0.0 114.611 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.38 8.4 43.32 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.902 1.281 . . . . 0.0 114.071 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -74.65 65.96 1.38 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.244 1.418 . . . . 0.0 112.567 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.76 2.024 . . . . 0.0 111.784 -173.45 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.637 0.256 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.25 149.68 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.969 1.708 . . . . 0.0 111.693 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' H ' ' HG3' ' A' ' 24' ' ' LYS . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.21 -36.3 83.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.78 165.15 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.546 1.939 . . . . 0.0 110.895 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.421 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.47 12.04 5.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.597 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.47 89.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.005 0.922 . . . . 0.0 112.943 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.8 m -84.41 -7.43 59.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.1 ttpt -62.54 -35.0 78.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.302 1.41 . . . . 0.0 113.763 -169.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 -42.44 41.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.373 0.669 . . . . 0.0 112.507 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -73.79 -31.56 63.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.41 1.084 . . . . 0.0 113.47 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.9 -17.45 64.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 114.217 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.75 -29.72 66.97 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -166.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.6 p -60.83 -26.56 67.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 114.188 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -97.47 -25.52 15.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 0.0 112.233 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.41 1.24 6.6 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.216 1.406 . . . . 0.0 114.404 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.06 154.38 0.78 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.126 2.171 . . . . 0.0 116.028 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 24.1 -68.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.031 1 C-N-CA 132.332 4.253 . . . . 0.0 117.342 167.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -54.86 -33.06 61.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.291 1.405 . . . . 0.0 113.625 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -99.18 -32.49 11.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.495 1.118 . . . . 0.0 112.702 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 m -59.48 -26.01 64.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.737 1.153 . . . . 0.0 113.797 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.17 -21.96 64.27 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.287 1.0 OUTLIER 67.26 -52.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.298 2.639 . . . . 0.0 115.97 177.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m 53.77 103.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.459 1.904 . . . . 0.0 113.195 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.59 -6.02 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.913 2.085 . . . . 0.0 116.378 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -114.43 -2.31 13.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.286 1.435 . . . . 0.0 112.764 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.75 -34.62 4.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.868 2.067 . . . . 0.0 114.164 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -17.26 8.45 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.52 -18.32 64.99 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.314 0.961 . . . . 0.0 113.117 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -73.85 -41.8 61.73 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 167.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -60.11 -27.01 66.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.87 1.268 . . . . 0.0 113.685 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.58 -15.9 59.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.82 1.648 . . . . 0.0 114.461 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 41.62 1.06 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.757 1.223 . . . . 0.0 112.301 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -140.33 -55.39 0.53 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.39 -41.16 72.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.426 2.29 . . . . 0.0 115.527 -165.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -164.02 28.96 0.08 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.494 2.317 . . . . 0.0 110.784 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -112.01 161.14 16.78 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.472 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -71.27 1.09 6.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 -101.99 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.099 1.759 . . . . 0.0 110.921 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -131.84 155.6 81.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.268 1.027 . . . . 0.0 110.634 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.27 12.48 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.291 3.328 . . . . 0.0 113.713 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.66 -4.56 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.11 2.564 . . . . 0.0 112.869 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -80.19 -3.26 48.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.203 1.401 . . . . 0.0 113.82 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.37 -26.08 67.59 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -155.78 159.24 39.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.514 0.726 . . . . 0.0 112.698 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.31 -42.81 0.4 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.472 1.511 . . . . 0.0 112.662 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.7 t -159.92 152.79 21.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.319 1.848 . . . . 0.0 110.371 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -88.67 -21.69 23.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.184 1.394 . . . . 0.0 112.819 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 58.2 -1.45 0.09 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.914 2.486 . . . . 0.0 117.094 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -135.74 18.74 3.29 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.995 1.718 . . . . 0.0 112.239 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.78 172.92 15.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.464 2.306 . . . . 0.0 109.868 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -72.52 46.37 0.15 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.649 1.98 . . . . 0.0 113.792 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.617 1.967 . . . . 0.0 110.746 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.67 152.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.445 1.498 . . . . 0.0 112.264 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.414 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -65.36 -49.9 67.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -166.52 173.39 9.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.799 2.44 . . . . 0.0 110.863 172.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.0 13.52 15.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -169.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.74 95.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.814 1.188 . . . . 0.0 112.08 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -59.72 -26.91 66.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.421 1.088 . . . . 0.0 113.851 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -68.37 -13.34 62.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.379 1.071 . . . . 0.0 113.865 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.78 -38.24 6.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -80.19 -23.36 41.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -49.58 -48.44 48.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.295 1.438 . . . . 0.0 114.002 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.0 ttp-105 -62.53 -41.81 99.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.623 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.1 m -77.34 -44.26 30.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.581 1.152 . . . . 0.0 112.902 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.01 -36.36 83.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.18 -0.95 . . . . 0.0 112.792 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.89 -10.83 52.82 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.71 -20.02 66.12 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -159.47 177.55 10.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.713 0.805 . . . . 0.0 112.511 -166.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 p -54.96 -16.97 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.436 . . . . 0.0 114.395 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -57.81 -11.77 2.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 115.614 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -60.06 -26.96 66.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.38 62.99 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.5 mt 66.3 -71.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.664 2.386 . . . . 0.0 112.809 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m -176.87 154.36 1.13 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.459 2.704 . . . . 0.0 109.394 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -59.29 -4.35 0.54 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -105.23 -14.33 15.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.857 1.663 . . . . 0.0 113.025 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -115.02 -29.24 6.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.008 2.123 . . . . 0.0 114.513 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -10.98 1.3 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.068 2.147 . . . . 0.0 116.483 -171.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -56.6 -26.09 54.59 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.712 -1.242 . . . . 0.0 112.762 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -62.06 -26.96 68.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.621 1.568 . . . . 0.0 112.775 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 m -103.58 -18.68 14.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.475 1.91 . . . . 0.0 114.391 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.39 -26.24 67.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.987 1.315 . . . . 0.0 113.392 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.72 132.79 19.27 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.102 1.361 . . . . 0.0 110.677 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 t -60.04 134.24 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.321 0.649 . . . . 0.0 112.307 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.2 mt 47.28 24.22 0.42 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.867 1.667 . . . . 0.0 113.833 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 3.9 t0 46.38 36.27 3.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.913 2.085 . . . . 0.0 114.364 -166.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -80.78 149.7 29.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.307 1.043 . . . . 0.0 112.646 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG2' ' H ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.412 ' H ' ' CG2' ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.53 -15.54 62.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.8 mt 60.54 -89.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.926 1.69 . . . . 0.0 110.615 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.31 159.8 66.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.677 1.991 . . . . 0.0 109.915 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -3.2 13.23 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.922 2.415 . . . . 0.0 115.147 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 pt -63.58 -13.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.594 1.958 . . . . 0.0 114.474 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -90.45 -2.32 57.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.375 1.47 . . . . 0.0 112.833 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.03 16.28 6.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.386 1.874 . . . . 0.0 113.35 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -156.68 165.08 37.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.753 1.221 . . . . 0.0 111.228 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.73 13.01 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.2 m -55.9 -22.6 26.57 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -168.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.19 -18.7 2.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.357 1.463 . . . . 0.0 113.298 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -62.54 -20.19 64.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.526 2.33 . . . . 0.0 113.701 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -65.85 -20.97 66.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 114.56 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.8 m170 45.9 31.2 1.02 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.237 1.815 . . . . 0.0 114.45 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -77.72 -3.04 39.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.82 . . . . 0.0 113.543 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 127.892 2.477 . . . . 0.0 114.077 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.54 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -148.86 161.27 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.916 1.286 . . . . 0.0 111.767 -175.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -60.01 -38.15 81.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.9 162.45 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 127.776 2.431 . . . . 0.0 108.577 -167.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.65 4.56 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.76 83.22 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.995 0.816 . . . . 0.0 110.822 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -64.97 -33.54 76.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.694 0.798 . . . . 0.0 112.201 170.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.57 -42.42 98.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.735 0.814 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.75 -44.08 93.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.278 0.631 . . . . 0.0 111.97 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -68.37 -38.47 81.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.598 0.759 . . . . 0.0 112.927 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -39.47 74.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.064 0.946 . . . . 0.0 111.686 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -65.52 -41.42 93.17 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.6 m -68.93 -35.75 77.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.011 1.325 . . . . 0.0 113.626 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.02 -39.91 87.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.208 1.003 . . . . 0.0 113.059 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.34 -11.29 59.93 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.37 158.26 43.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 112.538 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 58.32 -52.29 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.806 2.843 . . . . 0.0 117.236 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -81.82 29.28 0.39 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.478 1.511 . . . . 0.0 113.14 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -59.73 -31.59 69.77 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.888 1.275 . . . . 0.0 113.486 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.1 m -72.5 -16.0 61.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.033 1.333 . . . . 0.0 114.13 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.45 44.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.61 137.54 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.836 0.743 . . . . 0.0 112.714 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -75.02 149.84 39.11 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.697 -0.627 . . . . 0.0 111.984 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -60.92 -0.53 0.31 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.701 2.0 . . . . 0.0 115.052 172.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -113.88 -16.14 12.26 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.343 1.857 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.45 -37.76 9.46 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.947 1.699 . . . . 0.0 113.306 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -17.98 63.68 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 2.3 p30 41.76 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 131.22 3.808 . . . . 0.0 119.893 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.8 p -62.01 -21.62 65.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 119.952 -1.717 . . . . 0.0 114.477 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -85.9 -18.48 32.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.15 1.38 . . . . 0.0 114.279 170.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.09 -24.18 13.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.206 1.802 . . . . 0.0 113.546 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.85 177.11 8.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.077 1.351 . . . . 0.0 112.216 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.61 -176.9 4.5 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.018 1.327 . . . . 0.0 111.269 -168.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.437 ' H ' HG23 ' A' ' 64' ' ' THR . 52.4 mt -69.59 45.0 0.06 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 128.338 2.655 . . . . 0.0 114.754 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.5 29.38 18.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 114.402 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -95.13 155.05 16.89 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.54 ' H ' HG12 ' A' ' 2' ' ' VAL 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.24 134.89 45.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 mt -71.77 169.96 14.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.067 0.947 . . . . 0.0 113.291 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.37 159.8 63.8 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.865 0.866 . . . . 0.0 110.816 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.23 4.22 7.17 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.931 2.421 . . . . 0.0 114.724 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 pt -57.73 -18.41 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.23 2.212 . . . . 0.0 115.041 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.24 -9.15 59.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.642 1.577 . . . . 0.0 113.852 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.07 -13.0 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.04 163.2 39.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.036 0.835 . . . . 0.0 112.51 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.84 -41.86 1.51 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.234 1.873 . . . . 0.0 114.466 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.3 m -70.85 19.0 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.853 2.461 . . . . 0.0 115.13 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -69.45 176.72 3.25 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.186 1.794 . . . . 0.0 113.359 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -123.14 174.18 7.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.408 1.483 . . . . 0.0 111.569 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -125.67 -0.84 7.41 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -159.86 -51.99 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.754 1.221 . . . . 0.0 111.699 174.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -152.19 167.57 28.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 t60 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.899 1.68 . . . . 0.0 111.695 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.692 0.282 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 88' ' ' TYR . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 70' ' ' ILE . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 . . . . . 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.502 -0.899 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 97' ' ' VAL . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 . . . . . 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 70' ' ' ILE . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 98' ' ' ARG . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 97' ' ' VAL . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 70' ' ' ILE . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 119.79 -0.148 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' C ' HD12 ' A' ' 70' ' ' ILE . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.561 ' N ' HG22 ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 119.508 -0.282 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 70' ' ' ILE . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 97' ' ' VAL . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.5 ' H ' HG12 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.567 0.222 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 70' ' ' ILE . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 88' ' ' TYR . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 70' ' ' ILE . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 73' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 70' ' ' ILE . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 2' ' ' VAL . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 4' ' ' ILE . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.451 HG21 ' HG3' ' A' ' 73' ' ' PRO . 6.1 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 88' ' ' TYR . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HG3' HG21 ' A' ' 2' ' ' VAL . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 4' ' ' ILE . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.437 0.16 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 88' ' ' TYR . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' C ' HD12 ' A' ' 70' ' ' ILE . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 69' ' ' GLU . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 70' ' ' ILE . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 32' ' ' ILE . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 87' ' ' ASP . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 98' ' ' ARG . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 97' ' ' VAL . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 . . . . . 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 4' ' ' ILE . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.508 HD12 HD11 ' A' ' 70' ' ' ILE . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.524 ' C ' HG23 ' A' ' 99' ' ' VAL . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.55 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 70' ' ' ILE . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 32' ' ' ILE . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 99' ' ' VAL . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 70' ' ' ILE . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 99' ' ' VAL . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.508 HG13 ' HB ' ' A' ' 99' ' ' VAL . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 4' ' ' ILE . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 77' ' ' THR 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 119.932 -0.08 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.64 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.823 1.649 . . . . 0.0 111.112 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 88' ' ' TYR . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 70' ' ' ILE . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -71.02 28.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 37.1 -85.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.714 3.605 . . . . 0.0 116.259 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 8.0 4.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.27 89.99 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.132 0.967 . . . . 0.0 110.302 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 m -79.64 -2.21 41.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.78 2.032 . . . . 0.0 114.364 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -54.46 -38.86 66.87 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.76 -24.58 56.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.13 -25.77 14.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.866 1.667 . . . . 0.0 113.646 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.78 -42.15 91.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.704 2.002 . . . . 0.0 114.536 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -60.24 -44.05 95.58 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.3 p -59.23 -50.4 74.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -68.34 -35.47 77.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 -37.69 88.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 0.0 112.99 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.3 -56.9 6.98 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.981 0.913 . . . . 0.0 112.588 169.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -31.51 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -163.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -61.52 -19.44 62.11 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -50.11 -29.23 8.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.345 1.458 . . . . 0.0 114.679 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -77.66 -19.69 54.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.11 -172.77 4.33 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.48 -18.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.006 1.722 . . . . 0.0 111.763 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -57.38 135.46 56.54 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.067 1.347 . . . . 0.0 112.317 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.36 -6.38 0.99 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -168.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.99 -12.98 10.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.312 1.045 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -98.64 -40.98 7.93 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.316 2.246 . . . . 0.0 112.426 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.68 3.83 0.93 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.228 2.211 . . . . 0.0 116.761 -172.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.0 -19.4 52.22 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -167.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -59.9 -27.62 66.88 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.523 -1.36 . . . . 0.0 113.284 169.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.0 m -75.01 -16.92 60.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.5 -34.81 8.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 112.836 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.18 7.27 1.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m 46.23 -138.43 0.58 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.726 1.611 . . . . 0.0 111.506 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -77.1 55.38 1.15 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.854 1.662 . . . . 0.0 111.11 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 63.03 46.06 4.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 113.769 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -100.68 157.07 16.96 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -63.47 139.64 58.79 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.73 -59.75 4.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.098 1.759 . . . . 0.0 112.245 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -139.89 154.7 70.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.19 1.396 . . . . 0.0 111.056 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.2 -9.53 13.94 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.927 2.418 . . . . 0.0 114.715 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.9 pt -65.8 -23.61 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.37 1.468 . . . . 0.0 113.381 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -73.86 5.79 3.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.717 1.607 . . . . 0.0 114.264 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -140.86 -28.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.038 1.335 . . . . 0.0 114.506 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -150.76 30.04 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.284 0.947 . . . . 0.0 113.465 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.83 92.66 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 120.672 -1.267 . . . . 0.0 115.216 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 p -165.56 -35.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -139.78 3.43 2.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.065 1.346 . . . . 0.0 113.675 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -68.43 1.76 2.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.165 2.186 . . . . 0.0 115.076 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -60.81 -11.52 7.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.893 2.077 . . . . 0.0 113.873 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -116.77 16.35 15.31 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.705 2.002 . . . . 0.0 112.506 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -130.76 -7.89 4.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.309 2.244 . . . . 0.0 112.707 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.8 t60 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.264 1.826 . . . . 0.0 112.312 -169.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.82 146.4 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 126.867 2.067 . . . . 0.0 110.307 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -64.78 -7.37 10.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.36 42.33 17.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.088 2.155 . . . . 0.0 112.905 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.22 5.74 10.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -168.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.15 -58.53 5.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.289 1.036 . . . . 0.0 113.079 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -69.58 -25.35 63.94 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.42 -30.92 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.968 0.907 . . . . 0.0 112.302 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.25 -50.04 6.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.061 0.544 . . . . 0.0 111.453 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -69.89 -40.35 75.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -70.67 -39.23 73.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.321 -0.862 . . . . 0.0 111.065 172.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -68.11 -43.76 77.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.103 -169.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -14.88 33.55 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -57.08 -17.69 11.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.042 1.737 . . . . 0.0 114.114 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.62 12.44 1.7 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.414 1.486 . . . . 0.0 113.897 172.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -146.67 177.82 8.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.466 1.506 . . . . 0.0 112.933 -169.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -54.84 162.4 1.26 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.95 1.7 . . . . 0.0 113.597 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.6 p -149.12 164.88 33.41 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.4 -19.78 66.09 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.48 0.712 . . . . 0.0 112.838 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 m -78.96 -6.73 57.0 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.98 -20.0 61.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.35 160.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.729 2.012 . . . . 0.0 110.669 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.8 m -44.01 135.82 4.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.581 1.552 . . . . 0.0 113.57 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.19 0.71 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.899 2.48 . . . . 0.0 116.133 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -113.68 -24.73 9.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.379 1.872 . . . . 0.0 112.6 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -98.92 -37.37 9.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 113.276 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -8.75 6.63 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.74 -22.93 62.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -168.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -59.61 -26.07 65.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -85.67 -14.96 43.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.012 1.325 . . . . 0.0 113.592 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -102.3 -29.08 11.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.32 1.848 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.3 21.47 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -168.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -138.01 -175.72 4.19 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.696 -1.252 . . . . 0.0 111.992 172.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' HG22 ' A' ' 64' ' ' THR . 36.5 mt -118.6 24.59 10.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.725 2.01 . . . . 0.0 112.563 -166.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.333 5.7 p-10 47.77 36.34 5.66 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.357 1.463 . . . . 0.0 114.785 -172.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -81.44 155.84 25.66 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.38 -0.825 . . . . 0.0 113.104 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 97' ' ' VAL . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.71 -13.35 62.25 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 mt 52.75 -164.47 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.538 1.535 . . . . 0.0 111.76 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.05 156.5 87.64 Favored Pre-proline 0 CA--C 1.552 1.047 0 O-C-N 120.945 -1.097 . . . . 0.0 108.571 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.53 -16.43 30.57 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.223 1.949 . . . . 0.0 114.981 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 pt -63.92 -6.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.173 2.189 . . . . 0.0 115.227 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -117.62 4.53 12.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.27 1.828 . . . . 0.0 112.69 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.75 -14.34 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.946 1.298 . . . . 0.0 114.367 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -153.09 173.02 16.0 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 119.552 1.069 . . . . 0.0 112.263 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.01 -173.9 38.44 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.742 1.163 . . . . 0.0 113.941 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -145.25 153.05 40.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.827 1.251 . . . . 0.0 111.499 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -156.74 154.76 30.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.676 1.59 . . . . 0.0 111.452 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -152.44 138.34 18.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.484 1.514 . . . . 0.0 111.306 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -146.63 0.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.664 1.585 . . . . 0.0 112.968 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -70.44 161.63 30.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.373 2.269 . . . . 0.0 114.315 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -73.67 4.79 4.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.209 1.804 . . . . 0.0 114.634 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.002 2.121 . . . . 0.0 111.692 -170.194 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.45 0.167 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 156.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.548 1.939 . . . . 0.0 111.582 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 70' ' ' ILE . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.69 -52.47 65.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.65 161.66 1.7 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.412 2.285 . . . . 0.0 109.025 -167.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.442 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -139.63 12.63 2.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.78 66.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m -96.9 -2.99 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 32.9 ttpt -62.27 -24.62 67.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -119.48 -27.96 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.699 1.6 . . . . 0.0 112.286 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.4 -5.92 45.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -58.63 -15.45 11.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -58.83 -37.57 76.74 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -167.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -72.45 -35.06 68.18 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.549 1.14 . . . . 0.0 112.968 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -68.56 -31.16 70.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.405 1.482 . . . . 0.0 112.326 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -22.9 47.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.399 1.479 . . . . 0.0 114.333 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.76 -21.08 39.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.331 1.452 . . . . 0.0 114.346 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 9.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -75.96 2.63 12.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.95 1.7 . . . . 0.0 114.668 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -62.8 -17.82 61.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 114.265 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.1 p -62.83 -25.51 68.29 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.752 -1.217 . . . . 0.0 113.627 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.33 5.73 37.49 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.661 2.384 . . . . 0.0 112.564 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp 73.46 -59.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.741 2.817 . . . . 0.0 110.05 -169.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 m -167.36 144.52 4.51 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.783 2.033 . . . . 0.0 110.016 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.3 7.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.09 2.156 . . . . 0.0 115.578 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.02 -15.59 4.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.95 2.1 . . . . 0.0 113.23 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.76 -45.16 6.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 112.355 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -31.89 64.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.906 1.282 . . . . 0.0 114.285 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.2 -13.75 56.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.586 1.555 . . . . 0.0 113.95 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.2 p -57.89 -21.93 45.7 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -103.11 -12.67 17.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.293 1.437 . . . . 0.0 114.273 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.26 -55.18 2.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 0.0 113.061 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -175.99 67.34 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.455 2.302 . . . . 0.0 109.502 -168.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -50.31 129.78 22.09 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.042 1.337 . . . . 0.0 111.772 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt 43.69 39.31 2.38 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.039 1.336 . . . . 0.0 113.471 -173.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.66 22.09 12.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.611 1.564 . . . . 0.0 113.317 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -87.56 149.75 24.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 98' ' ' ARG . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 97' ' ' VAL . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.74 105.64 11.18 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.01 162.95 6.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.396 0.678 . . . . 0.0 111.32 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.8 149.07 55.39 Favored Pre-proline 0 CA--C 1.553 1.081 0 O-C-N 121.523 -0.735 . . . . 0.0 110.817 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.97 0.81 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.391 2.727 . . . . 0.0 114.008 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.5 pt -72.13 -9.35 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.084 2.154 . . . . 0.0 115.303 -169.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -61.71 -14.69 34.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.105 1.362 . . . . 0.0 114.661 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.97 -3.73 24.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.872 1.269 . . . . 0.0 114.387 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.04 -170.21 3.53 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.601 1.16 . . . . 0.0 111.795 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.41 5.71 0.03 OUTLIER Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.184 1.373 . . . . 0.0 114.855 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -83.73 18.05 2.09 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.153 1.476 . . . . 0.0 113.892 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -64.51 152.63 41.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.796 1.638 . . . . 0.0 113.111 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -126.41 1.68 6.98 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 58.96 -8.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 170.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -122.23 -7.53 8.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.896 1.678 . . . . 0.0 112.897 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -132.05 14.53 4.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.388 1.875 . . . . 0.0 112.509 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.699 2.4 . . . . 0.0 110.568 -175.686 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.373 0.13 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.58 153.2 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.767 1.627 . . . . 0.0 112.172 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 70' ' ' ILE . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -58.49 -41.64 85.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.34 170.36 10.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.188 1.795 . . . . 0.0 111.375 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.15 18.2 6.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.13 -52.83 64.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.827 0.851 . . . . 0.0 112.053 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -64.62 -30.06 71.08 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.73 1.212 . . . . 0.0 113.222 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 31.3 ttpt -66.89 -32.48 73.78 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.969 -0.457 . . . . 0.0 111.737 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -80.41 -35.27 35.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 171.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -98.38 -40.28 8.38 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -92.4 -51.42 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.75 0.82 . . . . 0.0 111.952 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -69.72 -21.51 63.47 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -65.74 -47.51 75.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 111.962 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -67.52 -36.54 81.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.15 1.38 . . . . 0.0 112.384 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.77 -20.47 50.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 114.152 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.18 -24.36 64.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.088 1.355 . . . . 0.0 113.891 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.01 11.28 0.55 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -167.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 t -146.91 163.82 34.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 112.404 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -72.69 -0.21 12.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.859 1.663 . . . . 0.0 113.573 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.1 p -52.95 -28.09 21.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.857 1.663 . . . . 0.0 115.215 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -12.97 6.38 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.0 mm -125.4 -10.95 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 126.945 2.098 . . . . 0.0 111.6 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.5 m -56.73 118.52 4.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.895 1.278 . . . . 0.0 112.296 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -54.37 -6.15 0.1 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -124.3 -4.94 7.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.368 1.867 . . . . 0.0 113.38 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.88 -34.24 5.83 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.406 1.482 . . . . 0.0 113.946 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -1.48 0.48 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.52 1.928 . . . . 0.0 116.005 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.38 -29.66 64.25 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.758 -1.214 . . . . 0.0 111.14 167.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.8 p -59.09 -18.35 34.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.646 1.578 . . . . 0.0 114.972 168.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -102.78 -33.19 9.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.066 2.147 . . . . 0.0 113.285 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.16 -35.07 79.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.7 1.2 . . . . 0.0 113.156 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.39 70.87 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.419 1.888 . . . . 0.0 108.725 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -35.87 114.51 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.316 2.247 . . . . 0.0 115.039 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.4 mt 41.36 27.15 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t0 46.76 45.58 14.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.587 1.555 . . . . 0.0 113.671 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -73.18 145.39 46.35 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 121.337 -0.852 . . . . 0.0 112.798 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.66 132.75 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.46 -69.11 0.35 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.099 0.96 . . . . 0.0 111.307 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.55 168.24 14.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.715 2.006 . . . . 0.0 110.139 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.07 22.23 0.88 Allowed 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.003 3.135 . . . . 0.0 112.769 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.5 pt -145.84 174.51 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 129.865 3.266 . . . . 0.0 108.584 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 63.27 -22.62 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.338 2.255 . . . . 0.0 116.285 -172.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.02 151.08 12.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.909 1.684 . . . . 0.0 113.158 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -100.35 117.44 34.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.979 0.912 . . . . 0.0 111.371 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.9 167.76 19.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.171 1.367 . . . . 0.0 113.435 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.2 p -75.85 -33.95 60.03 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.945 0.898 . . . . 0.0 113.22 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 47.01 30.81 1.35 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.059 2.144 . . . . 0.0 114.96 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -152.88 163.26 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.656 1.183 . . . . 0.0 112.458 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.51 -34.18 0.58 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.745 1.218 . . . . 0.0 114.134 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -80.87 56.76 2.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.818 1.247 . . . . 0.0 111.939 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -68.87 154.64 41.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.239 1.416 . . . . 0.0 113.365 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.383 1.873 . . . . 0.0 112.084 -179.06 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.03 148.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.412 1.885 . . . . 0.0 110.695 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -73.21 6.66 2.66 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 56.86 93.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.232 1.813 . . . . 0.0 113.03 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -59.15 4.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.818 2.847 . . . . 0.0 118.042 -169.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.4 62.7 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.997 1.319 . . . . 0.0 113.885 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -83.41 -9.64 58.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 35.9 ttpt -63.07 -44.58 95.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.066 0.848 . . . . 0.0 113.121 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 112.35 173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -74.77 -39.8 61.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.559 1.144 . . . . 0.0 112.391 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -67.61 -46.2 73.25 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.545 1.138 . . . . 0.0 112.447 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.11 -29.08 70.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.4 m -57.35 -23.41 48.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -70.16 -20.37 63.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.989 1.316 . . . . 0.0 114.16 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 68.47 2.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.195 1.398 . . . . 0.0 113.048 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -131.98 153.98 49.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.477 1.911 . . . . 0.0 111.38 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 23.44 -93.92 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.671 2.788 . . . . 0.0 116.828 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -70.71 -20.86 62.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -99.32 -34.5 10.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.089 1.756 . . . . 0.0 112.564 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -64.84 -20.87 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.076 0.853 . . . . 0.0 113.183 169.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -6.76 8.72 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.365 1.466 . . . . 0.0 114.073 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt 108.66 118.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 1 C-N-CA 132.016 4.126 . . . . 0.0 109.815 169.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -139.34 137.53 35.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.096 1.758 . . . . 0.0 110.414 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -58.93 -4.43 0.47 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -123.57 -6.12 8.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.235 2.214 . . . . 0.0 113.428 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.13 -33.37 6.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.407 1.883 . . . . 0.0 113.999 171.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -3.21 4.89 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -169.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -60.02 -22.96 63.28 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.944 -1.098 . . . . 0.0 113.289 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -62.19 -20.58 64.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.994 1.318 . . . . 0.0 114.365 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.2 m -102.88 -20.51 14.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.394 1.478 . . . . 0.0 113.616 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.7 mt -76.13 -22.31 55.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.839 1.255 . . . . 0.0 114.181 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.73 173.49 11.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.37 1.068 . . . . 0.0 113.761 -168.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -140.46 138.15 34.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.759 1.624 . . . . 0.0 110.121 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt 42.78 36.4 0.85 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.665 1.986 . . . . 0.0 113.843 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.8 p-10 46.23 28.62 0.7 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.801 2.04 . . . . 0.0 115.693 -171.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -91.18 160.11 15.72 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -77.03 153.12 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -133.95 -173.62 3.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.943 2.097 . . . . 0.0 109.827 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.36 155.63 6.84 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 121.239 -0.913 . . . . 0.0 111.129 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.25 5.57 5.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.38 2.72 . . . . 0.0 115.121 -167.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.87 -1.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 128.295 2.638 . . . . 0.0 115.011 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.45 -0.6 11.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.711 2.004 . . . . 0.0 113.053 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.11 179.18 3.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.466 1.106 . . . . 0.0 111.608 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.59 108.31 0.54 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.099 0.96 . . . . 0.0 112.597 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.77 -167.1 38.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.348 1.452 . . . . 0.0 112.332 -171.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.9 m -139.02 130.57 27.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 111.654 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -155.08 158.88 39.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.179 1.792 . . . . 0.0 109.954 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -87.76 -15.63 36.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.565 1.146 . . . . 0.0 113.707 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.3 m80 60.55 -16.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.404 2.682 . . . . 0.0 116.893 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -135.08 6.86 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.405 1.882 . . . . 0.0 113.095 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -153.18 162.91 40.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 110.1 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.374 1.47 . . . . 0.0 112.227 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.661 0.267 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.97 138.7 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.554 1.542 . . . . 0.0 110.768 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.33 52.46 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.14 -46.93 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.229 2.211 . . . . 0.0 114.296 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 7.9 pt20 -150.83 20.01 0.79 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.86 -46.48 78.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.178 0.899 . . . . 0.0 111.358 171.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 m -62.01 -27.92 69.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 24.8 ttpt -64.65 -23.36 67.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.642 1.177 . . . . 0.0 112.48 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.02 -46.16 7.26 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.44 1.096 . . . . 0.0 111.144 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.73 -32.89 74.68 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -65.48 -49.48 68.89 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -166.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 p -79.67 -36.38 37.75 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.056 1.342 . . . . 0.0 112.942 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -37.87 85.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.028 0.931 . . . . 0.0 112.858 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.22 -9.02 59.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.264 1.426 . . . . 0.0 114.233 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.83 -48.61 80.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.1 1.36 . . . . 0.0 113.857 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -11.83 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -163.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -129.04 -52.17 1.21 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -99.38 15.7 25.45 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 p -64.39 -15.04 59.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.056 1.343 . . . . 0.0 113.741 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.11 -17.52 27.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.971 1.708 . . . . 0.0 115.429 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 53' ' ' ILE . 9.1 tp -132.83 123.45 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.359 0.982 . . . . 0.0 112.499 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 m -56.2 140.88 42.97 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.484 1.514 . . . . 0.0 114.254 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -60.47 -6.49 1.61 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.947 2.099 . . . . 0.0 116.072 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -125.87 5.25 7.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.978 0.911 . . . . 0.0 112.946 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -108.03 -43.76 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.719 1.608 . . . . 0.0 112.739 168.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -59.81 -27.36 66.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.74 -17.61 64.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 0.0 114.074 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.1 m -60.68 -19.92 59.72 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.14 -0.975 . . . . 0.0 113.28 169.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -89.54 -12.44 39.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.806 1.242 . . . . 0.0 113.708 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.6 mt -102.2 -21.81 14.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.315 1.846 . . . . 0.0 113.947 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 154.83 37.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.5 m -66.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.801 1.24 . . . . 0.0 113.888 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -149.57 -59.65 0.21 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.732 3.213 . . . . 0.0 108.288 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -158.98 27.97 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.883 3.273 . . . . 0.0 111.248 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -121.07 160.54 23.44 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.844 1.258 . . . . 0.0 113.711 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' C ' HD12 ' A' ' 70' ' ' ILE . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.67 126.1 30.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 74.0 mt -71.22 -61.48 1.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.389 0.675 . . . . 0.0 111.274 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -140.14 159.25 64.81 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.487 1.515 . . . . 0.0 110.161 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.06 -6.39 8.43 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.964 2.443 . . . . 0.0 114.577 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.0 -27.91 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.446 1.498 . . . . 0.0 113.307 174.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -76.03 -13.67 60.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.188 1.795 . . . . 0.0 112.833 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.84 23.24 10.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.805 1.642 . . . . 0.0 113.702 -169.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 100.13 -7.88 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 130.037 3.335 . . . . 0.0 113.934 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.3 -42.0 97.98 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 114.585 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t 57.45 -52.82 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.965 2.906 . . . . 0.0 117.206 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -159.0 164.87 35.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 111.574 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -70.02 -35.72 74.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.288 1.035 . . . . 0.0 112.804 171.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -158.52 160.42 36.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.869 2.067 . . . . 0.0 110.476 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -62.57 160.31 14.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.282 1.033 . . . . 0.0 112.876 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -147.51 166.9 25.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 112.444 -169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.9 m80 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.793 1.637 . . . . 0.0 112.261 -169.683 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.842 -0.058 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.65 147.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.424 0.69 . . . . 0.0 110.32 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -73.06 3.59 5.3 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 -53.41 0.1 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 129.328 3.051 . . . . 0.0 117.122 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -151.09 8.34 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.02 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.906 -1.121 . . . . 0.0 113.321 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -75.93 -8.77 57.72 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 35.2 ttpt -63.3 -21.75 66.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.87 1.268 . . . . 0.0 114.401 -171.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -118.77 -26.5 6.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.527 1.131 . . . . 0.0 112.936 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -23.2 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 113.375 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -52.7 -33.48 47.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.715 1.206 . . . . 0.0 114.017 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 -60.22 -38.91 84.81 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -168.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 m -83.92 -21.03 31.99 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -62.44 -31.52 72.25 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.48 1.037 . . . . 0.0 112.542 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 -4.02 21.05 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.338 1.455 . . . . 0.0 114.331 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -121.27 -53.07 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.358 1.463 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.46 156.87 16.67 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -163.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.4 m -58.12 105.63 0.29 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.558 1.943 . . . . 0.0 113.643 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -67.74 -7.2 25.39 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 p -56.61 -20.85 23.16 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.278 -0.889 . . . . 0.0 113.243 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.19 59.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.66 158.76 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.552 1.541 . . . . 0.0 109.442 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -49.98 139.06 14.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.769 1.627 . . . . 0.0 114.177 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -61.5 -5.32 1.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.425 2.29 . . . . 0.0 116.826 -171.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -124.32 -3.92 7.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.34 1.856 . . . . 0.0 113.114 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -98.84 -40.37 8.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 112.482 168.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -3.72 9.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -169.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.77 -25.73 60.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 t -57.74 -26.55 61.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.774 1.229 . . . . 0.0 113.181 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.7 m -103.44 -5.0 23.31 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.46 -9.65 54.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.8 1.24 . . . . 0.0 113.443 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.48 -163.11 1.36 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.974 1.309 . . . . 0.0 112.056 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -174.16 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.346 1.859 . . . . 0.0 111.627 -176.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -48.94 -33.79 11.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -171.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -174.65 33.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.333 2.653 . . . . 0.0 111.946 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -122.7 165.05 17.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.561 ' N ' HG22 ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -67.9 132.32 47.13 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.6 mt -74.2 171.5 13.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 111.623 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -59.89 146.26 82.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.66 -0.65 . . . . 0.0 111.368 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.41 -6.43 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.946 2.43 . . . . 0.0 114.447 -167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.3 pt -63.12 -18.39 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.43 2.292 . . . . 0.0 113.862 170.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 -15.91 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -11.01 30.14 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.68 26.41 1.27 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.55 0.74 . . . . 0.0 112.435 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.01 177.98 53.88 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.576 1.084 . . . . 0.0 114.502 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.3 t -150.6 164.72 35.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.775 1.23 . . . . 0.0 112.132 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -67.84 -17.91 64.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.632 1.573 . . . . 0.0 114.362 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -151.34 177.69 10.01 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.556 1.542 . . . . 0.0 112.26 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.22 -7.47 4.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -158.63 -37.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -155.22 154.07 31.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 111.652 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.159 1.783 . . . . 0.0 112.274 -177.915 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.631 0.253 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -141.89 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.88 1.672 . . . . 0.0 110.604 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 70' ' ' ILE . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -66.17 -9.3 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.61 5.96 0.75 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.973 2.509 . . . . 0.0 114.889 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.329 6.0 pt20 42.83 30.3 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.558 2.343 . . . . 0.0 117.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.32 77.77 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.974 -1.078 . . . . 0.0 112.482 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 -26.77 65.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.963 1.305 . . . . 0.0 114.068 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.63 -15.88 32.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.78 -46.18 3.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.799 1.24 . . . . 0.0 110.816 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.44 -30.18 69.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -76.26 -39.07 55.3 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.429 -0.794 . . . . 0.0 112.814 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -57.01 -41.02 77.76 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -164.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.9 p -57.41 -25.93 60.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -99.36 -8.62 24.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.285 1.834 . . . . 0.0 114.045 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.63 39.19 1.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.807 1.243 . . . . 0.0 113.298 -169.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.66 155.83 25.16 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.068 0.947 . . . . 0.0 112.34 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 40.0 63.93 0.98 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.282 2.233 . . . . 0.0 116.27 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -151.25 154.96 37.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.724 0.81 . . . . 0.0 112.026 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.27 -30.57 68.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.125 0.97 . . . . 0.0 112.305 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 m -72.0 -4.05 26.35 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.512 1.525 . . . . 0.0 114.681 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.03 75.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -132.74 -5.44 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.3 m 55.39 106.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.345 2.258 . . . . 0.0 114.372 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.1 -6.31 0.36 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.224 2.21 . . . . 0.0 116.745 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -121.95 2.96 9.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.848 1.259 . . . . 0.0 112.62 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.66 -40.99 3.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.361 1.865 . . . . 0.0 113.153 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -58.32 -22.8 54.46 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.93 -16.83 46.69 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -60.6 -14.73 22.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.625 1.17 . . . . 0.0 114.144 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -103.28 -8.9 19.96 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.49 -31.75 11.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.999 1.32 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.38 6.3 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.415 1.486 . . . . 0.0 113.62 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.9 -163.95 1.91 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.688 1.995 . . . . 0.0 109.78 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.9 mt -124.89 36.59 4.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.856 2.062 . . . . 0.0 110.973 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.347 3.1 p30 51.11 29.73 4.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.381 1.872 . . . . 0.0 114.684 -168.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -79.65 154.68 28.49 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 97' ' ' VAL . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.5 ' H ' HG12 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -68.69 154.93 41.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.07 173.62 10.56 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.318 2.247 . . . . 0.0 108.832 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -56.16 147.12 47.63 Favored Pre-proline 0 CA--C 1.551 0.99 0 O-C-N 121.548 -0.72 . . . . 0.0 110.634 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.6 28.12 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.199 3.933 . . . . 0.0 113.21 -167.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.13 -0.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 127.49 2.316 . . . . 0.0 113.857 -168.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.04 132.67 54.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.329 -0.857 . . . . 0.0 112.238 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.05 173.57 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.25 1.42 . . . . 0.0 113.374 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.19 -31.34 62.62 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.91 40.03 0.11 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.086 0.85 . . . . 0.0 114.597 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.6 m -142.69 21.65 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.796 1.238 . . . . 0.0 113.518 -169.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -60.01 -41.7 92.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.18 1.792 . . . . 0.0 115.635 -168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -161.91 -33.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -62.8 -11.45 17.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.5 1.92 . . . . 0.0 115.96 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -74.42 -12.53 60.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 55.58 24.57 7.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.83 2.052 . . . . 0.0 114.755 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.364 1.866 . . . . 0.0 113.028 176.471 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.958 0.409 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.98 148.86 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.788 1.635 . . . . 0.0 111.377 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 70' ' ' ILE . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -71.11 41.12 0.06 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 61.34 8.77 2.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.77 2.428 . . . . 0.0 115.484 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.269 3.1 pt20 49.52 19.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.6 68.08 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 m -95.2 -23.61 17.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -64.26 -20.9 66.37 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.68 -5.82 18.32 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -107.79 -28.78 9.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.953 1.301 . . . . 0.0 113.568 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -68.38 -33.56 74.48 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.668 1.187 . . . . 0.0 114.072 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -62.71 -37.84 88.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -167.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -93.78 -31.73 14.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.689 1.596 . . . . 0.0 113.379 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -55.76 -36.23 67.1 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.99 1.316 . . . . 0.0 113.223 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.52 37.3 2.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.578 1.551 . . . . 0.0 112.481 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 125.09 19.58 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.98 1.712 . . . . 0.0 112.765 -174.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . 0.267 0.0 OUTLIER 62.55 4.4 1.35 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 165.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -52.25 -40.25 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.499 1.52 . . . . 0.0 114.606 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -99.84 -67.36 0.85 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.708 0.803 . . . . 0.0 110.981 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 p -133.35 -64.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.85 1.26 . . . . 0.0 112.822 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.61 -44.82 5.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.573 1.549 . . . . 0.0 112.802 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.8 mt -153.65 151.15 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.53 2.332 . . . . 0.0 107.008 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.7 m -55.03 144.7 22.59 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.912 1.233 . . . . 0.0 113.635 171.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.34 -1.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.254 2.621 . . . . 0.0 116.51 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -112.74 -26.66 8.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.352 1.861 . . . . 0.0 112.021 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -98.8 -30.75 12.23 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.273 1.829 . . . . 0.0 115.066 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 11.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.266 2.626 . . . . 0.0 117.31 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -45.12 -25.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.177 2.591 . . . . 0.0 115.386 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -50.78 -27.78 7.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.053 1.341 . . . . 0.0 113.924 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -95.69 -23.03 17.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.79 1.636 . . . . 0.0 113.95 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.3 mt -74.91 -34.4 62.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.051 1.341 . . . . 0.0 112.562 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.45 86.68 2.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.668 1.987 . . . . 0.0 108.172 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -48.47 123.64 6.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.44 1.496 . . . . 0.0 112.705 -168.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt 44.98 30.36 0.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.759 2.024 . . . . 0.0 114.818 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.308 4.0 p-10 46.39 32.34 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.876 2.07 . . . . 0.0 114.859 -170.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -82.36 154.45 25.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -71.13 165.67 23.06 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.3 mt -114.24 -174.1 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.742 1.617 . . . . 0.0 110.465 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -57.57 147.03 62.35 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.61 -7.36 16.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.487 2.791 . . . . 0.0 115.22 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 27.7 pt -65.15 -18.39 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.307 2.243 . . . . 0.0 114.221 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.92 -33.05 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.57 -11.9 56.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.27 28.28 0.74 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.51 -178.99 41.07 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.469 1.033 . . . . 0.0 114.408 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 m -140.22 30.25 1.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.964 1.706 . . . . 0.0 111.789 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -129.04 34.37 4.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.955 2.102 . . . . 0.0 111.869 -169.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -46.94 -46.43 21.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.708 2.403 . . . . 0.0 113.924 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -161.73 -178.83 6.78 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.554 1.942 . . . . 0.0 111.007 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.9 50.32 1.84 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.939 2.096 . . . . 0.0 110.639 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -56.11 -23.83 36.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 70.4 t60 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.585 1.554 . . . . 0.0 111.73 -178.367 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.534 -0.172 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.6 148.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 126.73 2.012 . . . . 0.0 109.929 -174.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 88' ' ' TYR . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 70' ' ' ILE . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -71.95 44.98 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 62.81 157.3 0.06 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.565 2.746 . . . . 0.0 115.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.26 12.05 4.77 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -169.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.45 -57.39 10.02 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 m -64.39 -21.43 66.63 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.932 -1.105 . . . . 0.0 113.872 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.6 ttpt -62.13 -22.3 65.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.457 1.103 . . . . 0.0 112.658 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.66 -32.87 6.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.211 1.004 . . . . 0.0 112.91 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.33 -28.03 64.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -74.62 -40.69 61.39 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.137 -0.977 . . . . 0.0 111.62 168.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -54.59 -36.01 63.97 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -166.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -63.09 -12.67 28.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.42 -10.72 58.93 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.634 1.106 . . . . 0.0 113.782 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.16 46.19 0.39 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.999 1.72 . . . . 0.0 114.708 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.44 -37.87 73.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.939 1.296 . . . . 0.0 114.147 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.42 -9.35 0.27 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 p -70.07 -13.37 62.18 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.611 1.565 . . . . 0.0 114.366 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' HA ' ' CG ' ' A' ' 58' ' ' TYR . 52.2 mt-30 -58.61 -28.61 65.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.0 m -72.61 -5.2 35.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.625 1.57 . . . . 0.0 114.824 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.3 68.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.5 mt -144.08 -65.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.036 1.334 . . . . 0.0 108.677 -170.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -168.09 150.78 5.57 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.878 2.471 . . . . 0.0 108.434 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.46 -6.28 2.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.706 1.603 . . . . 0.0 114.891 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -114.31 -1.24 13.61 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 112.464 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -120.99 -39.37 2.72 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.355 1.862 . . . . 0.0 114.773 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 50' ' ' GLN . 19.1 p90 -51.21 -34.34 31.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.05 -25.83 67.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.518 1.127 . . . . 0.0 113.406 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -63.11 -18.52 63.51 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.9 m -92.49 -10.96 35.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.954 1.301 . . . . 0.0 113.292 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -100.84 -37.33 8.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.455 1.502 . . . . 0.0 112.778 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.48 179.53 9.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.439 1.496 . . . . 0.0 111.843 -172.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.92 172.4 12.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.618 1.167 . . . . 0.0 111.704 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -77.76 2.49 16.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.839 1.656 . . . . 0.0 114.801 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.0 t0 58.02 50.58 9.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.995 1.318 . . . . 0.0 113.218 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -79.18 149.88 31.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.57 126.46 31.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.54 -175.66 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.029 1.732 . . . . 0.0 111.689 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -56.1 156.26 10.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 121.507 -0.745 . . . . 0.0 111.248 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -82.54 7.87 4.89 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 114.676 -168.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 pt -61.2 -22.44 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.77 2.028 . . . . 0.0 114.747 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -80.74 53.11 1.83 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.914 2.086 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.84 50.75 18.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.804 2.042 . . . . 0.0 114.898 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -133.34 -24.31 1.83 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.26 42.83 0.08 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 126.798 2.142 . . . . 0.0 110.968 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 p -71.58 1.44 6.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.612 2.365 . . . . 0.0 116.342 -169.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.17 158.89 43.9 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.961 1.304 . . . . 0.0 112.286 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 t60 48.05 36.84 6.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.275 1.83 . . . . 0.0 113.804 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -124.5 -11.05 7.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.276 1.83 . . . . 0.0 113.505 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -145.67 38.26 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.965 2.106 . . . . 0.0 109.791 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -137.7 144.6 41.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.621 1.568 . . . . 0.0 112.006 -167.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 125.949 1.7 . . . . 0.0 111.796 177.993 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.705 0.288 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 73' ' ' PRO . 5.3 t -85.62 152.1 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.005 2.122 . . . . 0.0 112.138 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 70' ' ' ILE . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.71 -19.25 62.08 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.7 t70 58.34 -34.32 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 130.262 3.425 . . . . 0.0 117.175 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -155.52 24.19 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -167.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.01 74.18 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.744 -1.223 . . . . 0.0 112.736 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -97.58 -27.51 14.37 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -66.31 -16.26 63.89 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.485 1.114 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -94.71 -37.33 11.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.6 -0.688 . . . . 0.0 111.798 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -33.26 75.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.618 1.167 . . . . 0.0 113.959 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.19 -8.76 59.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -55.42 -43.16 75.05 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -165.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.5 m -80.29 -25.04 39.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.076 0.95 . . . . 0.0 113.224 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -73.84 -15.8 61.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.29 -7.19 8.6 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.63 176.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.955 1.302 . . . . 0.0 112.95 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -27.76 -46.6 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 129.038 2.935 . . . . 0.0 117.247 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -65.14 -10.99 35.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -55.45 -14.4 1.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.308 1.843 . . . . 0.0 114.761 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -54.79 -28.84 52.0 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.514 -1.366 . . . . 0.0 114.588 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.84 -19.99 47.07 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mt 69.54 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 129.678 3.191 . . . . 0.0 109.461 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 m -60.53 155.39 18.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.985 1.314 . . . . 0.0 112.964 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.83 -6.84 2.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -124.62 8.05 8.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.087 0.955 . . . . 0.0 111.989 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -110.91 -44.74 3.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.934 2.093 . . . . 0.0 112.538 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -23.72 66.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.054 1.342 . . . . 0.0 113.98 -173.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.7 -10.97 57.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.305 1.442 . . . . 0.0 113.676 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.2 p -61.19 -21.8 64.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.413 1.006 . . . . 0.0 113.246 169.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -82.8 -18.55 40.16 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.232 1.013 . . . . 0.0 113.548 170.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.45 -28.93 11.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.379 1.872 . . . . 0.0 113.972 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.52 174.31 11.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.734 1.614 . . . . 0.0 112.816 -168.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -172.21 4.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.829 1.652 . . . . 0.0 113.043 -169.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.3 mt -71.72 54.56 0.25 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.583 2.353 . . . . 0.0 113.856 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 60.52 36.14 20.05 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.083 1.753 . . . . 0.0 112.619 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -79.96 147.59 31.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 2' ' ' VAL . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 4' ' ' ILE . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.24 139.69 54.46 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.05 -71.2 0.44 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.765 0.826 . . . . 0.0 109.846 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -136.22 157.95 74.58 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.16 1.384 . . . . 0.0 109.243 166.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.9 29.97 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.067 3.178 . . . . 0.0 113.4 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.1 pt -138.69 0.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.893 2.077 . . . . 0.0 113.999 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -63.13 114.63 3.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.136 0.974 . . . . 0.0 111.848 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -156.02 175.13 14.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.237 1.815 . . . . 0.0 112.087 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -134.05 144.52 48.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 111.85 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.66 -169.1 42.25 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.561 1.077 . . . . 0.0 113.443 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.8 p -146.31 162.05 38.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.253 1.421 . . . . 0.0 112.232 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -132.72 -16.78 2.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.241 1.416 . . . . 0.0 113.941 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -149.78 159.1 44.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.861 1.664 . . . . 0.0 110.703 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -134.93 23.95 3.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.864 1.266 . . . . 0.0 112.87 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 66.2 8.06 5.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.595 2.358 . . . . 0.0 116.157 171.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -70.39 159.29 34.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.807 1.243 . . . . 0.0 112.231 169.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.248 1.819 . . . . 0.0 111.598 179.402 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.475 0.178 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.451 HG21 ' HG3' ' A' ' 73' ' ' PRO . 6.1 t -85.75 145.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.358 0.663 . . . . 0.0 110.599 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 88' ' ' TYR . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -61.14 -41.13 96.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.43 168.0 13.36 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.609 1.964 . . . . 0.0 111.305 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.456 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -135.44 16.53 3.4 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.01 92.63 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -90.42 -6.48 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.612 1.165 . . . . 0.0 113.745 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.7 ttpt -64.28 -41.39 96.91 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.213 0.915 . . . . 0.0 113.055 -169.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.22 -34.14 56.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -78.81 -40.18 33.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.8 -36.09 57.18 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -59.18 -29.08 67.2 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -58.37 -24.22 59.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.059 1.344 . . . . 0.0 113.746 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.54 -22.73 56.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 113.84 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -20.85 47.53 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.96 -33.07 74.98 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -158.77 -11.96 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -166.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.4 m -134.64 -28.22 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -169.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.6 -23.42 67.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.989 -1.069 . . . . 0.0 113.014 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.6 p -69.2 -10.25 56.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.487 1.915 . . . . 0.0 114.8 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.82 -161.53 0.17 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.243 0.929 . . . . 0.0 112.404 174.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mt -131.16 18.69 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.971 1.309 . . . . 0.0 111.86 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.8 m -60.75 143.15 55.05 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.639 -1.288 . . . . 0.0 110.901 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -58.55 -6.81 0.77 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -126.67 0.28 6.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.066 0.947 . . . . 0.0 112.95 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -105.69 -44.63 4.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.321 . . . . 0.0 111.329 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.28 -25.16 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.314 1.445 . . . . 0.0 114.85 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.48 -1.26 26.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.3 p -55.79 -25.89 43.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.5 p -102.92 -9.94 19.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.704 1.602 . . . . 0.0 114.32 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.83 -23.45 18.13 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.742 1.617 . . . . 0.0 112.748 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.49 179.98 6.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.423 1.489 . . . . 0.0 112.817 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.3 p -130.51 178.64 6.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.76 1.624 . . . . 0.0 112.11 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.92 58.13 2.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.195 2.198 . . . . 0.0 112.669 -172.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 58.87 35.31 24.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.165 1.386 . . . . 0.0 113.75 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -90.04 155.79 18.83 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HG3' HG21 ' A' ' 2' ' ' VAL . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.1 142.45 42.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.04 168.64 3.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.989 0.9 . . . . 0.0 112.736 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -63.2 156.01 70.96 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -97.38 14.53 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.878 3.719 . . . . 0.0 113.569 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 pt -66.07 -15.1 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.044 1.738 . . . . 0.0 114.169 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -78.82 45.38 0.6 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.254 2.222 . . . . 0.0 112.344 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 51.85 46.92 25.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 114.088 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.42 1.34 3.43 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.01 -23.84 0.16 Allowed Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.826 1.091 . . . . 0.0 115.826 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -133.65 47.21 2.48 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.998 1.399 . . . . 0.0 112.869 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -144.79 148.69 34.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.181 1.392 . . . . 0.0 110.992 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -156.81 176.58 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.756 1.622 . . . . 0.0 111.039 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -141.87 133.18 26.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.227 1.011 . . . . 0.0 111.669 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -153.85 9.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -126.34 2.26 7.03 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.818 1.247 . . . . 0.0 112.274 174.466 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.628 0.252 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -91.45 151.08 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.371 1.869 . . . . 0.0 111.953 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -70.57 35.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.5 t0 50.5 95.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 129.218 3.007 . . . . 0.0 114.864 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -67.88 3.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.31 -38.65 13.12 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 120.387 1.448 . . . . 0.0 114.402 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -71.02 -25.15 62.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -65.57 -32.99 74.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.737 1.153 . . . . 0.0 112.499 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.06 -25.58 68.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 113.356 170.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -107.31 -10.43 15.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.646 1.578 . . . . 0.0 114.148 -171.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -60.29 -19.57 55.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -54.53 -27.54 39.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -166.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.6 p -59.95 -36.67 77.59 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.099 0.96 . . . . 0.0 113.452 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.56 -22.62 67.02 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.882 1.673 . . . . 0.0 113.295 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.32 -7.59 50.37 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.82 -44.62 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.788 1.635 . . . . 0.0 113.089 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -159.63 165.77 32.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.112 1.365 . . . . 0.0 111.569 -168.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m 53.17 26.34 4.96 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.21 -12.72 54.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.21 1.404 . . . . 0.0 113.596 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -55.36 -20.25 11.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.65 1.98 . . . . 0.0 115.898 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.38 66.21 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 mm 64.89 -67.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 128.768 2.827 . . . . 0.0 113.031 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 m 60.07 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 112.903 -168.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -54.76 2.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 130.399 3.48 . . . . 0.0 118.185 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -124.75 -14.57 6.71 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.28 2.632 . . . . 0.0 113.016 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.76 -34.06 6.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.86 2.064 . . . . 0.0 113.44 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -58.24 -31.13 67.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.64 124.57 7.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.924 0.89 . . . . 0.0 112.233 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m -70.54 -16.42 62.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 m -103.53 -38.84 6.98 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.715 1.206 . . . . 0.0 112.336 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -16.9 63.0 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.076 1.35 . . . . 0.0 114.398 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.68 147.23 32.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.05 1.34 . . . . 0.0 111.28 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -178.09 2.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.679 1.592 . . . . 0.0 112.603 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.435 ' H ' ' CD2' ' A' ' 65' ' ' LEU 0.263 0.2 OUTLIER -60.97 49.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.986 2.914 . . . . 0.0 115.514 167.633 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.36 0.4 OUTLIER 47.24 35.01 3.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.314 3.046 . . . . 0.0 118.15 177.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -97.1 159.99 14.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 4' ' ' ILE . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.73 135.79 56.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.49 -67.06 0.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.175 0.99 . . . . 0.0 111.873 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -139.15 157.07 71.81 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.274 1.43 . . . . 0.0 109.99 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -86.58 4.82 6.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.602 2.868 . . . . 0.0 113.692 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 pt -91.0 6.9 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 127.223 2.209 . . . . 0.0 113.295 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -101.94 27.7 6.33 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.925 2.09 . . . . 0.0 111.835 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.14 159.33 44.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.469 2.307 . . . . 0.0 110.988 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.9 t70 60.99 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.686 2.794 . . . . 0.0 118.058 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.59 -174.2 43.74 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.473 -1.392 . . . . 0.0 114.112 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 m -132.22 5.74 4.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.742 1.217 . . . . 0.0 114.252 -171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -147.02 69.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.655 1.582 . . . . 0.0 110.098 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -61.44 -26.79 68.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -172.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -152.47 157.64 41.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.484 . . . . 0.0 111.286 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -75.17 174.55 9.29 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -135.8 11.32 3.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.884 1.274 . . . . 0.0 113.748 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.119 1.768 . . . . 0.0 113.445 179.667 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.15 149.91 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.026 1.73 . . . . 0.0 111.393 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 88' ' ' TYR . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -64.67 -42.12 95.59 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -156.02 -6.05 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 52.26 13.45 0.28 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -46.35 89.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.368 0.986 . . . . 0.0 113.08 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 m -75.24 -17.0 60.42 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 38.8 ttpt -62.76 -35.81 81.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.534 1.061 . . . . 0.0 112.469 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.19 0.996 . . . . 0.0 113.525 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -107.42 -40.22 5.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -92.91 -38.76 11.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 113.963 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -62.86 -22.01 66.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -166.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -69.78 -15.0 63.05 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.02 -39.18 8.66 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.687 1.195 . . . . 0.0 112.345 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.86 59.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.414 1.086 . . . . 0.0 113.631 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.254 4.3 mm? 60.62 159.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.887 2.875 . . . . 0.0 114.895 -167.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -74.16 -43.3 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.477 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.7 p -71.63 146.01 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -64.61 -30.01 71.02 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.49 -0.756 . . . . 0.0 112.456 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.1 m -69.22 -12.83 62.01 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.49 65.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.58 135.72 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.273 1.429 . . . . 0.0 109.617 -167.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.6 m -77.48 163.16 26.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -58.97 -6.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.891 2.076 . . . . 0.0 116.591 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -124.51 -1.62 8.02 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.549 -0.719 . . . . 0.0 112.297 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -98.24 -40.76 8.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.691 1.996 . . . . 0.0 112.396 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -63.81 -8.9 12.12 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.97 -22.72 60.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.817 -1.177 . . . . 0.0 112.644 168.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.5 m -67.18 -49.09 65.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.515 -0.741 . . . . 0.0 110.688 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 m -60.9 -34.22 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.43 1.492 . . . . 0.0 113.544 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.69 -15.25 61.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.302 1.841 . . . . 0.0 114.317 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.52 39.74 1.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 -168.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.521 HG23 ' HG ' ' A' ' 65' ' ' LEU . 3.0 t -147.49 -174.75 4.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.894 1.678 . . . . 0.0 110.909 -178.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 64' ' ' THR . 10.0 mt 55.76 25.03 7.87 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.572 1.078 . . . . 0.0 112.589 -170.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.255 3.5 t0 58.91 36.65 24.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.531 2.332 . . . . 0.0 114.113 -169.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.37 144.18 48.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' C ' HD12 ' A' ' 70' ' ' ILE . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 69' ' ' GLU . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -75.72 152.04 37.53 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.88 -62.6 1.0 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.217 1.407 . . . . 0.0 108.606 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -133.25 162.96 54.49 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 126.411 1.884 . . . . 0.0 107.822 165.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.98 13.15 2.79 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.722 2.948 . . . . 0.0 113.704 -173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.8 pt -141.9 21.28 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.458 2.303 . . . . 0.0 111.358 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -11.53 56.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.492 -1.38 . . . . 0.0 114.389 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.15 68.19 3.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.385 1.088 . . . . 0.0 111.331 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.35 126.69 28.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 0.0 112.431 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.21 -12.37 61.94 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.82 1.2 . . . . 0.0 113.872 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -105.08 15.03 28.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.079 1.352 . . . . 0.0 113.095 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -155.11 -179.47 8.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.84 2.056 . . . . 0.0 110.912 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -142.9 157.08 44.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.873 1.269 . . . . 0.0 111.331 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.82 172.32 18.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.665 1.586 . . . . 0.0 111.292 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -65.47 -19.86 66.11 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.899 -1.126 . . . . 0.0 113.936 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 56.03 36.33 27.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.623 1.969 . . . . 0.0 113.731 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.064 2.146 . . . . 0.0 111.787 179.118 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.94 110.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 70' ' ' ILE . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -74.64 38.75 0.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t0 50.86 107.01 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 129.294 3.038 . . . . 0.0 115.881 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.493 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.09 17.65 6.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.352 1.861 . . . . 0.0 113.68 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.34 82.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -78.16 -14.32 59.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.8 ttpt -63.84 -44.48 93.07 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.014 0.925 . . . . 0.0 112.3 -171.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.84 -46.84 56.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.203 0.601 . . . . 0.0 111.301 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.11 -32.87 74.58 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -72.07 -55.66 6.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.654 0.781 . . . . 0.0 111.273 169.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -67.92 -29.81 68.97 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -167.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.5 p -50.87 -34.16 26.98 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.064 1.346 . . . . 0.0 113.875 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -73.67 -9.09 58.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.22 1.808 . . . . 0.0 114.855 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 15.21 1.57 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.9 mt -54.74 152.77 6.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.059 0.943 . . . . 0.0 113.347 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 62.17 -23.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -66.42 149.23 50.72 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.699 1.136 . . . . 0.0 112.214 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -57.45 -26.63 61.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.039 0.936 . . . . 0.0 113.457 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 p -59.4 -56.16 25.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.669 1.188 . . . . 0.0 112.47 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.13 63.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.0 -6.8 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.454 1.901 . . . . 0.0 111.912 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -60.46 146.09 45.94 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.683 -1.26 . . . . 0.0 112.055 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.416 ' HA ' ' CD2' ' A' ' 58' ' ' TYR 0.328 2.5 tt0 -62.38 -5.94 2.87 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -170.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -105.25 -13.93 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.79 -1.819 . . . . 0.0 113.603 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -98.45 -33.11 11.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.101 1.761 . . . . 0.0 114.057 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -66.12 1.59 1.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 118.416 2.747 . . . . 0.0 118.416 -167.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.5 -33.4 65.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -67.02 -12.93 61.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -102.62 -5.6 23.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.5 1.52 . . . . 0.0 113.431 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.01 -6.28 57.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.819 1.648 . . . . 0.0 113.434 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 171.25 17.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.247 1.419 . . . . 0.0 112.603 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.63 -177.26 0.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.244 1.817 . . . . 0.0 112.315 175.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 64' ' ' THR . 59.4 mt -64.97 21.66 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 128.222 2.609 . . . . 0.0 115.427 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.2 p30 48.66 31.25 2.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.606 2.363 . . . . 0.0 116.198 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -77.62 161.75 27.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 32' ' ' ILE . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 87' ' ' ASP . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 98' ' ' ARG . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 97' ' ' VAL . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.11 144.55 53.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.59 -72.57 0.26 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.074 1.35 . . . . 0.0 111.819 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -135.69 157.56 75.97 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.219 1.408 . . . . 0.0 111.121 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.96 0.37 9.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.415 2.743 . . . . 0.0 114.46 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 pt -72.79 -2.55 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.305 1.842 . . . . 0.0 114.215 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -121.11 -47.2 2.28 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.286 1.834 . . . . 0.0 111.138 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.87 143.57 8.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 108.807 170.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -84.07 50.03 1.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.704 -1.247 . . . . 0.0 112.435 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.98 32.89 56.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.354 0.978 . . . . 0.0 113.236 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.4 t -156.92 168.45 27.45 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 110.514 -168.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -67.64 -4.47 12.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.538 1.135 . . . . 0.0 113.556 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -139.94 172.73 12.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.18 2.192 . . . . 0.0 111.368 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -78.41 18.32 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.285 1.834 . . . . 0.0 113.799 172.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -146.97 159.42 43.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.223 1.809 . . . . 0.0 110.902 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -73.54 -4.86 36.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.594 1.558 . . . . 0.0 114.756 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.772 1.629 . . . . 0.0 112.713 -175.795 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -136.63 141.03 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.843 1.657 . . . . 0.0 110.665 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.78 -43.29 99.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.75 173.36 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.674 2.389 . . . . 0.0 110.719 -176.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.83 16.77 3.3 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.7 73.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.616 -0.678 . . . . 0.0 111.279 169.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.8 m -93.95 -5.43 47.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.132 1.373 . . . . 0.0 114.301 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -64.19 -17.71 63.79 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.073 1.306 . . . . 0.0 113.937 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.11 -40.14 6.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.25 1.02 . . . . 0.0 111.896 167.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -74.98 -19.53 60.06 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -170.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -54.88 -28.07 47.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.262 1.425 . . . . 0.0 114.413 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -57.63 -40.88 80.23 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 m -72.33 -27.11 62.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.51 -36.12 81.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -7.1 59.65 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 mt -74.38 134.28 42.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -12.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 N-CA-C 122.411 4.226 . . . . 0.0 122.411 161.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -147.07 -174.9 4.62 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.919 1.69 . . . . 0.0 112.694 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.55 -22.57 8.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.025 2.13 . . . . 0.0 114.661 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.4 m -52.72 -25.17 10.29 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.76 64.67 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.35 -13.56 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 m -58.18 128.55 37.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.69 -6.35 1.15 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -168.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -117.76 -1.71 11.52 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.164 1.386 . . . . 0.0 113.238 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.55 -30.76 3.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 114.434 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 2.53 0.21 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.87 -28.04 63.81 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 m -60.53 -33.71 73.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.635 0.774 . . . . 0.0 112.977 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -81.07 -30.23 34.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.543 1.537 . . . . 0.0 112.96 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.67 -40.3 63.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.64 1.176 . . . . 0.0 112.965 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.14 87.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.304 1.441 . . . . 0.0 111.405 -169.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 m -52.71 129.57 30.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.017 0.927 . . . . 0.0 110.769 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt 39.53 38.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.448 1.899 . . . . 0.0 114.327 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.43 27.25 16.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.347 1.459 . . . . 0.0 113.714 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -92.29 153.56 19.16 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 4' ' ' ILE . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -87.97 138.37 31.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.99 -174.39 3.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.248 2.219 . . . . 0.0 109.602 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -55.34 155.65 9.31 Favored Pre-proline 0 CA--C 1.557 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 112.039 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.04 10.27 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.646 2.897 . . . . 0.0 114.719 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 pt -62.06 -14.98 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.132 1.773 . . . . 0.0 114.622 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' CE1' ' HE3' ' A' ' 22' ' ' LYS . 28.7 m-85 -89.83 5.39 46.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.816 2.046 . . . . 0.0 113.674 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.63 15.7 8.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.878 1.671 . . . . 0.0 114.131 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -154.7 162.21 41.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 0.0 112.066 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.72 22.06 0.1 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.76 2.124 . . . . 0.0 113.015 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.5 m -61.62 -19.39 62.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.59 1.556 . . . . 0.0 114.639 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -0.34 56.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.653 1.981 . . . . 0.0 114.114 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.9 m80 50.08 29.14 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.337 1.855 . . . . 0.0 113.768 -172.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.6 t60 56.45 18.53 3.54 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.05 2.14 . . . . 0.0 115.587 -173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.04 161.29 31.38 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.152 -0.968 . . . . 0.0 112.048 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -147.72 168.83 21.09 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.304 1.441 . . . . 0.0 111.186 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.596 1.558 . . . . 0.0 112.261 -171.481 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.54 149.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.005 1.275 . . . . 0.0 113.576 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.508 HD12 HD11 ' A' ' 70' ' ' ILE . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -58.65 -26.49 63.83 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 167.92 141.6 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 128.229 2.611 . . . . 0.0 109.389 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 6.8 mp0 -67.93 145.31 54.68 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -170.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.46 -66.32 1.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 165.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 m -61.86 -26.56 68.21 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.834 -1.166 . . . . 0.0 113.845 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . 5.8 mptt -66.87 -24.75 66.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 111.967 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.86 -49.23 6.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.676 1.19 . . . . 0.0 110.016 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.26 -35.34 79.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -167.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -57.61 -38.49 75.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.884 0.766 . . . . 0.0 112.186 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -74.36 -32.07 62.63 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.917 -172.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.4 m -62.03 -32.8 73.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.454 1.102 . . . . 0.0 113.453 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.62 -24.63 49.38 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.641 1.176 . . . . 0.0 114.164 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -10.69 59.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.853 1.261 . . . . 0.0 114.327 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.89 -49.38 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.508 1.523 . . . . 0.0 113.825 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -160.77 159.67 30.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.309 1.043 . . . . 0.0 113.122 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -108.23 -7.45 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.651 1.181 . . . . 0.0 113.493 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -60.3 -23.02 63.84 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 0.0 113.658 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 m -56.77 -16.89 7.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.501 1.52 . . . . 0.0 114.09 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.88 18.13 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -94.82 -16.35 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.25 1.82 . . . . 0.0 112.035 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -62.51 140.34 58.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.49 1.116 . . . . 0.0 112.794 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.62 -6.01 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -168.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -130.65 1.42 4.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.787 1.635 . . . . 0.0 113.311 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.92 -37.37 5.13 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.263 2.225 . . . . 0.0 112.71 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.46 -17.76 60.23 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.05 7.45 33.96 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 114.021 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.9 m -57.01 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.522 -1.361 . . . . 0.0 113.072 171.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -73.32 -20.17 60.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 114.333 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.4 mt -102.34 -30.61 10.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.223 1.809 . . . . 0.0 113.413 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 6.75 2.61 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m 59.11 -71.31 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.322 2.649 . . . . 0.0 115.534 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -144.48 8.51 1.35 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.773 2.829 . . . . 0.0 113.011 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.2 44.85 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.333 1.453 . . . . 0.0 113.359 -174.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -77.92 151.63 33.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.524 ' C ' HG23 ' A' ' 99' ' ' VAL . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -101.55 110.9 22.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.59 174.63 1.28 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.043 1.737 . . . . 0.0 112.904 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -55.28 158.59 5.17 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.415 1.086 . . . . 0.0 112.305 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.86 5.47 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.533 2.822 . . . . 0.0 115.525 -168.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.4 pt -101.62 -2.5 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.133 2.173 . . . . 0.0 112.922 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -134.63 -21.69 1.72 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.092 1.757 . . . . 0.0 113.343 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.86 165.9 34.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.976 1.71 . . . . 0.0 111.232 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.17 -27.72 9.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.67 -166.91 25.99 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.68 1.134 . . . . 0.0 115.411 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.1 m -69.38 147.01 51.62 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.484 -1.01 . . . . 0.0 109.601 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -135.57 178.52 6.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -170.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -141.06 166.16 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.366 1.867 . . . . 0.0 110.932 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -58.98 -23.24 61.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.539 1.536 . . . . 0.0 114.611 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.38 8.4 43.32 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.902 1.281 . . . . 0.0 114.071 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -74.65 65.96 1.38 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.244 1.418 . . . . 0.0 112.567 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.76 2.024 . . . . 0.0 111.784 -173.45 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.637 0.256 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.25 149.68 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.969 1.708 . . . . 0.0 111.693 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.21 -36.3 83.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.78 165.15 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.546 1.939 . . . . 0.0 110.895 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.43 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.47 12.04 5.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.597 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.47 89.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.005 0.922 . . . . 0.0 112.943 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.8 m -84.41 -7.43 59.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.1 ttpt -62.54 -35.0 78.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.302 1.41 . . . . 0.0 113.763 -169.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 -42.44 41.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.373 0.669 . . . . 0.0 112.507 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -73.79 -31.56 63.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.41 1.084 . . . . 0.0 113.47 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.9 -17.45 64.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 114.217 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.75 -29.72 66.97 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -166.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.6 p -60.83 -26.56 67.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 114.188 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -97.47 -25.52 15.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 0.0 112.233 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.41 1.24 6.6 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.216 1.406 . . . . 0.0 114.404 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.06 154.38 0.78 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.126 2.171 . . . . 0.0 116.028 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 24.1 -68.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.031 1 C-N-CA 132.332 4.253 . . . . 0.0 117.342 167.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -54.86 -33.06 61.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.291 1.405 . . . . 0.0 113.625 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -99.18 -32.49 11.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.495 1.118 . . . . 0.0 112.702 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 m -59.48 -26.01 64.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.737 1.153 . . . . 0.0 113.797 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.17 -21.96 64.27 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.287 1.0 OUTLIER 67.26 -52.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.298 2.639 . . . . 0.0 115.97 177.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m 53.77 103.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.459 1.904 . . . . 0.0 113.195 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.59 -6.02 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.913 2.085 . . . . 0.0 116.378 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -114.43 -2.31 13.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.286 1.435 . . . . 0.0 112.764 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.75 -34.62 4.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.868 2.067 . . . . 0.0 114.164 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -17.26 8.45 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.52 -18.32 64.99 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.314 0.961 . . . . 0.0 113.117 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -73.85 -41.8 61.73 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 167.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -60.11 -27.01 66.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.87 1.268 . . . . 0.0 113.685 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.58 -15.9 59.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.82 1.648 . . . . 0.0 114.461 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 41.62 1.06 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.757 1.223 . . . . 0.0 112.301 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -140.33 -55.39 0.53 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.39 -41.16 72.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.426 2.29 . . . . 0.0 115.527 -165.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -164.02 28.96 0.08 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.494 2.317 . . . . 0.0 110.784 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -112.01 161.14 16.78 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.55 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -71.27 1.09 6.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 -101.99 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.099 1.759 . . . . 0.0 110.921 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -131.84 155.6 81.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.268 1.027 . . . . 0.0 110.634 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.27 12.48 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.291 3.328 . . . . 0.0 113.713 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.66 -4.56 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.11 2.564 . . . . 0.0 112.869 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -80.19 -3.26 48.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.203 1.401 . . . . 0.0 113.82 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.37 -26.08 67.59 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -155.78 159.24 39.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.514 0.726 . . . . 0.0 112.698 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.31 -42.81 0.4 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.472 1.511 . . . . 0.0 112.662 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.7 t -159.92 152.79 21.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.319 1.848 . . . . 0.0 110.371 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -88.67 -21.69 23.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.184 1.394 . . . . 0.0 112.819 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 58.2 -1.45 0.09 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.914 2.486 . . . . 0.0 117.094 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -135.74 18.74 3.29 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.995 1.718 . . . . 0.0 112.239 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.78 172.92 15.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.464 2.306 . . . . 0.0 109.868 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -72.52 46.37 0.15 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.649 1.98 . . . . 0.0 113.792 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.617 1.967 . . . . 0.0 110.746 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.67 152.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.445 1.498 . . . . 0.0 112.264 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 70' ' ' ILE . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -65.36 -49.9 67.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -166.52 173.39 9.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.799 2.44 . . . . 0.0 110.863 172.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.0 13.52 15.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -169.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.74 95.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.814 1.188 . . . . 0.0 112.08 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -59.72 -26.91 66.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.421 1.088 . . . . 0.0 113.851 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -68.37 -13.34 62.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.379 1.071 . . . . 0.0 113.865 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.78 -38.24 6.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -80.19 -23.36 41.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -49.58 -48.44 48.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.295 1.438 . . . . 0.0 114.002 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.0 ttp-105 -62.53 -41.81 99.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.623 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.1 m -77.34 -44.26 30.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.581 1.152 . . . . 0.0 112.902 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.01 -36.36 83.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.18 -0.95 . . . . 0.0 112.792 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.89 -10.83 52.82 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.71 -20.02 66.12 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -159.47 177.55 10.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.713 0.805 . . . . 0.0 112.511 -166.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 p -54.96 -16.97 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.436 . . . . 0.0 114.395 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -57.81 -11.77 2.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 115.614 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -60.06 -26.96 66.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.38 62.99 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.5 mt 66.3 -71.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.664 2.386 . . . . 0.0 112.809 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m -176.87 154.36 1.13 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.459 2.704 . . . . 0.0 109.394 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -59.29 -4.35 0.54 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -105.23 -14.33 15.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.857 1.663 . . . . 0.0 113.025 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -115.02 -29.24 6.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.008 2.123 . . . . 0.0 114.513 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -10.98 1.3 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.068 2.147 . . . . 0.0 116.483 -171.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -56.6 -26.09 54.59 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.712 -1.242 . . . . 0.0 112.762 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -62.06 -26.96 68.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.621 1.568 . . . . 0.0 112.775 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 m -103.58 -18.68 14.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.475 1.91 . . . . 0.0 114.391 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.39 -26.24 67.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.987 1.315 . . . . 0.0 113.392 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.72 132.79 19.27 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.102 1.361 . . . . 0.0 110.677 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 t -60.04 134.24 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.321 0.649 . . . . 0.0 112.307 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.2 mt 47.28 24.22 0.42 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.867 1.667 . . . . 0.0 113.833 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 3.9 t0 46.38 36.27 3.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.913 2.085 . . . . 0.0 114.364 -166.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -80.78 149.7 29.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.307 1.043 . . . . 0.0 112.646 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 32' ' ' ILE . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.53 -15.54 62.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.8 mt 60.54 -89.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.926 1.69 . . . . 0.0 110.615 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.31 159.8 66.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.677 1.991 . . . . 0.0 109.915 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -3.2 13.23 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.922 2.415 . . . . 0.0 115.147 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 pt -63.58 -13.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.594 1.958 . . . . 0.0 114.474 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -90.45 -2.32 57.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.375 1.47 . . . . 0.0 112.833 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.03 16.28 6.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.386 1.874 . . . . 0.0 113.35 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -156.68 165.08 37.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.753 1.221 . . . . 0.0 111.228 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.73 13.01 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.2 m -55.9 -22.6 26.57 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -168.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.19 -18.7 2.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.357 1.463 . . . . 0.0 113.298 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -62.54 -20.19 64.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.526 2.33 . . . . 0.0 113.701 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -65.85 -20.97 66.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 114.56 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.8 m170 45.9 31.2 1.02 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.237 1.815 . . . . 0.0 114.45 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -77.72 -3.04 39.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.82 . . . . 0.0 113.543 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 127.892 2.477 . . . . 0.0 114.077 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -148.86 161.27 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.916 1.286 . . . . 0.0 111.767 -175.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 99' ' ' VAL . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 70' ' ' ILE . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -60.01 -38.15 81.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.9 162.45 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 127.776 2.431 . . . . 0.0 108.577 -167.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.65 4.56 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.76 83.22 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.995 0.816 . . . . 0.0 110.822 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -64.97 -33.54 76.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.694 0.798 . . . . 0.0 112.201 170.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.57 -42.42 98.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.735 0.814 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.75 -44.08 93.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.278 0.631 . . . . 0.0 111.97 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -68.37 -38.47 81.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.598 0.759 . . . . 0.0 112.927 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -39.47 74.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.064 0.946 . . . . 0.0 111.686 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -65.52 -41.42 93.17 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.6 m -68.93 -35.75 77.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.011 1.325 . . . . 0.0 113.626 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.02 -39.91 87.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.208 1.003 . . . . 0.0 113.059 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.34 -11.29 59.93 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.37 158.26 43.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 112.538 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 58.32 -52.29 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.806 2.843 . . . . 0.0 117.236 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -81.82 29.28 0.39 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.478 1.511 . . . . 0.0 113.14 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -59.73 -31.59 69.77 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.888 1.275 . . . . 0.0 113.486 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.1 m -72.5 -16.0 61.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.033 1.333 . . . . 0.0 114.13 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.45 44.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.61 137.54 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.836 0.743 . . . . 0.0 112.714 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -75.02 149.84 39.11 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.697 -0.627 . . . . 0.0 111.984 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -60.92 -0.53 0.31 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.701 2.0 . . . . 0.0 115.052 172.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -113.88 -16.14 12.26 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.343 1.857 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.45 -37.76 9.46 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.947 1.699 . . . . 0.0 113.306 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -17.98 63.68 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 2.3 p30 41.76 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 131.22 3.808 . . . . 0.0 119.893 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.8 p -62.01 -21.62 65.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 119.952 -1.717 . . . . 0.0 114.477 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -85.9 -18.48 32.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.15 1.38 . . . . 0.0 114.279 170.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.09 -24.18 13.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.206 1.802 . . . . 0.0 113.546 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.85 177.11 8.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.077 1.351 . . . . 0.0 112.216 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.61 -176.9 4.5 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.018 1.327 . . . . 0.0 111.269 -168.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 64' ' ' THR . 52.4 mt -69.59 45.0 0.06 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 128.338 2.655 . . . . 0.0 114.754 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.5 29.38 18.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 114.402 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -95.13 155.05 16.89 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 99' ' ' VAL . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.508 HG13 ' HB ' ' A' ' 99' ' ' VAL . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 4' ' ' ILE . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 77' ' ' THR 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.24 134.89 45.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 mt -71.77 169.96 14.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.067 0.947 . . . . 0.0 113.291 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.37 159.8 63.8 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.865 0.866 . . . . 0.0 110.816 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.23 4.22 7.17 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.931 2.421 . . . . 0.0 114.724 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 pt -57.73 -18.41 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.23 2.212 . . . . 0.0 115.041 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.24 -9.15 59.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.642 1.577 . . . . 0.0 113.852 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.07 -13.0 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.04 163.2 39.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.036 0.835 . . . . 0.0 112.51 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.84 -41.86 1.51 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.234 1.873 . . . . 0.0 114.466 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.3 m -70.85 19.0 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.853 2.461 . . . . 0.0 115.13 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -69.45 176.72 3.25 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.186 1.794 . . . . 0.0 113.359 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -123.14 174.18 7.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.408 1.483 . . . . 0.0 111.569 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -125.67 -0.84 7.41 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -159.86 -51.99 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.754 1.221 . . . . 0.0 111.699 174.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -152.19 167.57 28.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 t60 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.899 1.68 . . . . 0.0 111.695 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.692 0.282 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 88' ' ' TYR . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 70' ' ' ILE . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 . . . . . 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 . . . . . 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.502 -0.899 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 . . . . . 0 C--O 1.236 0.344 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 97' ' ' VAL . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 . . . . . 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 70' ' ' ILE . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.432 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 98' ' ' ARG . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 97' ' ' VAL . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 . . . . . 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 70' ' ' ILE . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.477 0.912 0 CA-C-O 119.79 -0.148 . . . . 0.0 110.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.478 0.958 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' C ' HD12 ' A' ' 70' ' ' ILE . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 . . . . . 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 . . . . . 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.561 ' N ' HG22 ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 . . . . . 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.933 0 CA-C-O 119.508 -0.282 . . . . 0.0 110.604 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 70' ' ' ILE . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 . . . . . 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 97' ' ' VAL . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.5 ' H ' HG12 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 . . . . . 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.567 0.222 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 70' ' ' ILE . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 . . . . . 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 . . . . . 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 88' ' ' TYR . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 70' ' ' ILE . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 73' ' ' PRO . 5.3 t . . . . . 0 N--CA 1.471 0.622 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 70' ' ' ILE . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 . . . . . 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 2' ' ' VAL . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 4' ' ' ILE . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 . . . . . 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.451 HG21 ' HG3' ' A' ' 73' ' ' PRO . 6.1 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.786 0.327 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 88' ' ' TYR . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HG3' HG21 ' A' ' 2' ' ' VAL . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 4' ' ' ILE . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 . . . . . 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.479 0.989 0 CA-C-O 120.437 0.16 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 88' ' ' TYR . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 . . . . . 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 . . . . . 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' C ' HD12 ' A' ' 70' ' ' ILE . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 69' ' ' GLU . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 . . . . . 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 70' ' ' ILE . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 . . . . . 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 32' ' ' ILE . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 87' ' ' ASP . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 98' ' ' ARG . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 97' ' ' VAL . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 . . . . . 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 . . . . . 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 4' ' ' ILE . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 . . . . . 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.508 HD12 HD11 ' A' ' 70' ' ' ILE . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 . . . . . 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.524 ' C ' HG23 ' A' ' 99' ' ' VAL . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.55 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 70' ' ' ILE . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 32' ' ' ILE . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 . . . . . 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 99' ' ' VAL . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 70' ' ' ILE . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 99' ' ' VAL . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.508 HG13 ' HB ' ' A' ' 99' ' ' VAL . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 4' ' ' ILE . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 77' ' ' THR 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 119.932 -0.08 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.64 152.92 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 125.823 1.649 . . . . 0.0 111.112 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.27 92.2 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 N-CA-C 103.312 -2.848 . . . . 0.0 103.312 166.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.29 148.87 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 125.161 1.385 . . . . 0.0 110.01 -169.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.5 mttt -143.89 153.46 57.41 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 124.455 1.102 . . . . 0.0 113.656 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -81.41 146.69 15.58 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.916 2.411 . . . . 0.0 113.174 -173.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -75.64 -6.5 50.71 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.9 m -143.05 176.76 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 C-N-CA 126.329 1.852 . . . . 0.0 110.516 176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 79.4 p -108.98 163.73 13.04 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.545 1.138 . . . . 0.0 112.239 170.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.12 -129.36 3.73 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 108.381 -1.887 . . . . 0.0 108.381 -169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.417 HG22 ' HA ' ' A' ' 88' ' ' TYR . 11.3 t -152.1 144.15 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 112.929 -1.636 . . . . 0.0 109.055 -167.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 24.3 mm -63.05 146.15 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.59 -34.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 127.143 2.177 . . . . 0.0 112.37 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.97 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.512 0.725 . . . . 0.0 111.08 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -127.41 93.7 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 128.047 2.539 . . . . 0.0 108.154 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -72.7 -46.48 53.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.752 0.821 . . . . 0.0 111.94 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.16 -176.47 1.8 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.983 1.313 . . . . 0.0 111.72 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -135.93 135.7 39.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.699 1.2 . . . . 0.0 111.995 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.96 108.02 0.71 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.201 1.4 . . . . 0.0 111.758 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.16 -11.43 57.11 Favored Glycine 0 CA--C 1.543 1.795 0 C-N-CA 125.152 1.358 . . . . 0.0 115.446 178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.41 -161.25 0.21 Allowed 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 119.199 1.5 . . . . 0.0 113.572 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -108.3 169.11 8.84 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.012 1.725 . . . . 0.0 111.467 174.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.44 141.39 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.339 1.455 . . . . 0.0 111.455 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 -179.82 1.83 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.139 0.975 . . . . 0.0 111.457 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -67.94 41.41 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 127.869 2.468 . . . . 0.0 113.797 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.59 27.89 1.38 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.342 1.448 . . . . 0.0 116.298 -169.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.255 0.0 OUTLIER -53.07 143.8 16.76 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.679 1.739 . . . . 0.0 111.528 169.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.3 m -63.74 135.53 56.74 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.846 1.658 . . . . 0.0 110.937 170.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.4 mt -119.46 -44.11 2.58 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.968 1.707 . . . . 0.0 112.709 -168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -141.81 166.55 24.41 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.4 mt -129.37 141.84 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.967 1.707 . . . . 0.0 106.821 171.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.516 HD12 HD11 ' A' ' 70' ' ' ILE . 51.8 mt -127.52 150.56 33.46 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 C-N-CA 126.165 1.786 . . . . 0.0 111.186 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -110.93 128.52 55.85 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.127 1.371 . . . . 0.0 108.561 168.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -71.02 28.83 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.559 1.944 . . . . 0.0 114.734 -173.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.0 t70 37.1 -85.56 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 130.714 3.605 . . . . 0.0 116.259 174.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.87 8.0 4.43 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.63 -43.27 89.99 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 122.132 0.967 . . . . 0.0 110.302 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 m -79.64 -2.21 41.66 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.78 2.032 . . . . 0.0 114.364 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -54.46 -38.86 66.87 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -170.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -75.76 -24.58 56.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.35 1.06 . . . . 0.0 113.548 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -98.13 -25.77 14.8 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.866 1.667 . . . . 0.0 113.646 -169.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.78 -42.15 91.13 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.704 2.002 . . . . 0.0 114.536 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -60.24 -44.05 95.58 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -164.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.3 p -59.23 -50.4 74.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.68 0.673 . . . . 0.0 112.734 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -68.34 -35.47 77.8 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.1 -37.69 88.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.551 0.74 . . . . 0.0 112.99 176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 80.3 mt -68.3 -56.9 6.98 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.981 0.913 . . . . 0.0 112.588 169.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.92 -31.51 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 116.794 2.146 . . . . 0.0 116.794 -163.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.7 m -61.52 -19.44 62.11 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -50.11 -29.23 8.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.345 1.458 . . . . 0.0 114.679 174.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.2 t -77.66 -19.69 54.97 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -83.11 -172.77 4.33 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 mm -124.48 -18.89 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.006 1.722 . . . . 0.0 111.763 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.6 m -57.38 135.46 56.54 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 125.067 1.347 . . . . 0.0 112.317 177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.36 -6.38 0.99 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 -168.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.3 mttt -117.99 -12.98 10.03 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.312 1.045 . . . . 0.0 112.359 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -98.64 -40.98 7.93 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 127.316 2.246 . . . . 0.0 112.426 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.68 3.83 0.93 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 127.228 2.211 . . . . 0.0 116.761 -172.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -60.0 -19.4 52.22 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -167.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.9 m -59.9 -27.62 66.88 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.523 -1.36 . . . . 0.0 113.284 169.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 51.0 m -75.01 -16.92 60.59 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 172.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -102.5 -34.81 8.99 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.837 1.655 . . . . 0.0 112.836 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.18 7.27 1.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m 46.23 -138.43 0.58 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.726 1.611 . . . . 0.0 111.506 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -77.1 55.38 1.15 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.854 1.662 . . . . 0.0 111.11 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 63.03 46.06 4.94 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 113.769 170.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -100.68 157.07 16.96 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.5 m -140.8 142.04 34.7 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.463 1.105 . . . . 0.0 109.848 169.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -100.35 153.65 19.15 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.087 0.955 . . . . 0.0 111.304 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.516 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.33 139.01 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 125.174 1.39 . . . . 0.0 108.241 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.0 ptmt -136.36 155.18 50.42 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.184 1.394 . . . . 0.0 112.801 -172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.92 161.83 14.38 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.985 0.914 . . . . 0.0 112.481 174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -82.48 -42.09 0.1 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.676 2.25 . . . . 0.0 114.409 169.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -156.64 167.13 31.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.442 1.497 . . . . 0.0 113.54 -167.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -60.59 137.61 58.15 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.683 1.193 . . . . 0.0 112.185 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.56 30.58 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 122.096 0.831 . . . . 0.0 114.893 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.9 m -104.3 160.4 14.92 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.67 1.588 . . . . 0.0 109.343 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.13 136.82 47.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.43 0.634 . . . . 0.0 110.434 -176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.92 -171.02 45.43 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.817 0.676 . . . . 0.0 113.467 -169.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 127.07 30.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.445 0.64 . . . . 0.0 111.466 168.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.79 139.08 52.16 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.92 0.888 . . . . 0.0 110.222 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 71.0 mt -95.38 -6.45 40.97 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.586 1.154 . . . . 0.0 112.996 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.7 m -143.06 158.29 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.08 1.352 . . . . 0.0 112.775 -168.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.61 170.26 16.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.202 2.201 . . . . 0.0 110.375 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.25 102.9 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 126.805 2.042 . . . . 0.0 109.502 -178.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.54 -13.2 18.29 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.967 -175.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -65.33 126.49 28.38 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-N 118.909 1.355 . . . . 0.0 108.224 167.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.417 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.6 t80 -73.01 106.93 5.09 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.378 177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.6 m -109.33 150.99 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -139.23 149.47 44.38 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.805 1.242 . . . . 0.0 110.65 -175.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.271 . . -51.36 -25.42 6.03 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 121.508 3.892 . . . . 0.0 121.508 -162.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.0 p -136.89 3.27 2.68 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 165.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.0 m -96.61 -13.44 22.88 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 -163.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.7 m -125.55 -28.79 3.26 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.748 1.758 . . . . 0.0 115.748 -165.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.451 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.25 121.16 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.188 2.195 . . . . 0.0 113.055 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 17.3 mt -92.34 -39.26 11.58 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -166.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.538 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p -179.84 176.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 128.891 2.876 . . . . 0.0 108.348 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 97' ' ' VAL . 33.2 ptt-85 -109.01 140.67 42.21 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.352 1.461 . . . . 0.0 113.707 169.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -114.12 134.71 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.29 110.05 6.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.512 0.672 . . . . 0.0 112.291 -170.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -63.47 139.64 58.79 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 120.883 -1.136 . . . . 0.0 111.993 -173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.73 -59.75 4.46 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.098 1.759 . . . . 0.0 112.245 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -139.89 154.7 70.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 125.19 1.396 . . . . 0.0 111.056 171.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.2 -9.53 13.94 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.927 2.418 . . . . 0.0 114.715 -172.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.9 pt -65.8 -23.61 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.37 1.468 . . . . 0.0 113.381 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -73.86 5.79 3.83 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.717 1.607 . . . . 0.0 114.264 177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -140.86 -28.04 0.7 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.038 1.335 . . . . 0.0 114.506 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -150.76 30.04 0.66 Allowed 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.284 0.947 . . . . 0.0 113.465 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.03 -46.83 92.66 Favored Glycine 0 CA--C 1.537 1.443 0 O-C-N 120.672 -1.267 . . . . 0.0 115.216 -172.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 51.1 p -165.56 -35.5 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.9 p80 -139.78 3.43 2.05 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.065 1.346 . . . . 0.0 113.675 -175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -68.43 1.76 2.81 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.165 2.186 . . . . 0.0 115.076 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -60.81 -11.52 7.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.893 2.077 . . . . 0.0 113.873 171.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -116.77 16.35 15.31 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.705 2.002 . . . . 0.0 112.506 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -130.76 -7.89 4.02 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.309 2.244 . . . . 0.0 112.707 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 35.8 t60 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.264 1.826 . . . . 0.0 112.312 -169.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.82 146.4 32.74 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 126.867 2.067 . . . . 0.0 110.307 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.76 98.2 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 103.501 -2.778 . . . . 0.0 103.501 165.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.69 147.57 12.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 C-N-CA 124.591 1.156 . . . . 0.0 109.111 -169.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.81 154.05 58.45 Favored Pre-proline 0 N--CA 1.477 0.913 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 145.15 16.03 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.748 2.299 . . . . 0.0 112.302 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -73.16 -12.15 60.78 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.0 m -143.47 158.54 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.747 2.019 . . . . 0.0 110.883 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.7 p -80.1 158.19 26.46 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.919 -0.488 . . . . 0.0 110.931 167.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.99 -152.34 24.01 Favored Glycine 0 N--CA 1.467 0.755 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.02 145.55 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 119.025 1.412 . . . . 0.0 112.445 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.43 143.58 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.663 0.665 . . . . 0.0 112.121 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.4 -35.85 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 126.88 2.072 . . . . 0.0 111.413 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -148.23 159.21 44.2 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.511 1.125 . . . . 0.0 111.345 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.7 mmmm -124.29 93.62 3.97 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.35 2.66 . . . . 0.0 108.263 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.23 -46.81 60.28 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.578 0.751 . . . . 0.0 111.819 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.64 -179.56 3.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.887 1.275 . . . . 0.0 112.547 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -135.68 132.25 36.71 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.796 1.238 . . . . 0.0 111.481 177.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.3 98.3 0.08 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.941 1.696 . . . . 0.0 112.394 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.14 -12.39 21.98 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 125.416 1.484 . . . . 0.0 114.855 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -77.83 -169.71 1.62 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-N 119.129 1.464 . . . . 0.0 113.778 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -92.44 162.6 14.17 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.284 1.434 . . . . 0.0 111.534 169.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.5 m -131.14 137.61 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.908 2.083 . . . . 0.0 109.77 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -70.0 168.97 14.29 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.68 1.592 . . . . 0.0 109.788 168.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.6 mmmt -53.61 44.38 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 131.151 3.781 . . . . 0.0 116.993 -177.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.25 20.35 2.72 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 125.534 1.54 . . . . 0.0 115.488 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 1.7 pt20 -50.87 147.55 4.87 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 119.031 1.416 . . . . 0.0 112.953 174.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.2 m -69.36 139.44 54.19 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.755 0.822 . . . . 0.0 110.063 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 18.4 mt -121.81 -45.92 2.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.072 1.749 . . . . 0.0 112.885 -167.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -141.65 165.56 27.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.646 0.778 . . . . 0.0 112.378 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.7 mt -130.36 141.06 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 13.0 mt -125.45 152.52 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 C-N-CA 126.138 1.775 . . . . 0.0 111.346 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -114.28 116.04 28.37 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 168.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -64.78 -7.37 10.76 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.36 42.33 17.95 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.088 2.155 . . . . 0.0 112.905 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.22 5.74 10.26 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 115.217 1.562 . . . . 0.0 115.217 -168.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.15 -58.53 5.36 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.289 1.036 . . . . 0.0 113.079 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.2 m -69.58 -25.35 63.94 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -60.42 -30.92 69.93 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.968 0.907 . . . . 0.0 112.302 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -90.25 -50.04 6.21 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.061 0.544 . . . . 0.0 111.453 168.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -69.89 -40.35 75.7 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -167.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -70.67 -39.23 73.69 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.321 -0.862 . . . . 0.0 111.065 172.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.9 ttt-85 -68.11 -43.76 77.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.103 -169.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.2 p -61.55 -14.88 33.55 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 115.533 1.679 . . . . 0.0 115.533 -173.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -57.08 -17.69 11.46 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.042 1.737 . . . . 0.0 114.114 178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.62 12.44 1.7 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 125.414 1.486 . . . . 0.0 113.897 172.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.8 mt -146.67 177.82 8.78 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.466 1.506 . . . . 0.0 112.933 -169.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -54.84 162.4 1.26 Allowed 'General case' 0 C--O 1.24 0.571 0 C-N-CA 125.95 1.7 . . . . 0.0 113.597 168.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 83.6 p -149.12 164.88 33.41 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -65.4 -19.78 66.09 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.48 0.712 . . . . 0.0 112.838 169.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 m -78.96 -6.73 57.0 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 171.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.98 -20.0 61.79 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -63.35 160.5 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.729 2.012 . . . . 0.0 110.669 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 61.8 m -44.01 135.82 4.03 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.581 1.552 . . . . 0.0 113.57 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -59.19 0.71 0.09 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 127.899 2.48 . . . . 0.0 116.133 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -113.68 -24.73 9.04 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.379 1.872 . . . . 0.0 112.6 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -98.92 -37.37 9.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 113.276 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -8.75 6.63 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 -172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.74 -22.93 62.74 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -168.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.3 p -59.61 -26.07 65.16 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 171.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m -85.67 -14.96 43.91 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.012 1.325 . . . . 0.0 113.592 174.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -102.3 -29.08 11.88 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.32 1.848 . . . . 0.0 112.79 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.3 21.47 1.71 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -168.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -138.01 -175.72 4.19 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 120.696 -1.252 . . . . 0.0 111.992 172.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' H ' HG22 ' A' ' 64' ' ' THR . 36.5 mt -118.6 24.59 10.8 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.725 2.01 . . . . 0.0 112.563 -166.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.333 5.7 p-10 47.77 36.34 5.66 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.357 1.463 . . . . 0.0 114.785 -172.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -81.44 155.84 25.66 Favored 'General case' 0 C--O 1.236 0.344 0 O-C-N 121.38 -0.825 . . . . 0.0 113.104 169.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.8 m -143.81 142.49 30.89 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 110.727 170.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -95.94 154.04 17.44 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.471 1.108 . . . . 0.0 111.826 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.14 135.65 62.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.491 1.516 . . . . 0.0 108.021 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -133.87 149.38 51.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.982 1.313 . . . . 0.0 111.648 -169.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 162.26 12.28 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.036 0.935 . . . . 0.0 112.409 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.24 -41.5 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.902 2.401 . . . . 0.0 114.204 169.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -158.72 174.17 15.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.569 1.948 . . . . 0.0 113.074 -167.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -78.99 133.43 36.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.373 1.069 . . . . 0.0 111.751 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.58 -160.12 28.34 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 123.589 0.614 . . . . 0.0 112.828 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -104.58 157.42 17.19 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.445 1.498 . . . . 0.0 108.981 172.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.3 tt -132.2 136.33 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.369 0.604 . . . . 0.0 110.435 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.07 -172.01 32.9 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 123.747 0.689 . . . . 0.0 113.559 -171.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -64.4 135.75 56.43 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.566 -0.961 . . . . 0.0 111.384 168.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.1 137.71 56.69 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.298 175.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.69 -3.03 50.09 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.222 1.409 . . . . 0.0 112.843 175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -144.47 157.81 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 127.036 2.135 . . . . 0.0 111.943 -169.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -135.84 166.63 22.86 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 127.233 2.213 . . . . 0.0 109.568 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.8 mp -56.03 104.6 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.225 1.81 . . . . 0.0 109.694 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.06 -9.99 15.43 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.492 1.52 . . . . 0.0 113.344 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.96 123.01 19.42 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.792 1.296 . . . . 0.0 111.717 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -65.31 135.71 55.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.483 0.713 . . . . 0.0 110.62 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.67 160.21 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 126.202 1.801 . . . . 0.0 111.853 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -132.37 151.18 51.97 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.951 1.7 . . . . 0.0 109.721 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.98 -19.18 60.8 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 119.931 3.308 . . . . 0.0 119.931 -165.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.8 p -134.47 -3.26 2.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 165.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.98 -15.63 21.0 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 -163.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.5 m -120.75 -27.49 5.05 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -164.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 61.45 126.06 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 127.156 2.183 . . . . 0.0 114.045 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.43 -35.2 9.98 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.328 1.973 . . . . 0.0 116.328 -167.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.5 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 177.18 172.35 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 128.465 2.706 . . . . 0.0 109.053 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 97' ' ' VAL . 1.4 ptt180 -104.09 147.09 27.82 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 120.438 1.472 . . . . 0.0 114.775 168.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -122.3 132.55 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.855 1.207 . . . . 0.0 108.452 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.0 t -141.33 121.23 13.59 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -172.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -69.71 -13.35 62.25 Favored 'General case' 0 CA--C 1.548 0.883 0 O-C-N 121.2 -0.937 . . . . 0.0 113.419 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 mt 52.75 -164.47 0.08 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.538 1.535 . . . . 0.0 111.76 -171.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.05 156.5 87.64 Favored Pre-proline 0 CA--C 1.552 1.047 0 O-C-N 120.945 -1.097 . . . . 0.0 108.571 166.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.53 -16.43 30.57 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.223 1.949 . . . . 0.0 114.981 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 pt -63.92 -6.63 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 127.173 2.189 . . . . 0.0 115.227 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -117.62 4.53 12.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.27 1.828 . . . . 0.0 112.69 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -141.75 -14.34 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.946 1.298 . . . . 0.0 114.367 -176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -153.09 173.02 16.0 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 119.552 1.069 . . . . 0.0 112.263 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.01 -173.9 38.44 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.742 1.163 . . . . 0.0 113.941 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.6 t -145.25 153.05 40.9 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.827 1.251 . . . . 0.0 111.499 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 75.3 t60 -156.74 154.76 30.51 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.676 1.59 . . . . 0.0 111.452 -174.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -152.44 138.34 18.07 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.484 1.514 . . . . 0.0 111.306 171.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -146.63 0.62 0.78 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.664 1.585 . . . . 0.0 112.968 169.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -70.44 161.63 30.18 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.373 2.269 . . . . 0.0 114.315 -168.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -73.67 4.79 4.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.209 1.804 . . . . 0.0 114.634 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.0 m80 . . . . . 0 C--O 1.253 1.269 0 C-N-CA 127.002 2.121 . . . . 0.0 111.692 -170.194 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.45 0.167 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 156.25 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.548 1.939 . . . . 0.0 111.582 -174.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 mm -127.35 95.44 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 128.89 2.876 . . . . 0.0 104.127 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.5 150.31 10.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 C-N-CA 126.202 1.801 . . . . 0.0 110.571 -170.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 68.5 mttt -143.69 153.55 58.22 Favored Pre-proline 0 N--CA 1.47 0.529 0 C-N-CA 124.715 1.206 . . . . 0.0 113.438 -175.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -80.11 142.48 15.35 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.708 2.272 . . . . 0.0 112.173 -174.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -70.63 -14.24 62.4 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.42 160.41 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.095 1.758 . . . . 0.0 110.978 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.7 p -82.66 156.92 23.58 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 121.636 -0.665 . . . . 0.0 111.639 169.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.68 -150.89 22.66 Favored Glycine 0 N--CA 1.465 0.576 0 C-N-CA 125.112 1.339 . . . . 0.0 109.906 -174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -132.12 145.05 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 118.92 1.36 . . . . 0.0 112.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.5 mm -62.05 142.51 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 118.973 0.806 . . . . 0.0 111.676 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -122.51 -35.43 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 127.111 2.165 . . . . 0.0 111.39 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -149.01 158.24 44.03 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.209 1.004 . . . . 0.0 111.621 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -123.5 93.84 4.06 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 128.482 2.713 . . . . 0.0 107.921 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.79 -48.16 64.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.877 0.871 . . . . 0.0 110.903 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -71.15 178.82 3.09 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.511 1.124 . . . . 0.0 112.498 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -138.86 135.19 34.26 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.413 1.485 . . . . 0.0 110.782 176.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.46 108.83 0.77 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.644 1.178 . . . . 0.0 111.907 177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.27 -13.14 51.84 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.339 1.447 . . . . 0.0 115.367 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -77.11 -176.52 4.06 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 119.116 1.458 . . . . 0.0 113.5 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -87.73 165.23 15.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.365 1.466 . . . . 0.0 111.867 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -137.04 139.15 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.843 2.057 . . . . 0.0 109.503 169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -69.61 -177.95 1.34 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.595 1.158 . . . . 0.0 111.924 169.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.3 mmmt -59.08 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 128.737 2.815 . . . . 0.0 116.688 177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.8 29.86 1.11 Allowed Glycine 0 N--CA 1.467 0.761 0 O-C-N 120.488 -1.382 . . . . 0.0 115.62 -169.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -57.98 150.8 19.84 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 118.787 1.293 . . . . 0.0 112.904 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.0 m -68.8 138.29 54.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.91 1.284 . . . . 0.0 110.934 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.12 -44.31 2.29 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.455 1.902 . . . . 0.0 112.986 -169.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -140.03 164.76 29.15 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 53.6 mt -130.48 139.75 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.961 1.705 . . . . 0.0 106.864 171.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.534 HD12 HD11 ' A' ' 70' ' ' ILE . 14.9 mt -126.41 151.45 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 126.016 1.726 . . . . 0.0 112.443 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -115.25 114.88 25.8 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.349 0.66 . . . . 0.0 109.774 168.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -57.69 -52.47 65.3 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.65 161.66 1.7 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 127.412 2.285 . . . . 0.0 109.025 -167.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.442 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -139.63 12.63 2.52 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -178.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.87 -35.78 66.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 75.0 m -96.9 -2.99 42.68 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 175.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 32.9 ttpt -62.27 -24.62 67.38 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -168.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -119.48 -27.96 5.44 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.699 1.6 . . . . 0.0 112.286 168.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -74.4 -5.92 45.2 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -58.63 -15.45 11.71 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -58.83 -37.57 76.74 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -167.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.3 p -72.45 -35.06 68.18 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.549 1.14 . . . . 0.0 112.968 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -68.56 -31.16 70.17 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.405 1.482 . . . . 0.0 112.326 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.61 -22.9 47.99 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.399 1.479 . . . . 0.0 114.333 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.3 mp -57.76 -21.08 39.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.331 1.452 . . . . 0.0 114.346 172.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.31 9.03 1.22 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -169.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.1 m -75.96 2.63 12.08 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.95 1.7 . . . . 0.0 114.668 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -62.8 -17.82 61.76 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.969 1.308 . . . . 0.0 114.265 -172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.1 p -62.83 -25.51 68.29 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.752 -1.217 . . . . 0.0 113.627 168.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.33 5.73 37.49 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 127.661 2.384 . . . . 0.0 112.564 170.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mp 73.46 -59.68 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.741 2.817 . . . . 0.0 110.05 -169.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.4 m -167.36 144.52 4.51 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.783 2.033 . . . . 0.0 110.016 169.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -61.3 7.76 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 127.09 2.156 . . . . 0.0 115.578 174.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.02 -15.59 4.22 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.95 2.1 . . . . 0.0 113.23 -175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.76 -45.16 6.12 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.665 1.186 . . . . 0.0 112.355 171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.62 -31.89 64.75 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.906 1.282 . . . . 0.0 114.285 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -82.2 -13.75 56.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.586 1.555 . . . . 0.0 113.95 -173.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.2 p -57.89 -21.93 45.7 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -103.11 -12.67 17.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.293 1.437 . . . . 0.0 114.273 172.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -102.26 -55.18 2.53 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 0.0 113.061 -170.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -175.99 67.34 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 127.455 2.302 . . . . 0.0 109.502 -168.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -50.31 129.78 22.09 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.042 1.337 . . . . 0.0 111.772 -174.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 76.9 mt 43.69 39.31 2.38 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.039 1.336 . . . . 0.0 113.471 -173.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.66 22.09 12.98 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.611 1.564 . . . . 0.0 113.317 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -87.56 149.75 24.14 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.0 m -135.28 141.32 45.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.824 0.85 . . . . 0.0 110.007 170.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -96.95 153.68 17.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.463 1.105 . . . . 0.0 111.631 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.534 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.37 136.87 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 125.602 1.561 . . . . 0.0 107.618 -178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -135.09 158.97 42.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.489 1.116 . . . . 0.0 113.309 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 162.74 14.72 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.676 1.191 . . . . 0.0 112.791 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.01 -40.99 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.048 2.498 . . . . 0.0 114.306 169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -159.36 170.41 21.88 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.159 1.783 . . . . 0.0 112.631 -167.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.12 134.4 44.47 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.571 1.148 . . . . 0.0 112.415 178.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.23 -158.21 26.59 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.477 0.56 . . . . 0.0 113.49 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 m -110.05 160.25 16.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.572 1.149 . . . . 0.0 109.45 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.8 tt -131.58 139.32 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 O-C-N 121.489 -0.757 . . . . 0.0 111.268 -171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.46 -171.05 47.16 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 114.031 0.372 . . . . 0.0 114.031 -169.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.2 130.87 47.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.967 0.889 . . . . 0.0 112.185 168.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.79 148.39 29.93 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.422 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.3 mt -104.85 -1.46 25.98 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.772 1.629 . . . . 0.0 113.082 176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.68 158.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 126.705 2.002 . . . . 0.0 111.557 -169.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -136.34 167.14 21.88 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.801 2.04 . . . . 0.0 109.981 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.432 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -56.44 103.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 126.248 1.819 . . . . 0.0 109.977 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.53 -10.1 12.86 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.763 1.649 . . . . 0.0 113.14 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -68.37 122.6 18.72 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.941 1.37 . . . . 0.0 112.052 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -64.76 136.63 57.13 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.125 0.57 . . . . 0.0 110.465 167.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.5 m -140.69 159.53 24.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 C-N-CA 126.116 1.767 . . . . 0.0 112.018 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.2 t -133.04 149.87 52.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.571 1.548 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.09 -22.66 29.26 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 121.023 3.712 . . . . 0.0 121.023 -163.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.1 t -135.53 0.46 2.75 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 164.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.2 m -96.55 -13.92 22.62 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -164.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.0 m -120.97 -29.52 4.58 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -166.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.75 128.44 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 127.467 2.307 . . . . 0.0 113.805 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.0 mt -99.7 -38.73 8.58 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -166.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 98' ' ' ARG . 10.8 p 177.93 160.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 127.461 2.304 . . . . 0.0 109.957 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 97' ' ' VAL . 27.8 ptt-85 -84.7 143.82 28.95 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 168.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.9 t -116.75 136.31 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-N 119.892 1.224 . . . . 0.0 108.328 170.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.09 113.47 8.07 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.667 1.222 . . . . 0.0 114.157 -170.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -79.74 105.64 11.18 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.033 -1.042 . . . . 0.0 109.317 171.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.01 162.95 6.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.396 0.678 . . . . 0.0 111.32 169.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -57.8 149.07 55.39 Favored Pre-proline 0 CA--C 1.553 1.081 0 O-C-N 121.523 -0.735 . . . . 0.0 110.817 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.97 0.81 6.89 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.391 2.727 . . . . 0.0 114.008 -168.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.5 pt -72.13 -9.35 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 127.084 2.154 . . . . 0.0 115.303 -169.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.8 m-30 -61.71 -14.69 34.0 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.105 1.362 . . . . 0.0 114.661 -178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.97 -3.73 24.39 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.872 1.269 . . . . 0.0 114.387 169.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -148.04 -170.21 3.53 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.601 1.16 . . . . 0.0 111.795 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.41 5.71 0.03 OUTLIER Glycine 0 CA--C 1.542 1.728 0 C-N-CA 125.184 1.373 . . . . 0.0 114.855 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.4 m -83.73 18.05 2.09 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.153 1.476 . . . . 0.0 113.892 -177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -64.51 152.63 41.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.796 1.638 . . . . 0.0 113.111 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -126.41 1.68 6.98 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 69.9 m-70 58.96 -8.11 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 118.518 2.784 . . . . 0.0 118.518 170.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 68.3 t60 -122.23 -7.53 8.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.896 1.678 . . . . 0.0 112.897 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -132.05 14.53 4.72 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.388 1.875 . . . . 0.0 112.509 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.699 2.4 . . . . 0.0 110.568 -175.686 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.2 t70 . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.373 0.13 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.58 153.2 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.767 1.627 . . . . 0.0 112.172 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -117.95 94.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 103.346 -2.835 . . . . 0.0 103.346 165.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -66.73 148.93 11.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 125.104 1.361 . . . . 0.0 110.258 -169.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.448 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.3 mttt -144.05 153.85 57.37 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.12 146.01 14.08 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 123.343 2.695 . . . . 0.0 112.816 -172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -75.7 -13.95 60.33 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -141.14 156.61 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 125.622 1.569 . . . . 0.0 110.746 172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 98.2 p -75.91 164.16 26.47 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.741 -0.6 . . . . 0.0 110.921 168.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.7 -151.22 23.35 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.9 m -130.26 145.11 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 118.984 1.392 . . . . 0.0 112.712 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 18.2 mm -61.84 143.72 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 118.75 0.705 . . . . 0.0 111.91 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.6 t -124.12 -35.06 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 126.788 2.035 . . . . 0.0 111.664 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -148.94 157.21 43.25 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.231 1.012 . . . . 0.0 110.877 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -122.94 93.89 4.1 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 128.103 2.561 . . . . 0.0 107.445 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -68.34 -49.44 60.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.795 0.807 . . . . 0.0 111.294 -179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -70.27 178.79 2.68 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.535 -1.211 . . . . 0.0 112.301 172.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 39.9 mmtm -139.86 139.44 36.28 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.22 1.408 . . . . 0.0 110.299 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.06 104.21 0.23 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.051 0.941 . . . . 0.0 112.427 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 105.9 -8.62 42.81 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.468 1.509 . . . . 0.0 115.202 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -70.3 -175.1 0.93 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 119.208 1.504 . . . . 0.0 113.142 173.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -98.12 172.53 7.54 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.551 1.541 . . . . 0.0 111.999 169.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.91 135.67 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.023 1.729 . . . . 0.0 111.006 173.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.401 ' HD2' ' H ' ' A' ' 25' ' ' LYS . 16.3 tptm -73.8 163.45 27.93 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.19 1.796 . . . . 0.0 108.447 166.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 17.1 mmmt -50.7 57.74 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 130.086 3.354 . . . . 0.0 116.623 -175.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.42 28.03 5.6 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 120.394 -1.441 . . . . 0.0 114.416 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -54.4 150.84 8.33 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.018 0.909 . . . . 0.0 113.103 171.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.8 m -67.27 138.77 57.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.813 1.245 . . . . 0.0 110.866 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.5 mt -123.01 -43.51 2.23 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.084 1.754 . . . . 0.0 112.721 -169.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -139.37 167.03 22.99 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 42.2 mt -132.1 140.85 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 126.104 1.761 . . . . 0.0 107.646 171.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 70' ' ' ILE . 20.2 mt -126.02 151.13 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 126.577 1.951 . . . . 0.0 112.196 -177.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -111.7 115.93 29.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.827 0.851 . . . . 0.0 110.22 170.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -58.49 -41.64 85.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -168.34 170.36 10.0 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.188 1.795 . . . . 0.0 111.375 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.15 18.2 6.02 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.13 -52.83 64.01 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.827 0.851 . . . . 0.0 112.053 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.2 p -64.62 -30.06 71.08 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.73 1.212 . . . . 0.0 113.222 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 31.3 ttpt -66.89 -32.48 73.78 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.969 -0.457 . . . . 0.0 111.737 175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -80.41 -35.27 35.42 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 171.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -98.38 -40.28 8.38 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -167.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -92.4 -51.42 5.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 123.75 0.82 . . . . 0.0 111.952 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.9 mmt180 -69.72 -21.51 63.47 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -168.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -65.74 -47.51 75.04 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.006 1.322 . . . . 0.0 111.962 168.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -67.52 -36.54 81.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.15 1.38 . . . . 0.0 112.384 174.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.77 -20.47 50.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.038 1.335 . . . . 0.0 114.152 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.18 -24.36 64.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.088 1.355 . . . . 0.0 113.891 171.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -152.01 11.28 0.55 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 -167.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 15.1 t -146.91 163.82 34.91 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 112.404 -174.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -72.69 -0.21 12.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.859 1.663 . . . . 0.0 113.573 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.1 p -52.95 -28.09 21.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.857 1.663 . . . . 0.0 115.215 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -12.97 6.38 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.0 mm -125.4 -10.95 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 126.945 2.098 . . . . 0.0 111.6 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.5 m -56.73 118.52 4.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.895 1.278 . . . . 0.0 112.296 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -54.37 -6.15 0.1 Allowed 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 118.759 2.874 . . . . 0.0 118.759 -168.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -124.3 -4.94 7.81 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.368 1.867 . . . . 0.0 113.38 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -112.88 -34.24 5.83 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.406 1.482 . . . . 0.0 113.946 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.15 -1.48 0.48 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.52 1.928 . . . . 0.0 116.005 -174.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.38 -29.66 64.25 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.758 -1.214 . . . . 0.0 111.14 167.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.8 p -59.09 -18.35 34.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.646 1.578 . . . . 0.0 114.972 168.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.9 m -102.78 -33.19 9.47 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.066 2.147 . . . . 0.0 113.285 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.7 mt -64.16 -35.07 79.58 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.7 1.2 . . . . 0.0 113.156 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.39 70.87 1.33 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.419 1.888 . . . . 0.0 108.725 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.6 m -35.87 114.51 0.27 Allowed 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 127.316 2.247 . . . . 0.0 115.039 -168.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.4 mt 41.36 27.15 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.3 t0 46.76 45.58 14.81 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.587 1.555 . . . . 0.0 113.671 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 38.0 m170 -73.18 145.39 46.35 Favored 'General case' 0 C--N 1.343 0.305 0 O-C-N 121.337 -0.852 . . . . 0.0 112.798 172.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 95.1 m -136.26 137.78 41.11 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.823 0.849 . . . . 0.0 110.922 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -90.29 154.93 19.35 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.372 1.069 . . . . 0.0 111.742 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.19 137.75 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 125.558 1.543 . . . . 0.0 108.026 178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -136.81 156.48 48.44 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.38 166.58 6.72 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 126.066 1.746 . . . . 0.0 113.555 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.77 -41.88 0.14 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.301 2.667 . . . . 0.0 114.673 169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -157.92 178.91 9.71 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.622 1.569 . . . . 0.0 113.837 -165.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -82.45 135.77 35.06 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.727 1.211 . . . . 0.0 112.087 175.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.15 -151.4 16.57 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-O 121.522 0.512 . . . . 0.0 113.407 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.6 m -115.11 156.2 25.66 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.439 1.496 . . . . 0.0 109.195 175.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -130.51 132.74 64.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.51 0.671 . . . . 0.0 110.56 -172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.91 -167.68 41.54 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 122.421 1.012 . . . . 0.0 114.227 -167.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -59.58 125.26 22.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 122.194 0.997 . . . . 0.0 112.153 169.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.96 156.46 5.28 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.769 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 95.6 mt -118.22 -0.99 11.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.478 1.511 . . . . 0.0 112.834 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.9 m -145.93 159.1 11.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 127.251 2.22 . . . . 0.0 111.165 -170.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -136.49 167.6 21.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.497 1.919 . . . . 0.0 109.954 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -57.28 104.98 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.959 1.703 . . . . 0.0 109.521 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.3 -10.91 12.98 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.847 1.689 . . . . 0.0 112.935 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -68.71 123.58 21.29 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.178 1.489 . . . . 0.0 111.7 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -65.31 136.54 56.69 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.158 0.583 . . . . 0.0 111.055 168.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.87 160.79 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 126.462 1.905 . . . . 0.0 112.045 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -132.62 151.96 51.79 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 109.886 178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.07 -21.17 58.74 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 120.521 3.526 . . . . 0.0 120.521 -165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.0 p -135.58 -1.26 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 166.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.84 -14.56 21.78 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 118.094 2.628 . . . . 0.0 118.094 -164.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.9 m -122.1 -28.12 4.44 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -164.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.448 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.89 127.74 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.357 . . . . 0.0 114.05 173.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.0 mt -99.27 -37.03 9.44 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -167.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.544 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 179.63 177.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 128.386 2.674 . . . . 0.0 108.187 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 97' ' ' VAL . 11.7 ptt180 -109.28 140.4 42.99 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.631 1.573 . . . . 0.0 113.927 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.33 135.96 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.4 106.88 5.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 122.184 0.992 . . . . 0.0 112.983 -168.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -64.66 132.75 50.59 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 120.996 -1.065 . . . . 0.0 111.352 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 27.0 mt -68.46 -69.11 0.35 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.099 0.96 . . . . 0.0 111.307 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.55 168.24 14.53 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 126.715 2.006 . . . . 0.0 110.139 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -82.07 22.23 0.88 Allowed 'Trans proline' 0 CA--C 1.551 1.333 0 C-N-CA 124.003 3.135 . . . . 0.0 112.769 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.5 pt -145.84 174.51 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 129.865 3.266 . . . . 0.0 108.584 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 63.27 -22.62 0.06 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.338 2.255 . . . . 0.0 116.285 -172.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.02 151.08 12.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.909 1.684 . . . . 0.0 113.158 173.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -100.35 117.44 34.55 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.979 0.912 . . . . 0.0 111.371 -177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.9 167.76 19.29 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.171 1.367 . . . . 0.0 113.435 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 64.2 p -75.85 -33.95 60.03 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.945 0.898 . . . . 0.0 113.22 176.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 47.01 30.81 1.35 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 127.059 2.144 . . . . 0.0 114.96 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -152.88 163.26 40.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.656 1.183 . . . . 0.0 112.458 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -139.51 -34.18 0.58 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.745 1.218 . . . . 0.0 114.134 -176.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -80.87 56.76 2.82 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.818 1.247 . . . . 0.0 111.939 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -68.87 154.64 41.65 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.239 1.416 . . . . 0.0 113.365 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.383 1.873 . . . . 0.0 112.084 -179.06 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.03 148.18 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.412 1.885 . . . . 0.0 110.695 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.18 97.44 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 166.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.86 146.05 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.439 1.095 . . . . 0.0 110.224 -169.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -144.98 154.78 55.26 Favored Pre-proline 0 N--CA 1.466 0.356 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -174.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.47 162.01 38.97 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.786 2.324 . . . . 0.0 112.483 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -103.32 1.71 33.12 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.226 1.411 . . . . 0.0 114.015 177.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.76 169.27 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 127.144 2.177 . . . . 0.0 110.028 174.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -98.23 145.19 26.88 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.153 0.981 . . . . 0.0 109.14 168.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.1 -151.91 21.79 Favored Glycine 0 N--CA 1.465 0.623 0 C-N-CA 124.364 0.983 . . . . 0.0 111.032 -172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.0 m -135.43 147.24 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 118.044 0.922 . . . . 0.0 112.084 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 10.4 mm -62.68 144.88 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 119.068 0.849 . . . . 0.0 111.593 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 51.4 t -123.43 -35.3 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.317 1.847 . . . . 0.0 112.001 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -148.76 160.09 43.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.159 0.984 . . . . 0.0 111.616 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.6 mmmm -126.11 94.42 4.09 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 128.891 2.876 . . . . 0.0 107.777 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -74.44 -40.0 62.21 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.348 0.659 . . . . 0.0 112.439 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -78.65 179.94 6.83 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.255 1.022 . . . . 0.0 112.619 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -128.45 134.6 48.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.163 1.385 . . . . 0.0 111.433 173.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -56.11 113.06 1.38 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.003 1.321 . . . . 0.0 111.385 173.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.65 -10.98 68.68 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 116.199 1.24 . . . . 0.0 116.199 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.54 -170.77 3.27 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 119.591 1.695 . . . . 0.0 114.033 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.3 mmtm -86.5 158.53 19.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.106 1.362 . . . . 0.0 111.453 172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.4 m -136.98 133.92 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.199 1.8 . . . . 0.0 108.845 171.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.85 158.56 36.17 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.374 1.069 . . . . 0.0 111.075 169.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.409 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.419 0.0 OUTLIER -52.22 75.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 127.949 2.499 . . . . 0.0 114.216 171.093 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.12 17.21 11.87 Favored Glycine 0 N--CA 1.463 0.446 0 C-N-CA 126.12 1.819 . . . . 0.0 114.577 174.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 0.2 OUTLIER -54.09 140.21 32.59 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.28 1.04 . . . . 0.0 111.381 168.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 43.6 m -66.73 138.78 57.64 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.96 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.6 mt -121.19 -44.99 2.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.23 1.812 . . . . 0.0 111.973 -168.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -141.28 163.92 31.64 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -129.32 143.29 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 126.513 1.925 . . . . 0.0 106.724 170.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.2 mt -128.11 153.25 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 C-N-CA 126.971 2.108 . . . . 0.0 112.072 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -116.75 123.08 46.3 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.735 0.647 . . . . 0.0 110.13 168.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -73.21 6.66 2.66 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 56.86 93.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.232 1.813 . . . . 0.0 113.03 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.469 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -59.15 4.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.818 2.847 . . . . 0.0 118.042 -169.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.15 -38.4 62.7 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.997 1.319 . . . . 0.0 113.885 178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 m -83.41 -9.64 58.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 35.9 ttpt -63.07 -44.58 95.38 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 119.066 0.848 . . . . 0.0 113.121 -169.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -62.99 -41.01 99.45 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.449 0.7 . . . . 0.0 112.35 173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -74.77 -39.8 61.56 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.559 1.144 . . . . 0.0 112.391 -172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -67.61 -46.2 73.25 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.545 1.138 . . . . 0.0 112.447 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -63.11 -29.08 70.52 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.4 m -57.35 -23.41 48.76 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -70.16 -20.37 63.15 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.989 1.316 . . . . 0.0 114.16 175.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 68.47 2.55 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.195 1.398 . . . . 0.0 113.048 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.6 mt -131.98 153.98 49.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.477 1.911 . . . . 0.0 111.38 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 23.44 -93.92 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 128.671 2.788 . . . . 0.0 116.828 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.0 p -70.71 -20.86 62.62 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -99.32 -34.5 10.29 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.089 1.756 . . . . 0.0 112.564 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.1 p -64.84 -20.87 66.64 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 119.076 0.853 . . . . 0.0 113.183 169.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -6.76 8.72 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 125.365 1.466 . . . . 0.0 114.073 168.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.8 mt 108.66 118.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 1 C-N-CA 132.016 4.126 . . . . 0.0 109.815 169.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.3 m -139.34 137.53 35.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.096 1.758 . . . . 0.0 110.414 173.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -58.93 -4.43 0.47 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.9 ptmm? -123.57 -6.12 8.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.235 2.214 . . . . 0.0 113.428 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -109.13 -33.37 6.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.407 1.883 . . . . 0.0 113.999 171.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -3.21 4.89 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 116.387 1.995 . . . . 0.0 116.387 -169.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -60.02 -22.96 63.28 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 120.944 -1.098 . . . . 0.0 113.289 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 77.6 p -62.19 -20.58 64.32 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.994 1.318 . . . . 0.0 114.365 170.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.2 m -102.88 -20.51 14.25 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.394 1.478 . . . . 0.0 113.616 174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.7 mt -76.13 -22.31 55.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.839 1.255 . . . . 0.0 114.181 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.73 173.49 11.5 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.37 1.068 . . . . 0.0 113.761 -168.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.7 m -140.46 138.15 34.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.759 1.624 . . . . 0.0 110.121 -173.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 79.3 mt 42.78 36.4 0.85 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 126.665 1.986 . . . . 0.0 113.843 -175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.8 p-10 46.23 28.62 0.7 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.801 2.04 . . . . 0.0 115.693 -171.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -91.18 160.11 15.72 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 169.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.9 m -137.09 154.19 50.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.921 1.288 . . . . 0.0 109.75 169.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -122.68 144.18 49.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.271 1.028 . . . . 0.0 111.256 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.58 138.02 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.537 1.535 . . . . 0.0 107.848 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -134.07 150.33 51.18 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.62 1.568 . . . . 0.0 110.815 -169.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.36 155.34 48.1 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.19 -37.99 3.03 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.335 2.023 . . . . 0.0 113.339 170.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.59 165.9 23.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.875 1.67 . . . . 0.0 113.885 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.1 p-10 -62.17 130.97 47.87 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.969 1.707 . . . . 0.0 112.674 169.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.3 -152.28 21.26 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 121.71 0.617 . . . . 0.0 113.276 -173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.7 m -119.94 157.32 29.04 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 126.212 1.805 . . . . 0.0 108.72 -178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.5 tt -128.89 144.43 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 123.273 0.629 . . . . 0.0 110.802 -173.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.18 -173.67 21.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.004 0.812 . . . . 0.0 112.533 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 25.8 m-20 -71.38 144.44 49.84 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.477 -1.014 . . . . 0.0 110.522 168.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.19 152.83 39.68 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.394 0.616 . . . . 0.0 111.595 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.8 mt -120.15 4.69 10.83 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.746 1.618 . . . . 0.0 112.465 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.52 158.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.643 2.377 . . . . 0.0 110.508 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -134.23 168.21 19.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.808 2.043 . . . . 0.0 109.551 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.1 mp -55.92 103.5 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 126.163 1.785 . . . . 0.0 110.0 175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.8 -5.35 24.22 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.802 1.668 . . . . 0.0 113.736 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.63 121.79 16.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.092 1.446 . . . . 0.0 111.512 176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.09 135.89 56.08 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.896 0.878 . . . . 0.0 111.009 169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.69 154.12 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 126.73 2.012 . . . . 0.0 111.218 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.7 t -129.57 137.97 51.04 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.218 1.807 . . . . 0.0 108.148 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -34.81 -71.47 0.07 Allowed 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 117.913 2.56 . . . . 0.0 117.913 -166.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.0 t -95.3 -4.26 45.89 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.659 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 m -96.72 -14.26 22.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 125.741 1.617 . . . . 0.0 114.458 -167.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -141.64 123.01 14.9 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-O 122.837 1.303 . . . . 0.0 107.902 -171.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.91 136.62 43.23 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 113.306 -1.77 . . . . 0.0 112.365 -164.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.5 mt -99.09 -35.72 9.93 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -165.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.7 p 175.35 172.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 128.746 2.819 . . . . 0.0 108.388 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.8 ptt180 -105.59 148.71 27.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.317 -1.489 . . . . 0.0 114.44 169.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -122.45 135.5 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 120.21 1.368 . . . . 0.0 109.707 175.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.2 t -141.46 121.46 13.69 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -169.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -77.03 153.12 34.77 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.631 1.172 . . . . 0.0 112.494 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 94.9 mt -133.95 -173.62 3.3 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.943 2.097 . . . . 0.0 109.827 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -54.36 155.63 6.84 Favored Pre-proline 0 CA--C 1.554 1.117 0 O-C-N 121.239 -0.913 . . . . 0.0 111.129 170.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.25 5.57 5.34 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.38 2.72 . . . . 0.0 115.121 -167.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 31.9 pt -61.87 -1.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 128.295 2.638 . . . . 0.0 115.011 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -118.45 -0.6 11.39 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.711 2.004 . . . . 0.0 113.053 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.11 179.18 3.42 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.466 1.106 . . . . 0.0 111.608 169.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.59 108.31 0.54 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.099 0.96 . . . . 0.0 112.597 176.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 164.77 -167.1 38.38 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.348 1.452 . . . . 0.0 112.332 -171.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 54.9 m -139.02 130.57 27.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.38 1.072 . . . . 0.0 111.654 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -155.08 158.88 39.74 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.179 1.792 . . . . 0.0 109.954 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -87.76 -15.63 36.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.565 1.146 . . . . 0.0 113.707 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.3 m80 60.55 -16.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 128.404 2.682 . . . . 0.0 116.893 -175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -135.08 6.86 3.38 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.405 1.882 . . . . 0.0 113.095 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -153.18 162.91 40.78 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.106 2.162 . . . . 0.0 110.1 -177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 . . . . . 0 C--O 1.25 1.12 0 C-N-CA 125.374 1.47 . . . . 0.0 112.227 178.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 120.661 0.267 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -139.97 138.7 37.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.554 1.542 . . . . 0.0 110.768 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.7 94.49 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 164.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 147.54 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.37 1.468 . . . . 0.0 110.869 -169.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.6 mttt -144.23 155.08 58.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.78 143.55 14.84 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.87 2.38 . . . . 0.0 111.994 -174.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -75.35 -11.29 60.02 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -143.13 158.04 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 126.292 1.837 . . . . 0.0 110.073 173.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 99.5 p -80.3 154.79 27.6 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.333 -0.854 . . . . 0.0 111.105 168.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.1 -154.15 25.3 Favored Glycine 0 C--N 1.337 0.607 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -172.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.0 m -130.8 145.21 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 119.096 1.448 . . . . 0.0 113.263 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 17.6 mm -62.84 144.54 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 119.22 0.918 . . . . 0.0 111.629 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.13 -35.68 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.406 1.883 . . . . 0.0 111.96 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -147.23 159.12 44.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.987 0.915 . . . . 0.0 111.23 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.43 93.69 3.93 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 128.694 2.798 . . . . 0.0 108.407 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.28 -39.99 64.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 123.312 0.645 . . . . 0.0 112.704 -176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -81.18 -178.36 6.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.711 1.204 . . . . 0.0 112.924 -177.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -123.41 129.89 51.92 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.17 1.388 . . . . 0.0 111.775 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 111.21 1.07 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.113 1.365 . . . . 0.0 110.732 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -5.82 62.03 Favored Glycine 0 CA--C 1.541 1.693 0 N-CA-C 116.565 1.386 . . . . 0.0 116.565 176.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -92.23 -151.13 0.27 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.732 1.766 . . . . 0.0 114.206 -170.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -107.0 162.55 13.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 111.697 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.8 m -138.03 139.74 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.816 1.646 . . . . 0.0 110.815 174.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.66 178.54 2.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.419 1.088 . . . . 0.0 111.576 167.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 mmmt -64.07 42.27 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.305 3.042 . . . . 0.0 115.624 -172.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.02 22.0 2.48 Favored Glycine 0 N--CA 1.465 0.585 0 C-N-CA 125.826 1.679 . . . . 0.0 115.35 -172.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.262 1.4 pt20 -50.65 145.93 6.24 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 119.058 1.429 . . . . 0.0 112.563 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 33.3 m -69.09 138.28 54.18 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.404 1.081 . . . . 0.0 110.539 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.0 mt -120.95 -44.28 2.42 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.865 1.666 . . . . 0.0 113.23 -167.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -141.15 165.14 28.37 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.6 mt -129.91 140.96 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.46 1.904 . . . . 0.0 106.739 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.5 mt -125.35 149.04 29.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 126.714 2.005 . . . . 0.0 111.721 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -100.31 126.18 46.61 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 167.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.33 52.46 0.18 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.505 1.922 . . . . 0.0 112.325 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -36.14 -46.93 0.53 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.229 2.211 . . . . 0.0 114.296 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 7.9 pt20 -150.83 20.01 0.79 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.86 -46.48 78.23 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 119.178 0.899 . . . . 0.0 111.358 171.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.7 m -62.01 -27.92 69.21 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 175.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 24.8 ttpt -64.65 -23.36 67.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.642 1.177 . . . . 0.0 112.48 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -94.02 -46.16 7.26 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.44 1.096 . . . . 0.0 111.144 168.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.73 -32.89 74.68 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -170.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -67.04 -27.29 67.28 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -65.48 -49.48 68.89 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -166.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.7 p -79.67 -36.38 37.75 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.056 1.342 . . . . 0.0 112.942 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -37.87 85.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.028 0.931 . . . . 0.0 112.858 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.22 -9.02 59.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.264 1.426 . . . . 0.0 114.233 -173.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.83 -48.61 80.71 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.1 1.36 . . . . 0.0 113.857 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -166.22 -11.83 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 -163.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -129.04 -52.17 1.21 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -99.38 15.7 25.45 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.5 p -64.39 -15.04 59.77 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.056 1.343 . . . . 0.0 113.741 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.11 -17.52 27.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.971 1.708 . . . . 0.0 115.429 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 53' ' ' ILE . 9.1 tp -132.83 123.45 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.359 0.982 . . . . 0.0 112.499 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 m -56.2 140.88 42.97 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.484 1.514 . . . . 0.0 114.254 -169.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -60.47 -6.49 1.61 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.947 2.099 . . . . 0.0 116.072 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -125.87 5.25 7.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.978 0.911 . . . . 0.0 112.946 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -108.03 -43.76 4.34 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.719 1.608 . . . . 0.0 112.739 168.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -59.81 -27.36 66.53 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -171.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -64.74 -17.61 64.31 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.447 1.499 . . . . 0.0 114.074 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 69.1 m -60.68 -19.92 59.72 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.14 -0.975 . . . . 0.0 113.28 169.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -89.54 -12.44 39.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.806 1.242 . . . . 0.0 113.708 171.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 52.6 mt -102.2 -21.81 14.3 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.315 1.846 . . . . 0.0 113.947 -177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -151.55 154.83 37.24 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 20.5 m -66.03 -35.97 82.0 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.801 1.24 . . . . 0.0 113.888 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -149.57 -59.65 0.21 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 129.732 3.213 . . . . 0.0 108.288 174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -158.98 27.97 0.21 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 129.883 3.273 . . . . 0.0 111.248 172.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -121.07 160.54 23.44 Favored 'General case' 0 C--N 1.345 0.385 0 C-N-CA 124.844 1.258 . . . . 0.0 113.711 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.3 m -137.44 145.41 43.1 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.367 1.067 . . . . 0.0 110.739 169.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' C ' HD12 ' A' ' 70' ' ' ILE . 50.8 mt-10 -100.31 157.02 16.91 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.259 1.024 . . . . 0.0 111.79 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.1 mp -128.16 137.37 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.093 1.357 . . . . 0.0 107.657 177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -134.52 147.81 50.39 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.785 1.634 . . . . 0.0 110.296 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.41 163.59 10.99 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.941 0.896 . . . . 0.0 112.584 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.16 -42.43 0.3 Allowed 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 122.307 2.005 . . . . 0.0 114.833 170.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.77 177.2 10.67 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.02 1.728 . . . . 0.0 113.426 -165.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -73.99 132.94 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.118 0.967 . . . . 0.0 111.756 173.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 174.74 -160.12 29.14 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 121.878 0.71 . . . . 0.0 113.489 -176.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 89.3 m -112.1 153.65 26.63 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.079 1.351 . . . . 0.0 109.264 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 tt -128.83 148.28 33.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.275 0.63 . . . . 0.0 111.389 -170.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.58 -172.77 47.35 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 123.806 0.717 . . . . 0.0 112.526 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -70.56 141.55 51.83 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.205 1.003 . . . . 0.0 111.242 167.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.82 136.24 56.93 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.68 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.27 -2.23 49.87 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.376 1.47 . . . . 0.0 113.102 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 m -144.28 159.59 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 126.895 2.078 . . . . 0.0 111.756 -169.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -138.12 167.23 22.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.965 2.106 . . . . 0.0 109.698 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -56.56 101.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 126.837 2.055 . . . . 0.0 110.008 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.13 -8.99 13.92 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.428 1.49 . . . . 0.0 113.295 178.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.88 121.71 16.6 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.216 1.508 . . . . 0.0 111.077 177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -64.68 135.2 55.64 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.656 0.782 . . . . 0.0 110.422 167.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.08 157.65 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.717 1.607 . . . . 0.0 112.049 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.3 t -129.65 148.2 51.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 109.674 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.48 -21.43 25.78 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 120.222 3.415 . . . . 0.0 120.222 -165.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.7 p -136.02 1.57 2.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 165.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -98.86 -15.24 19.29 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 -164.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 6.8 m -121.92 -27.39 4.63 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -165.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.82 127.34 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.649 2.38 . . . . 0.0 114.648 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.6 mt -99.41 -34.67 10.19 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 -167.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.2 p 174.79 178.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 129.517 3.127 . . . . 0.0 108.227 -177.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.517 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -117.1 139.75 50.35 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.308 -1.495 . . . . 0.0 113.243 168.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -118.15 127.12 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.636 1.574 . . . . 0.0 108.246 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -142.72 129.37 20.33 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -76.67 126.1 30.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 121.593 -0.692 . . . . 0.0 110.135 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 74.0 mt -71.22 -61.48 1.75 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.389 0.675 . . . . 0.0 111.274 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -140.14 159.25 64.81 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 125.487 1.515 . . . . 0.0 110.161 169.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -86.06 -6.39 8.43 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.964 2.443 . . . . 0.0 114.577 -173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.0 -27.91 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.446 1.498 . . . . 0.0 113.307 174.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -76.03 -13.67 60.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.188 1.795 . . . . 0.0 112.833 171.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -120.84 23.24 10.81 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.805 1.642 . . . . 0.0 113.702 -169.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.3 t70 100.13 -7.88 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 130.037 3.335 . . . . 0.0 113.934 167.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.3 -42.0 97.98 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 121.456 -0.777 . . . . 0.0 114.585 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.7 t 57.45 -52.82 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 128.965 2.906 . . . . 0.0 117.206 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -159.0 164.87 35.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.089 1.756 . . . . 0.0 111.574 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -70.02 -35.72 74.55 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.288 1.035 . . . . 0.0 112.804 171.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -158.52 160.42 36.67 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.869 2.067 . . . . 0.0 110.476 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -62.57 160.31 14.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.282 1.033 . . . . 0.0 112.876 176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -147.51 166.9 25.88 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.23 1.412 . . . . 0.0 112.444 -169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 61.9 m80 . . . . . 0 C--O 1.254 1.337 0 C-N-CA 125.793 1.637 . . . . 0.0 112.261 -169.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 110.842 -0.058 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -85.65 147.38 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.424 0.69 . . . . 0.0 110.32 169.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.14 96.14 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 102.816 -3.031 . . . . 0.0 102.816 166.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.27 146.73 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.771 1.228 . . . . 0.0 109.494 -170.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.0 mttt -143.9 155.36 59.2 Favored Pre-proline 0 N--CA 1.472 0.643 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.74 143.65 13.43 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.024 2.483 . . . . 0.0 112.593 -173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -74.87 -11.8 60.22 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.1 m -142.33 157.1 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.683 1.993 . . . . 0.0 110.757 172.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.3 p -79.88 156.25 27.41 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.697 -0.627 . . . . 0.0 110.52 168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 -152.8 24.31 Favored Glycine 0 N--CA 1.471 0.978 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 -172.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 m -131.25 143.97 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 119.069 1.435 . . . . 0.0 112.404 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 13.0 mm -61.74 143.87 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 118.459 0.572 . . . . 0.0 111.368 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.2 t -124.4 -33.5 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 126.328 1.851 . . . . 0.0 111.507 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -150.47 160.42 43.78 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 111.868 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -125.55 94.29 4.1 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 128.967 2.907 . . . . 0.0 108.241 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -75.22 -39.66 59.82 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -76.23 -177.59 4.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.74 1.216 . . . . 0.0 112.059 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -128.1 130.2 47.8 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.002 1.321 . . . . 0.0 111.532 173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.78 111.45 1.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.729 1.212 . . . . 0.0 111.268 176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.19 -8.2 58.93 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.606 1.098 . . . . 0.0 115.507 178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.55 -158.39 0.63 Allowed 'General case' 0 CA--C 1.552 1.022 0 CA-C-N 119.46 1.63 . . . . 0.0 114.083 -170.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -94.06 159.62 15.08 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.876 1.67 . . . . 0.0 111.718 176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.1 m -137.37 141.04 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 125.55 1.54 . . . . 0.0 110.269 170.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -75.15 152.83 38.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.608 1.563 . . . . 0.0 110.024 169.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 75' ' ' ASP 0.363 0.0 OUTLIER -52.49 89.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.587 1.555 . . . . 0.0 111.355 168.19 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.9 17.53 40.69 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.877 1.703 . . . . 0.0 115.489 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.11 136.93 47.75 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.251 1.526 . . . . 0.0 109.09 165.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.0 m -60.14 135.08 57.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.851 2.06 . . . . 0.0 110.32 169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.8 mt -119.32 -41.91 2.7 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.929 2.091 . . . . 0.0 111.801 -169.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -142.92 163.73 31.99 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.082 0.944 . . . . 0.0 112.854 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.23 140.35 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.355 1.862 . . . . 0.0 106.997 171.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.1 mt -127.42 146.35 33.34 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 C-N-CA 126.53 1.932 . . . . 0.0 111.812 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -97.92 126.21 43.21 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 168.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -73.06 3.59 5.3 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -175.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.6 t70 61.02 -53.41 0.1 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 129.328 3.051 . . . . 0.0 117.122 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -151.09 8.34 0.54 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -178.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.57 96.02 Favored 'General case' 0 CA--C 1.548 0.899 0 O-C-N 120.906 -1.121 . . . . 0.0 113.321 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 m -75.93 -8.77 57.72 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 35.2 ttpt -63.3 -21.75 66.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.87 1.268 . . . . 0.0 114.401 -171.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -118.77 -26.5 6.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.527 1.131 . . . . 0.0 112.936 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.5 -23.2 66.21 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.083 0.953 . . . . 0.0 113.375 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -52.7 -33.48 47.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 124.715 1.206 . . . . 0.0 114.017 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 44.1 mtm105 -60.22 -38.91 84.81 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -168.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.3 m -83.92 -21.03 31.99 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.502 1.121 . . . . 0.0 113.596 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -62.44 -31.52 72.25 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 119.48 1.037 . . . . 0.0 112.542 173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.57 -4.02 21.05 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.338 1.455 . . . . 0.0 114.331 172.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -121.27 -53.07 2.04 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.358 1.463 . . . . 0.0 113.535 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -164.46 156.87 16.67 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -163.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.4 m -58.12 105.63 0.29 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.558 1.943 . . . . 0.0 113.643 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -67.74 -7.2 25.39 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 p -56.61 -20.85 23.16 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.278 -0.889 . . . . 0.0 113.243 168.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -77.01 -11.19 59.77 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 174.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.66 158.76 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 125.552 1.541 . . . . 0.0 109.442 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.2 m -49.98 139.06 14.45 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.769 1.627 . . . . 0.0 114.177 -177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -61.5 -5.32 1.71 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 127.425 2.29 . . . . 0.0 116.826 -171.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -124.32 -3.92 7.9 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.34 1.856 . . . . 0.0 113.114 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -98.84 -40.37 8.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.722 1.609 . . . . 0.0 112.482 168.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -3.72 9.62 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 116.782 2.141 . . . . 0.0 116.782 -169.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -57.77 -25.73 60.9 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -168.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.0 t -57.74 -26.55 61.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.774 1.229 . . . . 0.0 113.181 176.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.7 m -103.44 -5.0 23.31 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -87.46 -9.65 54.04 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.8 1.24 . . . . 0.0 113.443 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -136.48 -163.11 1.36 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.974 1.309 . . . . 0.0 112.056 -168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.31 -174.16 0.8 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.346 1.859 . . . . 0.0 111.627 -176.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -48.94 -33.79 11.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -171.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -174.65 33.28 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 128.333 2.653 . . . . 0.0 111.946 -175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -122.7 165.05 17.16 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 53.6 m -137.75 142.15 40.94 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.537 1.135 . . . . 0.0 110.328 169.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.6 mt-10 -100.15 157.12 16.8 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.82 0.848 . . . . 0.0 111.545 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.6 mp -127.73 138.41 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 125.599 1.56 . . . . 0.0 107.066 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.6 ptpp? -134.48 157.86 45.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.559 1.144 . . . . 0.0 112.838 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.59 152.92 64.5 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.567 1.147 . . . . 0.0 113.718 -178.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.13 -34.26 8.39 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.048 2.499 . . . . 0.0 113.248 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.75 165.09 23.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.046 1.338 . . . . 0.0 114.095 -170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 9.2 t70 -62.66 129.76 41.99 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 126.01 1.724 . . . . 0.0 111.596 169.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 175.56 -158.77 26.22 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-O 122.092 0.829 . . . . 0.0 114.34 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 94.2 m -112.46 158.0 20.4 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.323 1.449 . . . . 0.0 108.387 172.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.4 tt -132.73 139.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 123.197 0.599 . . . . 0.0 109.972 -171.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.98 -168.87 38.15 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 121.668 0.593 . . . . 0.0 113.929 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -66.81 133.1 49.43 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.997 0.903 . . . . 0.0 111.345 168.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.31 153.52 12.11 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.08 175.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 96.0 mt -115.11 0.97 13.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.892 1.677 . . . . 0.0 112.477 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -147.0 159.47 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 127.178 2.191 . . . . 0.0 111.045 -170.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -137.51 168.87 18.79 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.323 1.849 . . . . 0.0 109.511 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.13 102.99 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.479 1.912 . . . . 0.0 109.742 176.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.86 -8.66 16.54 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.91 1.719 . . . . 0.0 113.487 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.24 122.59 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.766 1.283 . . . . 0.0 112.097 178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -64.9 135.6 55.9 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.317 0.647 . . . . 0.0 110.222 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.0 m -140.88 159.72 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 126.012 1.725 . . . . 0.0 111.862 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 t -132.57 147.65 52.36 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.113 1.765 . . . . 0.0 110.352 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.13 41.56 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 120.699 3.592 . . . . 0.0 120.699 -164.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.1 p -133.34 -1.06 3.22 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 165.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 m -98.98 -15.16 19.19 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 117.614 2.45 . . . . 0.0 117.614 -164.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 7.5 m -119.66 -27.76 5.42 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -165.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.434 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.8 127.29 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.287 2.235 . . . . 0.0 114.517 172.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 mt -98.93 -36.08 9.87 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.907 1.818 . . . . 0.0 115.907 -168.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.0 p 177.93 -179.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 128.897 2.879 . . . . 0.0 108.198 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.561 ' N ' HG22 ' A' ' 97' ' ' VAL . 25.8 ptt-85 -112.4 146.44 38.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.406 1.482 . . . . 0.0 113.754 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.89 140.66 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 CA-C-N 119.799 1.181 . . . . 0.0 109.299 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.3 t -141.06 111.7 6.98 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 122.247 1.022 . . . . 0.0 112.527 -169.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -67.9 132.32 47.13 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.73 -1.231 . . . . 0.0 111.311 -170.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 29.6 mt -74.2 171.5 13.49 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.631 1.173 . . . . 0.0 111.623 171.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -59.89 146.26 82.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.66 -0.65 . . . . 0.0 111.368 176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.41 -6.43 13.69 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.946 2.43 . . . . 0.0 114.447 -167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.3 pt -63.12 -18.39 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 127.43 2.292 . . . . 0.0 113.862 170.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 -15.91 0.28 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.56 -11.01 30.14 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 167.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -145.68 26.41 1.27 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.55 0.74 . . . . 0.0 112.435 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.01 177.98 53.88 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.576 1.084 . . . . 0.0 114.502 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.3 t -150.6 164.72 35.36 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.775 1.23 . . . . 0.0 112.132 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -67.84 -17.91 64.66 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.632 1.573 . . . . 0.0 114.362 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -151.34 177.69 10.01 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.556 1.542 . . . . 0.0 112.26 177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.22 -7.47 4.31 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -158.63 -37.12 0.06 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -155.22 154.07 31.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.322 1.449 . . . . 0.0 111.652 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.159 1.783 . . . . 0.0 112.274 -177.915 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.631 0.253 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -141.89 167.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.88 1.672 . . . . 0.0 110.604 -178.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mm -127.13 107.81 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 167.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.01 148.11 11.31 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 125.171 1.389 . . . . 0.0 110.903 -175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.6 mttt -144.09 154.22 57.7 Favored Pre-proline 0 N--CA 1.469 0.51 0 C-N-CA 125.892 1.677 . . . . 0.0 113.074 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.23 149.48 25.03 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.795 2.33 . . . . 0.0 112.817 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 pt20 -76.05 -12.44 60.12 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.97 159.25 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.537 1.935 . . . . 0.0 110.562 175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 91.0 p -80.71 157.72 25.78 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.593 -0.692 . . . . 0.0 111.176 168.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.18 -151.54 23.4 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.5 m -132.27 146.82 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 118.787 1.294 . . . . 0.0 112.859 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.4 mm -61.67 142.61 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 118.641 0.655 . . . . 0.0 112.158 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.1 t -123.32 -35.25 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 127.024 2.13 . . . . 0.0 111.519 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -148.05 159.14 44.22 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.157 0.983 . . . . 0.0 111.682 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -124.71 93.98 4.06 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 128.772 2.829 . . . . 0.0 107.555 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.55 -45.07 66.15 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 123.86 0.864 . . . . 0.0 111.926 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -72.68 -176.85 2.09 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.539 1.135 . . . . 0.0 112.713 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -133.27 132.44 41.41 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.223 1.409 . . . . 0.0 111.692 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.72 89.22 0.11 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.802 1.641 . . . . 0.0 112.941 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 122.43 -9.87 9.32 Favored Glycine 0 CA--C 1.541 1.69 0 C-N-CA 125.671 1.605 . . . . 0.0 115.582 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.9 -168.05 1.9 Allowed 'General case' 0 CA--C 1.559 1.291 0 CA-C-N 119.447 1.623 . . . . 0.0 114.157 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -87.74 164.81 15.78 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.836 1.654 . . . . 0.0 112.391 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.3 m -133.67 142.59 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.882 1.673 . . . . 0.0 110.91 169.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -73.23 175.97 6.33 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 126.057 1.743 . . . . 0.0 109.379 167.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.9 mmmt -58.15 38.02 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 129.986 3.315 . . . . 0.0 116.673 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.24 27.76 1.45 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 124.936 1.255 . . . . 0.0 115.45 -170.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.256 2.0 pt20 -52.72 149.69 5.91 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.474 1.137 . . . . 0.0 113.097 173.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.6 m -69.86 137.8 52.0 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.111 0.965 . . . . 0.0 110.922 177.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.9 mt -121.2 -46.13 2.32 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.823 1.649 . . . . 0.0 113.108 -169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -139.59 166.71 23.86 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 44.9 mt -131.52 142.56 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 126.036 1.734 . . . . 0.0 106.436 170.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.552 HD12 HD11 ' A' ' 70' ' ' ILE . 14.6 mt -127.35 153.17 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 111.757 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -114.69 116.33 28.53 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.949 0.899 . . . . 0.0 109.309 168.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -66.17 -9.3 30.52 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.868 1.432 . . . . 0.0 114.868 -175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 59.61 5.96 0.75 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 127.973 2.509 . . . . 0.0 114.889 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.329 6.0 pt20 42.83 30.3 0.23 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.558 2.343 . . . . 0.0 117.206 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.94 -39.32 77.77 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.974 -1.078 . . . . 0.0 112.482 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 m -59.62 -26.77 65.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.963 1.305 . . . . 0.0 114.068 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -60.63 -15.88 32.93 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -111.78 -46.18 3.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.799 1.24 . . . . 0.0 110.816 168.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -68.44 -30.18 69.0 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -76.26 -39.07 55.3 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.429 -0.794 . . . . 0.0 112.814 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -57.01 -41.02 77.76 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -164.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.9 p -57.41 -25.93 60.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -99.36 -8.62 24.59 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.285 1.834 . . . . 0.0 114.045 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.63 39.19 1.26 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.807 1.243 . . . . 0.0 113.298 -169.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.66 155.83 25.16 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.068 0.947 . . . . 0.0 112.34 171.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 40.0 63.93 0.98 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.282 2.233 . . . . 0.0 116.27 170.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.6 t -151.25 154.96 37.81 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.724 0.81 . . . . 0.0 112.026 169.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.27 -30.57 68.39 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.125 0.97 . . . . 0.0 112.305 169.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.4 m -72.0 -4.05 26.35 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.512 1.525 . . . . 0.0 114.681 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.81 -40.03 75.25 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -132.74 -5.44 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -169.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.3 m 55.39 106.37 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.345 2.258 . . . . 0.0 114.372 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.1 -6.31 0.36 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 127.224 2.21 . . . . 0.0 116.745 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.5 mtmt -121.95 2.96 9.97 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.848 1.259 . . . . 0.0 112.62 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -114.66 -40.99 3.47 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.361 1.865 . . . . 0.0 113.153 174.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -58.32 -22.8 54.46 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -60.93 -16.83 46.69 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 97.9 p -60.6 -14.73 22.02 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.625 1.17 . . . . 0.0 114.144 171.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.5 m -103.28 -8.9 19.96 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.49 -31.75 11.82 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.999 1.32 . . . . 0.0 111.983 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.38 6.3 4.86 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.415 1.486 . . . . 0.0 113.62 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.9 -163.95 1.91 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.688 1.995 . . . . 0.0 109.78 174.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 40.9 mt -124.89 36.59 4.57 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.856 2.062 . . . . 0.0 110.973 -169.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.347 3.1 p30 51.11 29.73 4.97 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.381 1.872 . . . . 0.0 114.684 -168.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -79.65 154.68 28.49 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 169.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.8 m -142.96 142.92 31.76 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.739 0.815 . . . . 0.0 111.037 171.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.11 153.11 17.96 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.853 1.261 . . . . 0.0 111.527 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.25 137.27 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.475 1.51 . . . . 0.0 108.5 -177.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -134.96 148.12 49.93 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.183 1.393 . . . . 0.0 111.702 -170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.22 164.48 4.76 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 124.688 1.195 . . . . 0.0 112.593 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.5 -39.84 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.866 2.377 . . . . 0.0 114.586 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -159.51 176.07 12.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.769 . . . . 0.0 113.133 -165.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.33 144.38 42.42 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.803 1.241 . . . . 0.0 112.991 175.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.04 -155.03 26.19 Favored Glycine 0 CA--C 1.522 0.485 0 O-C-N 121.494 -0.754 . . . . 0.0 112.929 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 41.6 m -112.84 158.01 20.68 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.133 1.373 . . . . 0.0 108.343 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tt -122.74 139.65 48.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 123.837 0.855 . . . . 0.0 109.346 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.55 97.49 1.04 Allowed Glycine 0 N--CA 1.47 0.918 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.45 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . 0.311 0.8 OUTLIER 54.97 -144.45 0.68 Allowed 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 126.039 1.736 . . . . 0.0 114.318 -169.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -151.79 154.83 37.01 Favored 'General case' 0 C--N 1.319 -0.747 1 C-N-CA 131.784 4.034 . . . . 0.0 107.444 171.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.0 mt -125.28 5.62 7.76 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.001 1.321 . . . . 0.0 113.112 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 159.77 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 127.413 2.285 . . . . 0.0 111.265 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -137.18 166.82 22.84 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.721 2.009 . . . . 0.0 109.43 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mp -56.23 103.57 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 126.419 1.888 . . . . 0.0 109.385 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 -10.15 13.48 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.768 1.651 . . . . 0.0 113.535 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -67.32 122.13 17.22 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.994 1.397 . . . . 0.0 111.586 177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -65.63 136.94 56.97 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.606 0.762 . . . . 0.0 111.065 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.72 157.91 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 126.219 1.808 . . . . 0.0 111.286 -177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.8 t -135.37 147.72 49.16 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.31 1.444 . . . . 0.0 110.206 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.05 -23.82 55.98 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 120.558 3.54 . . . . 0.0 120.558 -164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -130.97 -3.43 4.01 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 165.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.0 m -96.6 -15.73 21.41 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.99 122.84 17.68 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-O 122.992 1.377 . . . . 0.0 107.68 -171.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.75 132.91 49.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 113.214 -1.812 . . . . 0.0 111.397 -165.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.6 mt -95.1 -38.25 10.71 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 115.332 1.605 . . . . 0.0 115.332 -165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.2 p 176.21 154.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 127.31 2.244 . . . . 0.0 110.417 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.402 ' N ' HG22 ' A' ' 97' ' ' VAL . 16.3 ptt180 -81.44 142.7 32.71 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.215 1.371 . . . . 0.0 114.658 168.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.5 ' H ' HG12 ' A' ' 2' ' ' VAL . 3.5 t -118.58 133.28 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 169.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.9 t -141.48 116.76 10.08 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.972 -1.08 . . . . 0.0 113.66 -170.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -68.69 154.93 41.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.31 1.444 . . . . 0.0 112.933 -174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.3 mt -130.07 173.62 10.56 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.318 2.247 . . . . 0.0 108.832 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -56.16 147.12 47.63 Favored Pre-proline 0 CA--C 1.551 0.99 0 O-C-N 121.548 -0.72 . . . . 0.0 110.634 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.6 28.12 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.341 0 C-N-CA 125.199 3.933 . . . . 0.0 113.21 -167.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.13 -0.83 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 127.49 2.316 . . . . 0.0 113.857 -168.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -61.04 132.67 54.57 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.329 -0.857 . . . . 0.0 112.238 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.05 173.57 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.25 1.42 . . . . 0.0 113.374 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -74.19 -31.34 62.62 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 173.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.91 40.03 0.11 Allowed Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.086 0.85 . . . . 0.0 114.597 -173.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.6 m -142.69 21.65 1.99 Allowed 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.796 1.238 . . . . 0.0 113.518 -169.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -60.01 -41.7 92.69 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.18 1.792 . . . . 0.0 115.635 -168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -161.91 -33.31 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -62.8 -11.45 17.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.5 1.92 . . . . 0.0 115.96 -172.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -74.42 -12.53 60.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 169.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 55.58 24.57 7.1 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.83 2.052 . . . . 0.0 114.755 -174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 76.1 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.364 1.866 . . . . 0.0 113.028 176.471 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.958 0.409 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.98 148.86 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.788 1.635 . . . . 0.0 111.377 -173.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.48 93.62 2.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 165.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -63.61 147.08 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 125.683 1.593 . . . . 0.0 110.711 -168.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -144.11 155.2 58.53 Favored Pre-proline 0 N--CA 1.474 0.73 0 C-N-CA 124.916 1.286 . . . . 0.0 113.778 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.45 154.89 28.08 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.208 2.605 . . . . 0.0 112.009 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -85.83 -7.12 58.93 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.08 158.74 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 126.04 1.736 . . . . 0.0 110.489 173.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.7 p -83.46 155.82 23.22 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.279 0.562 . . . . 0.0 110.693 168.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.69 -151.05 22.61 Favored Glycine 0 N--CA 1.467 0.711 0 O-C-N 120.815 -1.178 . . . . 0.0 110.243 -172.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.2 m -134.1 146.97 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 118.802 1.301 . . . . 0.0 112.061 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.2 mm -61.78 143.59 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 119.105 0.866 . . . . 0.0 111.588 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.3 t -122.09 -34.41 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.888 2.075 . . . . 0.0 111.736 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -150.01 160.41 43.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.536 1.134 . . . . 0.0 111.347 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -126.0 93.97 3.97 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 128.611 2.764 . . . . 0.0 107.561 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -72.3 -42.92 64.93 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.031 0.932 . . . . 0.0 112.608 -177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -80.63 177.18 9.18 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.345 172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttt -131.97 144.93 51.16 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.66 1.184 . . . . 0.0 111.422 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.7 108.63 0.41 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.046 0.938 . . . . 0.0 111.994 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.19 -3.27 59.95 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.977 1.275 . . . . 0.0 115.624 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.22 -165.21 0.12 Allowed 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.251 1.526 . . . . 0.0 113.023 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -117.36 162.8 17.33 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.441 1.897 . . . . 0.0 110.728 176.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.45 133.43 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.349 1.059 . . . . 0.0 111.551 -178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -75.56 159.08 31.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.247 1.019 . . . . 0.0 109.597 166.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.393 0.0 OUTLIER -52.53 79.59 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 126.447 1.899 . . . . 0.0 113.34 169.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.59 17.18 13.88 Favored Glycine 0 N--CA 1.464 0.544 0 C-N-CA 126.447 1.975 . . . . 0.0 114.58 172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.263 0.4 OUTLIER -56.08 144.28 29.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.491 1.145 . . . . 0.0 111.591 168.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.1 m -70.89 138.35 50.08 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.929 1.292 . . . . 0.0 111.031 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.55 -42.94 2.3 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.17 1.788 . . . . 0.0 112.303 -168.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -141.84 166.25 25.23 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.651 0.78 . . . . 0.0 112.689 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 28.8 mt -130.61 144.43 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.326 1.85 . . . . 0.0 107.357 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.401 HD12 HD11 ' A' ' 70' ' ' ILE . 13.4 mt -128.44 153.2 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 C-N-CA 126.937 2.095 . . . . 0.0 111.91 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -116.41 123.11 46.74 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 166.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -71.11 41.12 0.06 Allowed 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.607 1.963 . . . . 0.0 113.549 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.6 t70 61.34 8.77 2.26 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.77 2.428 . . . . 0.0 115.484 176.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . 0.269 3.1 pt20 49.52 19.06 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 118.179 2.659 . . . . 0.0 118.179 171.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.6 68.08 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.4 m -95.2 -23.61 17.18 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.5 ttpt -64.26 -20.9 66.37 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.68 -5.82 18.32 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 173.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -107.79 -28.78 9.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.953 1.301 . . . . 0.0 113.568 -175.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -68.38 -33.56 74.48 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.668 1.187 . . . . 0.0 114.072 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 85.2 mtm-85 -62.71 -37.84 88.09 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -167.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -93.78 -31.73 14.27 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.689 1.596 . . . . 0.0 113.379 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.0 ttmt -55.76 -36.23 67.1 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.99 1.316 . . . . 0.0 113.223 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.52 37.3 2.04 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.578 1.551 . . . . 0.0 112.481 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.58 125.09 19.58 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.98 1.712 . . . . 0.0 112.765 -174.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . 0.267 0.0 OUTLIER 62.55 4.4 1.35 Allowed 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 165.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -52.25 -40.25 61.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.499 1.52 . . . . 0.0 114.606 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -99.84 -67.36 0.85 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.708 0.803 . . . . 0.0 110.981 168.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 p -133.35 -64.1 0.73 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.85 1.26 . . . . 0.0 112.822 172.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.61 -44.82 5.0 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.573 1.549 . . . . 0.0 112.802 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.8 mt -153.65 151.15 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 127.53 2.332 . . . . 0.0 107.008 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.7 m -55.03 144.7 22.59 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 119.912 1.233 . . . . 0.0 113.635 171.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -55.34 -1.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.254 2.621 . . . . 0.0 116.51 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -112.74 -26.66 8.48 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.352 1.861 . . . . 0.0 112.021 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -98.8 -30.75 12.23 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.273 1.829 . . . . 0.0 115.066 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.14 11.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 128.266 2.626 . . . . 0.0 117.31 -174.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -45.12 -25.18 0.31 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.177 2.591 . . . . 0.0 115.386 -177.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 m -50.78 -27.78 7.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.053 1.341 . . . . 0.0 113.924 169.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.1 m -95.69 -23.03 17.19 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.79 1.636 . . . . 0.0 113.95 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.3 mt -74.91 -34.4 62.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.051 1.341 . . . . 0.0 112.562 171.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -140.45 86.68 2.08 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.668 1.987 . . . . 0.0 108.172 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -48.47 123.64 6.93 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.44 1.496 . . . . 0.0 112.705 -168.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.0 mt 44.98 30.36 0.56 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.759 2.024 . . . . 0.0 114.818 -175.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.308 4.0 p-10 46.39 32.34 1.54 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.876 2.07 . . . . 0.0 114.859 -170.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 35.6 m170 -82.36 154.45 25.25 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 172.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.1 m -140.17 151.95 45.65 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.985 1.314 . . . . 0.0 109.767 172.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -123.53 134.54 53.85 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.366 1.067 . . . . 0.0 111.156 -171.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 70' ' ' ILE . 1.8 mp -107.65 136.63 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.501 1.52 . . . . 0.0 107.537 -172.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -133.19 149.6 52.03 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.4 1.48 . . . . 0.0 110.969 -169.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 153.27 43.88 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 0.0 113.711 -177.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.72 -35.03 4.87 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.036 2.491 . . . . 0.0 112.862 172.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -165.96 165.21 18.22 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.766 1.627 . . . . 0.0 114.108 -171.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.92 127.57 32.23 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.096 1.758 . . . . 0.0 112.452 169.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.75 -149.84 13.17 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 122.121 0.845 . . . . 0.0 113.88 -172.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.8 t -123.91 160.73 26.85 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.248 1.419 . . . . 0.0 109.71 177.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.0 tt -134.88 132.96 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.446 0.641 . . . . 0.0 111.239 -169.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.57 -169.65 33.24 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 114.132 -169.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -64.9 129.36 39.44 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 122.296 1.046 . . . . 0.0 112.011 168.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.46 153.01 10.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.896 1.678 . . . . 0.0 112.319 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 62.6 mt -122.84 4.5 9.43 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.628 1.571 . . . . 0.0 113.012 -177.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.7 m -146.27 158.02 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 127.498 2.319 . . . . 0.0 110.827 -174.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -135.14 168.72 18.64 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.374 1.87 . . . . 0.0 109.512 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 1.9 mp -57.18 103.37 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.084 1.754 . . . . 0.0 110.217 176.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.43 -9.44 15.0 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.59 1.567 . . . . 0.0 113.224 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.2 121.93 16.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.987 1.393 . . . . 0.0 111.337 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -64.08 137.34 57.93 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.726 0.81 . . . . 0.0 111.09 168.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 m -143.91 158.58 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 126.57 1.948 . . . . 0.0 111.1 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 t -134.65 148.2 50.32 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 110.332 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.81 -21.15 55.62 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 -164.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.2 p -133.1 -3.76 3.12 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 165.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.82 -14.61 21.78 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -168.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.59 122.78 15.78 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.726 1.25 . . . . 0.0 108.18 -171.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.12 132.02 50.8 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 113.274 -1.784 . . . . 0.0 111.435 -164.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.8 mt -92.69 -37.66 12.26 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -165.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.9 p 178.64 178.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 129.373 3.069 . . . . 0.0 108.486 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.7 ptt-85 -109.25 146.59 33.99 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.995 1.318 . . . . 0.0 113.998 168.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.87 136.48 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 119.398 0.999 . . . . 0.0 108.908 173.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.1 t -141.51 136.27 31.02 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 122.053 -0.405 . . . . 0.0 112.028 -170.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -71.13 165.67 23.06 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 -168.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 65.3 mt -114.24 -174.1 2.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.742 1.617 . . . . 0.0 110.465 172.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -57.57 147.03 62.35 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -77.61 -7.36 16.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.487 2.791 . . . . 0.0 115.22 -167.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 27.7 pt -65.15 -18.39 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.307 2.243 . . . . 0.0 114.221 170.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.92 -33.05 0.1 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -168.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -83.57 -11.9 56.79 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 172.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -150.27 28.28 0.74 Allowed 'General case' 0 CA--C 1.552 1.023 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -169.51 -178.99 41.07 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.469 1.033 . . . . 0.0 114.408 -173.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 m -140.22 30.25 1.98 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.964 1.706 . . . . 0.0 111.789 -169.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -129.04 34.37 4.45 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.955 2.102 . . . . 0.0 111.869 -169.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -46.94 -46.43 21.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.708 2.403 . . . . 0.0 113.924 -174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -161.73 -178.83 6.78 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.554 1.942 . . . . 0.0 111.007 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -138.9 50.32 1.84 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.939 2.096 . . . . 0.0 110.639 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -56.11 -23.83 36.68 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 70.4 t60 . . . . . 0 C--O 1.252 1.224 0 C-N-CA 125.585 1.554 . . . . 0.0 111.73 -178.367 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 110.534 -0.172 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.6 148.18 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 C-N-CA 126.73 2.012 . . . . 0.0 109.929 -174.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -111.52 96.69 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 165.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.18 148.24 12.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 124.913 1.285 . . . . 0.0 109.839 -169.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.463 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 73.2 mttt -143.66 154.51 59.55 Favored Pre-proline 0 N--CA 1.478 0.945 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.36 150.32 15.2 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.086 2.524 . . . . 0.0 112.995 -173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -77.6 -14.01 59.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.5 m -140.94 164.54 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 125.916 1.686 . . . . 0.0 111.111 174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 93.8 p -90.93 161.72 15.07 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.862 0.865 . . . . 0.0 112.098 170.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.19 -131.25 4.16 Favored Glycine 0 CA--C 1.486 -1.767 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 88' ' ' TYR . 6.1 t -152.56 145.25 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 CA-C-N 112.68 -1.76 . . . . 0.0 108.853 -168.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.1 mm -63.34 144.55 14.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 175.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.9 t -125.56 -35.72 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 127.154 2.182 . . . . 0.0 112.341 -178.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -148.73 159.33 44.23 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.915 0.886 . . . . 0.0 111.09 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -126.55 93.83 3.89 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 128.201 2.6 . . . . 0.0 107.601 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -71.67 -41.64 68.46 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.042 0.937 . . . . 0.0 112.52 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -79.32 179.27 7.51 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.705 1.202 . . . . 0.0 112.796 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -132.61 135.07 45.65 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.188 1.395 . . . . 0.0 110.97 172.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -58.82 116.3 3.66 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.471 1.109 . . . . 0.0 111.589 174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.9 -14.42 62.81 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.927 1.251 . . . . 0.0 115.272 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -76.83 -177.63 4.45 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 119.02 1.41 . . . . 0.0 113.638 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -80.58 165.11 22.39 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.498 1.119 . . . . 0.0 112.132 169.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.4 m -137.25 138.79 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 126.814 2.045 . . . . 0.0 108.762 168.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.25 -178.94 1.82 Allowed 'General case' 0 C--N 1.346 0.418 0 C-N-CA 124.384 1.074 . . . . 0.0 111.273 169.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -58.86 35.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 129.039 2.936 . . . . 0.0 116.562 177.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.84 27.39 1.42 Allowed Glycine 0 N--CA 1.466 0.686 0 O-C-N 120.689 -1.257 . . . . 0.0 115.438 -171.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -54.98 151.28 9.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.892 1.346 . . . . 0.0 112.866 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.7 m -70.84 140.04 51.04 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.44 1.096 . . . . 0.0 110.842 178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 21.8 mt -123.48 -45.67 2.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.239 1.815 . . . . 0.0 113.164 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -140.55 167.35 22.37 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.947 0.88 . . . . 0.0 113.261 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 46.0 mt -130.46 143.5 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.959 1.704 . . . . 0.0 107.051 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.559 HD12 HD11 ' A' ' 70' ' ' ILE . 37.9 mt -126.64 155.25 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.49 1.916 . . . . 0.0 111.326 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -116.05 119.69 36.68 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.328 1.851 . . . . 0.0 109.551 169.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -71.95 44.98 0.11 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.429 1.892 . . . . 0.0 112.948 176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 62.81 157.3 0.06 Allowed 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 128.565 2.746 . . . . 0.0 115.771 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.472 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -82.26 12.05 4.77 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -169.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.45 -57.39 10.02 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -171.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.1 m -64.39 -21.43 66.63 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.932 -1.105 . . . . 0.0 113.872 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.6 ttpt -62.13 -22.3 65.72 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.457 1.103 . . . . 0.0 112.658 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.66 -32.87 6.02 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.211 1.004 . . . . 0.0 112.91 169.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -70.33 -28.03 64.83 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -74.62 -40.69 61.39 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.137 -0.977 . . . . 0.0 111.62 168.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -54.59 -36.01 63.97 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 -166.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 79.0 p -63.09 -12.67 28.67 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -82.42 -10.72 58.93 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.634 1.106 . . . . 0.0 113.782 172.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.16 46.19 0.39 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 125.999 1.72 . . . . 0.0 114.708 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.44 -37.87 73.53 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.939 1.296 . . . . 0.0 114.147 -178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.42 -9.35 0.27 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.8 p -70.07 -13.37 62.18 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.611 1.565 . . . . 0.0 114.366 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' HA ' ' CG ' ' A' ' 58' ' ' TYR . 52.2 mt-30 -58.61 -28.61 65.77 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.0 m -72.61 -5.2 35.7 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.625 1.57 . . . . 0.0 114.824 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -38.3 68.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.5 mt -144.08 -65.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.036 1.334 . . . . 0.0 108.677 -170.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -168.09 150.78 5.57 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.878 2.471 . . . . 0.0 108.434 170.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -61.46 -6.28 2.24 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.706 1.603 . . . . 0.0 114.891 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -114.31 -1.24 13.61 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.32 1.448 . . . . 0.0 112.464 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -120.99 -39.37 2.72 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.355 1.862 . . . . 0.0 114.773 -176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 50' ' ' GLN . 19.1 p90 -51.21 -34.34 31.57 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.05 -25.83 67.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.518 1.127 . . . . 0.0 113.406 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -63.11 -18.52 63.51 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 173.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 56.9 m -92.49 -10.96 35.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.954 1.301 . . . . 0.0 113.292 172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 68.5 mt -100.84 -37.33 8.73 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.455 1.502 . . . . 0.0 112.778 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -157.48 179.53 9.16 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.439 1.496 . . . . 0.0 111.843 -172.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.92 172.4 12.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.618 1.167 . . . . 0.0 111.704 172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -77.76 2.49 16.83 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.839 1.656 . . . . 0.0 114.801 -170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.0 t0 58.02 50.58 9.96 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.995 1.318 . . . . 0.0 113.218 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 46.6 m170 -79.18 149.88 31.84 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 44.6 m -141.92 145.11 34.18 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.213 1.005 . . . . 0.0 110.357 176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -103.83 152.78 21.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.62 1.168 . . . . 0.0 111.821 -174.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.559 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.03 134.99 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 125.43 1.492 . . . . 0.0 108.322 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -133.94 150.48 51.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.366 1.467 . . . . 0.0 111.498 -169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.45 162.68 10.5 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.404 1.081 . . . . 0.0 113.009 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -79.58 -41.17 0.21 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.943 2.428 . . . . 0.0 114.011 170.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.65 170.69 20.31 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.61 1.564 . . . . 0.0 113.361 -166.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -73.6 136.87 43.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.129 0.972 . . . . 0.0 112.85 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -144.74 9.24 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 123.565 0.602 . . . . 0.0 112.937 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 50.8 m -120.98 158.8 26.95 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.638 1.575 . . . . 0.0 109.215 178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.7 tt -131.51 136.79 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 123.268 0.627 . . . . 0.0 111.168 -171.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.26 -171.68 32.9 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.032 0.825 . . . . 0.0 113.888 -171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.417 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 4.4 p-10 -63.87 131.55 48.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 122.622 1.201 . . . . 0.0 111.971 168.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.2 128.05 35.19 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.118 -1.401 . . . . 0.0 110.714 177.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.24 -8.83 58.36 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.412 1.085 . . . . 0.0 113.206 175.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.65 158.82 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.522 1.529 . . . . 0.0 113.176 -168.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.51 168.75 19.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.154 2.181 . . . . 0.0 110.049 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.27 102.73 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.643 1.977 . . . . 0.0 109.923 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.99 -12.44 17.32 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-O 118.817 -0.991 . . . . 0.0 112.391 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.19 125.38 24.35 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 119.064 1.432 . . . . 0.0 108.03 167.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.411 ' HA ' HG22 ' A' ' 11' ' ' VAL . 10.2 t80 -72.16 106.78 4.51 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.122 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.92 152.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.5 t -136.76 151.69 49.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.471 1.508 . . . . 0.0 110.676 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -55.66 -24.83 36.24 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 120.98 3.696 . . . . 0.0 120.98 -163.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.4 p -134.79 0.62 2.96 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 165.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.3 m -96.79 -13.52 22.55 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 117.306 2.336 . . . . 0.0 117.306 -163.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 4.9 m -122.2 -28.47 4.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -165.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 59.67 123.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.075 2.15 . . . . 0.0 113.516 174.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.3 mt -96.91 -36.75 10.47 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -166.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.8 p 177.03 170.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 128.558 2.743 . . . . 0.0 108.771 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.475 ' N ' HG22 ' A' ' 97' ' ' VAL . 4.1 ptt180 -99.78 149.35 23.45 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.271 1.582 . . . . 0.0 115.271 168.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.8 t -124.6 135.66 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 120.115 1.325 . . . . 0.0 109.073 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -141.44 123.9 15.82 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -171.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -80.57 126.46 31.27 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.699 1.2 . . . . 0.0 111.471 -176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.3 mt -78.54 -175.66 4.43 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.029 1.732 . . . . 0.0 111.689 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -56.1 156.26 10.8 Favored Pre-proline 0 CA--C 1.554 1.134 0 O-C-N 121.507 -0.745 . . . . 0.0 111.248 169.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -82.54 7.87 4.89 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 114.676 -168.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 pt -61.2 -22.44 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 126.77 2.028 . . . . 0.0 114.747 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -80.74 53.11 1.83 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 126.914 2.086 . . . . 0.0 111.395 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 50.84 50.75 18.42 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.804 2.042 . . . . 0.0 114.898 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -133.34 -24.31 1.83 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -178.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.26 42.83 0.08 OUTLIER Glycine 0 CA--C 1.533 1.207 0 C-N-CA 126.798 2.142 . . . . 0.0 110.968 175.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 61.0 p -71.58 1.44 6.6 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 127.612 2.365 . . . . 0.0 116.342 -169.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.17 158.89 43.9 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.961 1.304 . . . . 0.0 112.286 -175.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 32.2 t60 48.05 36.84 6.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.275 1.83 . . . . 0.0 113.804 -173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -124.5 -11.05 7.39 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.276 1.83 . . . . 0.0 113.505 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -145.67 38.26 1.11 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.965 2.106 . . . . 0.0 109.791 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -137.7 144.6 41.84 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.621 1.568 . . . . 0.0 112.006 -167.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 125.949 1.7 . . . . 0.0 111.796 177.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.705 0.288 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG21 ' HG3' ' A' ' 73' ' ' PRO . 5.3 t -85.62 152.1 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 127.005 2.122 . . . . 0.0 112.138 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -119.41 92.46 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -65.39 150.04 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 125.612 1.565 . . . . 0.0 111.404 -167.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -144.0 154.41 58.23 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 124.877 1.271 . . . . 0.0 113.607 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -80.68 153.73 20.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.031 2.487 . . . . 0.0 112.973 -173.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -79.21 -12.91 59.97 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -142.4 167.66 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.016 1.727 . . . . 0.0 110.295 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 85.5 p -96.13 163.7 13.0 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.056 0.942 . . . . 0.0 112.126 173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.44 -133.89 6.19 Favored Glycine 0 CA--C 1.481 -2.046 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.3 t -147.68 145.19 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.365 -168.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.9 mm -62.48 145.14 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.3 t -127.18 -33.03 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 126.864 2.066 . . . . 0.0 112.805 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -150.92 160.13 44.11 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 111.09 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -127.52 92.55 3.52 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.877 2.471 . . . . 0.0 107.645 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -70.18 -49.07 54.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.857 0.837 . . . . 0.0 111.83 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -72.21 -178.85 2.61 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.788 174.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -137.23 138.77 40.5 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.885 1.274 . . . . 0.0 111.67 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.32 102.54 0.07 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.891 1.677 . . . . 0.0 112.238 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.65 -7.12 49.58 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.549 1.547 . . . . 0.0 115.579 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -78.28 -149.56 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.166 0 CA-C-N 119.652 1.726 . . . . 0.0 114.016 -176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -122.79 161.78 23.33 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.615 1.966 . . . . 0.0 110.764 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.47 136.85 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.153 0.981 . . . . 0.0 111.866 175.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -77.14 155.25 32.47 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.14 1.376 . . . . 0.0 107.704 165.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.354 2.5 tptp -56.7 69.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 128.516 2.726 . . . . 0.0 115.079 176.649 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.74 17.04 5.67 Favored Glycine 0 N--CA 1.464 0.503 0 C-N-CA 127.21 2.338 . . . . 0.0 115.295 176.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.265 0.7 OUTLIER -55.13 146.57 18.13 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.671 1.236 . . . . 0.0 111.898 169.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 42.0 m -71.31 137.37 48.45 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.364 1.465 . . . . 0.0 111.347 176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.0 mt -120.28 -44.6 2.47 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.623 1.969 . . . . 0.0 113.042 -168.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -142.1 168.78 18.94 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.236 1.014 . . . . 0.0 112.406 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.07 143.59 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.166 1.786 . . . . 0.0 107.255 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 70' ' ' ILE . 41.3 mt -127.07 154.13 36.95 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 C-N-CA 126.56 1.944 . . . . 0.0 111.709 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -114.16 111.97 22.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.172 1.789 . . . . 0.0 109.686 170.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -71.71 -19.25 62.08 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.7 t70 58.34 -34.32 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 130.262 3.425 . . . . 0.0 117.175 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -155.52 24.19 0.4 Allowed 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -167.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.04 -34.01 74.18 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 120.744 -1.223 . . . . 0.0 112.736 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.7 m -97.58 -27.51 14.37 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 171.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -66.31 -16.26 63.89 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.485 1.114 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -94.71 -37.33 11.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.6 -0.688 . . . . 0.0 111.798 167.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -33.26 75.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.618 1.167 . . . . 0.0 113.959 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -81.19 -8.76 59.82 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.3 mtp180 -55.42 -43.16 75.05 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -165.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.5 m -80.29 -25.04 39.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.076 0.95 . . . . 0.0 113.224 174.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -73.84 -15.8 61.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.567 1.547 . . . . 0.0 113.178 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.29 -7.19 8.6 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.63 176.28 0.53 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.955 1.302 . . . . 0.0 112.95 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -27.76 -46.6 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 129.038 2.935 . . . . 0.0 117.247 178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.3 m -65.14 -10.99 35.4 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -55.45 -14.4 1.96 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 126.308 1.843 . . . . 0.0 114.761 175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 40.0 m -54.79 -28.84 52.0 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.514 -1.366 . . . . 0.0 114.588 172.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -79.84 -19.99 47.07 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 mt 69.54 110.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 129.678 3.191 . . . . 0.0 109.461 -169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 m -60.53 155.39 18.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.985 1.314 . . . . 0.0 112.964 -170.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -61.83 -6.84 2.98 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -124.62 8.05 8.26 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.087 0.955 . . . . 0.0 111.989 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -110.91 -44.74 3.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.934 2.093 . . . . 0.0 112.538 171.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -23.72 66.35 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.054 1.342 . . . . 0.0 113.98 -173.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.7 -10.97 57.13 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.305 1.442 . . . . 0.0 113.676 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.2 p -61.19 -21.8 64.16 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.413 1.006 . . . . 0.0 113.246 169.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.3 m -82.8 -18.55 40.16 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.232 1.013 . . . . 0.0 113.548 170.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.9 mt -102.45 -28.93 11.91 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.379 1.872 . . . . 0.0 113.972 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -145.52 174.31 11.27 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.734 1.614 . . . . 0.0 112.816 -168.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -172.21 4.04 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.829 1.652 . . . . 0.0 113.043 -169.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.3 mt -71.72 54.56 0.25 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.583 2.353 . . . . 0.0 113.856 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.4 t0 60.52 36.14 20.05 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.083 1.753 . . . . 0.0 112.619 -174.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.9 m170 -79.96 147.59 31.54 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 65.8 m -140.61 139.33 34.89 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.917 0.887 . . . . 0.0 110.765 175.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -95.34 155.29 16.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.109 0.963 . . . . 0.0 111.63 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -127.85 135.82 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.838 1.655 . . . . 0.0 107.482 -177.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -133.76 151.78 51.69 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.982 1.313 . . . . 0.0 111.348 -169.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.35 155.8 55.45 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 124.158 0.983 . . . . 0.0 111.875 177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.456 ' HG3' HG21 ' A' ' 2' ' ' VAL . 83.7 Cg_endo -78.48 -39.94 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 121.183 1.255 . . . . 0.0 111.163 167.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.511 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 26.7 p90 -158.91 165.68 33.59 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -172.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.45 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 7.2 p-10 -60.3 134.49 57.11 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.751 2.421 . . . . 0.0 113.891 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.32 -147.69 15.42 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 122.128 0.849 . . . . 0.0 114.613 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.5 m -108.67 160.58 15.83 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.408 1.883 . . . . 0.0 109.667 176.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.2 tt -136.73 134.84 48.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.675 -175.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.5 -170.88 35.27 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-O 121.583 0.546 . . . . 0.0 113.32 -169.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.18 129.58 40.92 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.499 -1.0 . . . . 0.0 111.338 168.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.41 149.92 12.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.725 173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.5 mt -119.07 1.84 11.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.171 1.388 . . . . 0.0 112.563 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.7 m -145.46 157.66 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 126.529 1.932 . . . . 0.0 111.448 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -140.91 168.67 19.25 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.771 2.028 . . . . 0.0 109.801 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.01 102.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.911 2.085 . . . . 0.0 109.399 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.46 -14.31 13.31 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 118.816 -0.991 . . . . 0.0 112.931 -175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.34 125.87 26.42 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 118.743 1.272 . . . . 0.0 107.668 168.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -70.52 107.19 3.74 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.8 175.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.29 149.93 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 177.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.3 t -137.52 147.98 45.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.657 1.183 . . . . 0.0 110.515 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.9 -23.96 21.27 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 120.844 3.646 . . . . 0.0 120.844 -163.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.3 p -132.77 -0.11 3.5 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 165.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.01 -14.12 23.24 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -167.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.51 119.3 10.53 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.983 1.373 . . . . 0.0 108.613 -169.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.45 118.31 36.46 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 112.69 -2.05 . . . . 0.0 108.981 -165.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 4' ' ' ILE . 10.5 mt -80.76 -38.32 28.83 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -164.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.1 p 179.39 176.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 128.914 2.886 . . . . 0.0 108.653 -175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.525 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.7 ptt-85 -109.54 144.76 37.39 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 125.222 1.409 . . . . 0.0 113.846 169.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.45 134.25 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.54 116.18 9.67 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -168.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.24 139.69 54.46 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 120.778 -1.201 . . . . 0.0 111.552 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.05 -71.2 0.44 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.765 0.826 . . . . 0.0 109.846 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -136.22 157.95 74.58 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 125.16 1.384 . . . . 0.0 109.243 166.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -83.9 29.97 0.54 Allowed 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.067 3.178 . . . . 0.0 113.4 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.1 pt -138.69 0.66 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 126.893 2.077 . . . . 0.0 113.999 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -63.13 114.63 3.86 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.136 0.974 . . . . 0.0 111.848 -176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -156.02 175.13 14.37 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.237 1.815 . . . . 0.0 112.087 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -134.05 144.52 48.72 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.173 0.989 . . . . 0.0 111.85 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.66 -169.1 42.25 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.561 1.077 . . . . 0.0 113.443 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.8 p -146.31 162.05 38.97 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.253 1.421 . . . . 0.0 112.232 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -132.72 -16.78 2.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.241 1.416 . . . . 0.0 113.941 -173.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -149.78 159.1 44.63 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.861 1.664 . . . . 0.0 110.703 173.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -134.93 23.95 3.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.864 1.266 . . . . 0.0 112.87 -169.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 66.2 8.06 5.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.595 2.358 . . . . 0.0 116.157 171.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -70.39 159.29 34.44 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.807 1.243 . . . . 0.0 112.231 169.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.248 1.819 . . . . 0.0 111.598 179.402 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.475 0.178 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.451 HG21 ' HG3' ' A' ' 73' ' ' PRO . 6.1 t -85.75 145.24 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.358 0.663 . . . . 0.0 110.599 170.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.13 94.55 3.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 102.367 -3.197 . . . . 0.0 102.367 165.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.76 147.85 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 124.362 1.065 . . . . 0.0 109.638 -169.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.0 mttt -144.28 153.51 56.12 Favored Pre-proline 0 N--CA 1.476 0.852 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -177.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.06 148.8 17.23 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.279 2.652 . . . . 0.0 113.28 -174.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -76.99 -9.74 58.9 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -142.82 170.66 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.614 1.966 . . . . 0.0 110.923 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 89.0 p -99.21 164.74 12.02 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.148 0.979 . . . . 0.0 112.15 169.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.87 -133.86 5.72 Favored Glycine 0 CA--C 1.483 -1.908 0 N-CA-C 108.265 -1.934 . . . . 0.0 108.265 -169.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 88' ' ' TYR . 13.8 t -150.23 144.65 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.748 -1.726 . . . . 0.0 109.045 -168.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.4 mm -62.4 144.08 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.9 t -125.96 -35.03 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 126.589 1.955 . . . . 0.0 112.159 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -149.43 160.46 43.42 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.183 0.993 . . . . 0.0 110.716 177.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mmmm -127.3 93.81 3.83 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 128.712 2.805 . . . . 0.0 107.639 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.38 -42.3 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.079 0.952 . . . . 0.0 112.2 -177.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.1 -179.05 6.46 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.704 -1.134 . . . . 0.0 112.166 177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -130.52 135.2 47.7 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.709 1.604 . . . . 0.0 111.814 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.98 114.67 2.02 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.567 1.147 . . . . 0.0 111.603 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.39 -8.72 72.06 Favored Glycine 0 CA--C 1.543 1.824 0 C-N-CA 124.781 1.181 . . . . 0.0 115.658 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -85.15 -152.57 0.15 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 119.444 1.622 . . . . 0.0 113.662 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.3 mmtt -114.02 165.68 12.38 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.51 1.524 . . . . 0.0 112.036 177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.5 m -143.55 133.92 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 126.226 1.81 . . . . 0.0 110.955 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.25 159.91 33.16 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.981 0.912 . . . . 0.0 110.39 167.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 74' ' ' PHE 0.315 0.9 OUTLIER -54.44 74.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.045 2.538 . . . . 0.0 113.659 169.802 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.67 17.33 9.24 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.59 2.043 . . . . 0.0 115.129 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.13 142.79 41.28 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.287 1.043 . . . . 0.0 111.794 168.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.7 m -66.25 137.12 56.73 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.534 1.533 . . . . 0.0 110.534 175.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.5 mt -121.38 -44.94 2.35 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.525 1.93 . . . . 0.0 112.652 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -140.91 167.17 22.82 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.997 0.919 . . . . 0.0 113.322 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.6 mt -129.71 142.81 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.937 1.695 . . . . 0.0 107.206 171.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 70' ' ' ILE . 44.8 mt -126.77 151.12 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.503 1.921 . . . . 0.0 111.132 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -114.4 113.87 25.09 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.16 1.784 . . . . 0.0 109.32 169.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -61.14 -41.13 96.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -175.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.43 168.0 13.36 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 126.609 1.964 . . . . 0.0 111.305 179.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.456 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -135.44 16.53 3.4 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.01 92.63 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.4 m -90.42 -6.48 54.89 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.612 1.165 . . . . 0.0 113.745 176.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.7 ttpt -64.28 -41.39 96.91 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.213 0.915 . . . . 0.0 113.055 -169.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.22 -34.14 56.08 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 171.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -78.81 -40.18 33.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -168.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.8 -36.09 57.18 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -59.18 -29.08 67.2 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -167.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 38.7 m -58.37 -24.22 59.27 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.059 1.344 . . . . 0.0 113.746 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -58.54 -22.73 56.47 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.873 1.269 . . . . 0.0 113.84 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.39 -20.85 47.53 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.8 mt -65.96 -33.07 74.98 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -158.77 -11.96 0.07 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 -166.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.4 m -134.64 -28.22 1.26 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.559 1.689 . . . . 0.0 115.559 -169.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.6 -23.42 67.38 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 120.989 -1.069 . . . . 0.0 113.014 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.6 p -69.2 -10.25 56.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.487 1.915 . . . . 0.0 114.8 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -75.82 -161.53 0.17 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.243 0.929 . . . . 0.0 112.404 174.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 mt -131.16 18.69 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.971 1.309 . . . . 0.0 111.86 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.8 m -60.75 143.15 55.05 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.639 -1.288 . . . . 0.0 110.901 169.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -58.55 -6.81 0.77 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.007 2.595 . . . . 0.0 118.007 -168.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -126.67 0.28 6.78 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.066 0.947 . . . . 0.0 112.95 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -105.69 -44.63 4.61 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.501 2.321 . . . . 0.0 111.329 174.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.28 -25.16 67.7 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.314 1.445 . . . . 0.0 114.85 -171.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -76.48 -1.26 26.34 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.3 p -55.79 -25.89 43.43 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 72.5 p -102.92 -9.94 19.44 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.704 1.602 . . . . 0.0 114.32 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -93.83 -23.45 18.13 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.742 1.617 . . . . 0.0 112.748 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.49 179.98 6.63 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.423 1.489 . . . . 0.0 112.817 -169.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.3 p -130.51 178.64 6.46 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.76 1.624 . . . . 0.0 112.11 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.2 mp -78.92 58.13 2.31 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.195 2.198 . . . . 0.0 112.669 -172.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 58.87 35.31 24.15 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.165 1.386 . . . . 0.0 113.75 171.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -90.04 155.79 18.83 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.1 m -142.69 143.1 32.17 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.268 1.027 . . . . 0.0 110.086 170.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -102.68 156.68 17.46 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.758 0.823 . . . . 0.0 112.216 -177.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.542 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -128.14 137.86 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 125.268 1.427 . . . . 0.0 107.94 -176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -135.46 155.29 50.78 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.695 1.598 . . . . 0.0 112.229 -172.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.02 154.65 59.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.037 0.935 . . . . 0.0 112.522 177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.451 ' HG3' HG21 ' A' ' 2' ' ' VAL . 86.0 Cg_endo -78.17 -40.54 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 121.607 1.538 . . . . 0.0 111.19 168.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.497 ' HA ' ' HD3' ' A' ' 25' ' ' LYS . 35.2 p90 -155.73 163.99 39.16 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 117.288 2.329 . . . . 0.0 117.288 -173.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 14.2 t70 -60.86 130.7 47.77 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.017 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.79 -156.22 27.68 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-O 122.755 1.197 . . . . 0.0 115.739 -176.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.9 m -106.21 160.76 15.09 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 126.446 1.898 . . . . 0.0 108.808 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.3 tt -136.77 139.64 44.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.098 0.475 . . . . 0.0 110.781 -174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.84 -170.0 34.65 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 121.419 0.455 . . . . 0.0 113.479 -172.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.05 130.21 42.45 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.112 0.958 . . . . 0.0 111.213 167.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.16 139.42 41.96 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 114.495 -1.23 . . . . 0.0 111.638 174.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.6 mt -97.82 -6.69 32.07 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.618 1.167 . . . . 0.0 112.947 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.7 m -142.2 158.2 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.534 1.533 . . . . 0.0 113.025 -168.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -141.13 168.91 18.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.001 2.12 . . . . 0.0 110.131 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.5 mp -60.72 103.21 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 126.689 1.996 . . . . 0.0 109.554 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.15 -13.02 16.67 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.663 -1.076 . . . . 0.0 112.413 -175.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.09 125.34 24.66 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 119.53 1.665 . . . . 0.0 107.961 168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.434 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.9 t80 -72.26 106.67 4.52 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.538 176.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 m -108.06 153.09 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 116.111 1.893 . . . . 0.0 116.111 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.9 t -138.28 149.24 45.5 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.883 1.273 . . . . 0.0 110.943 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.25 . . -52.47 -24.44 7.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 120.955 3.687 . . . . 0.0 120.955 -162.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.4 p -136.62 3.25 2.75 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 121.324 -0.86 . . . . 0.0 113.231 164.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -96.71 -13.49 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 -163.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -124.79 -28.35 3.53 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -165.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.462 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.8 mt-10 60.38 121.21 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.144 2.178 . . . . 0.0 113.137 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.0 mt -93.43 -37.34 12.02 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -167.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.557 HG22 ' N ' ' A' ' 98' ' ' ARG . 14.9 p 178.85 178.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 129.182 2.993 . . . . 0.0 108.647 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' N ' HG22 ' A' ' 97' ' ' VAL . 26.5 ptt-85 -111.17 145.77 38.06 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.125 1.37 . . . . 0.0 113.419 168.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.5 t -118.94 135.59 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.065 0.946 . . . . 0.0 108.833 176.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 2.3 t -141.15 114.61 8.81 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.387 0.613 . . . . 0.0 112.598 -170.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.1 142.45 42.36 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 120.907 -1.121 . . . . 0.0 110.681 -172.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 15.7 mt -63.04 168.64 3.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.989 0.9 . . . . 0.0 112.736 175.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -63.2 156.01 70.96 Favored Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -175.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -97.38 14.53 0.78 Allowed 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 124.878 3.719 . . . . 0.0 113.569 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 pt -66.07 -15.1 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 126.044 1.738 . . . . 0.0 114.169 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -78.82 45.38 0.6 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.254 2.222 . . . . 0.0 112.344 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 51.85 46.92 25.78 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.198 1.799 . . . . 0.0 114.088 -170.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -133.42 1.34 3.43 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -172.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 165.01 -23.84 0.16 Allowed Glycine 0 CA--C 1.541 1.696 0 N-CA-C 115.826 1.091 . . . . 0.0 115.826 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -133.65 47.21 2.48 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 118.998 1.399 . . . . 0.0 112.869 -176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -144.79 148.69 34.35 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.181 1.392 . . . . 0.0 110.992 171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -156.81 176.58 12.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.756 1.622 . . . . 0.0 111.039 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -141.87 133.18 26.48 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.227 1.011 . . . . 0.0 111.669 174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.8 p-80 -153.85 9.58 0.39 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 -170.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -126.34 2.26 7.03 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 . . . . . 0 C--O 1.252 1.195 0 C-N-CA 124.818 1.247 . . . . 0.0 112.274 174.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.628 0.252 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -91.45 151.08 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 126.371 1.869 . . . . 0.0 111.953 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -119.55 90.91 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 103.361 -2.829 . . . . 0.0 103.361 165.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -61.68 150.41 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 126.61 1.964 . . . . 0.0 111.908 -167.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.2 mttt -144.05 153.11 56.41 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 125.345 1.458 . . . . 0.0 113.91 -175.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.62 162.4 35.59 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.865 2.377 . . . . 0.0 113.558 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -95.87 -3.78 44.82 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.62 1.168 . . . . 0.0 114.094 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.43 -178.55 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 127.108 2.163 . . . . 0.0 109.588 175.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.4 p -118.12 156.68 28.26 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.461 1.104 . . . . 0.0 112.416 172.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 146.93 -127.43 2.69 Favored Glycine 0 CA--C 1.491 -1.422 0 C-N-CA 126.45 1.976 . . . . 0.0 109.111 -169.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.6 t -151.47 144.0 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 113.204 -1.498 . . . . 0.0 109.86 -166.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.3 mm -61.02 144.77 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 47.9 t -125.75 -33.68 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 127.167 2.187 . . . . 0.0 112.337 -179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -149.5 161.65 41.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.857 0.863 . . . . 0.0 111.078 177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -128.57 94.18 3.81 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 128.913 2.885 . . . . 0.0 107.379 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -73.08 -43.02 62.39 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.593 0.757 . . . . 0.0 112.46 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -80.01 -178.84 6.7 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.673 1.189 . . . . 0.0 112.644 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -128.39 134.31 48.79 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.455 1.502 . . . . 0.0 112.215 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.37 105.14 0.18 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.768 1.627 . . . . 0.0 111.708 174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.85 -6.68 48.28 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.239 1.4 . . . . 0.0 115.767 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.97 -147.83 0.09 Allowed 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 119.128 1.464 . . . . 0.0 114.452 -174.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -122.36 161.38 23.52 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 127.134 2.174 . . . . 0.0 110.936 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.1 m -137.8 143.41 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.899 1.279 . . . . 0.0 111.203 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.69 -175.06 0.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.597 1.159 . . . . 0.0 110.924 168.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -59.5 33.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 128.12 2.568 . . . . 0.0 116.515 174.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.55 32.11 0.91 Allowed Glycine 0 CA--C 1.523 0.579 0 C-N-CA 124.909 1.242 . . . . 0.0 115.865 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -55.59 153.14 8.18 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 18.1 m -69.15 138.7 54.39 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.399 1.48 . . . . 0.0 110.663 177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 17.6 mt -123.82 -43.86 2.1 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.148 1.779 . . . . 0.0 113.952 -169.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -142.37 169.49 17.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.327 1.051 . . . . 0.0 112.926 -179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 43.2 mt -133.2 144.58 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 126.091 1.756 . . . . 0.0 106.919 172.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 52.8 mt -129.17 148.21 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.116 1.766 . . . . 0.0 110.956 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -102.79 128.92 49.34 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 166.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -70.57 35.0 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.173 1.789 . . . . 0.0 113.539 176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.5 t0 50.5 95.24 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 129.218 3.007 . . . . 0.0 114.864 -177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -67.88 3.14 1.62 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 116.943 2.201 . . . . 0.0 116.943 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.31 -38.65 13.12 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 120.387 1.448 . . . . 0.0 114.402 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -71.02 -25.15 62.54 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.1 mtpt -65.57 -32.99 74.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.737 1.153 . . . . 0.0 112.499 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -64.06 -25.58 68.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.935 0.894 . . . . 0.0 113.356 170.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -107.31 -10.43 15.8 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.646 1.578 . . . . 0.0 114.148 -171.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -60.29 -19.57 55.58 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 -169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.3 mtp-105 -54.53 -27.54 39.09 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -166.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.6 p -59.95 -36.67 77.59 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.099 0.96 . . . . 0.0 113.452 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -64.56 -22.62 67.02 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.882 1.673 . . . . 0.0 113.295 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.32 -7.59 50.37 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.701 1.0 . . . . 0.0 113.701 171.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.5 mt -122.82 -44.62 2.19 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.788 1.635 . . . . 0.0 113.089 -175.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -159.63 165.77 32.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.112 1.365 . . . . 0.0 111.569 -168.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.7 m 53.17 26.34 4.96 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -65.21 -12.72 54.26 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.21 1.404 . . . . 0.0 113.596 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.3 m -55.36 -20.25 11.27 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 126.65 1.98 . . . . 0.0 115.898 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.86 -20.38 66.21 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 170.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.2 mm 64.89 -67.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 128.768 2.827 . . . . 0.0 113.031 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.9 m 60.07 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.663 1.585 . . . . 0.0 112.903 -168.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -54.76 2.01 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 130.399 3.48 . . . . 0.0 118.185 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -124.75 -14.57 6.71 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 128.28 2.632 . . . . 0.0 113.016 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.76 -34.06 6.37 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.86 2.064 . . . . 0.0 113.44 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -58.24 -31.13 67.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.64 124.57 7.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.924 0.89 . . . . 0.0 112.233 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.8 m -70.54 -16.42 62.88 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 m -103.53 -38.84 6.98 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.715 1.206 . . . . 0.0 112.336 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.41 -16.9 63.0 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.076 1.35 . . . . 0.0 114.398 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.68 147.23 32.79 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.05 1.34 . . . . 0.0 111.28 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.92 -178.09 2.22 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.679 1.592 . . . . 0.0 112.603 173.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.435 ' H ' ' CD2' ' A' ' 65' ' ' LEU 0.263 0.2 OUTLIER -60.97 49.24 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.986 2.914 . . . . 0.0 115.514 167.633 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.36 0.4 OUTLIER 47.24 35.01 3.4 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.314 3.046 . . . . 0.0 118.15 177.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 26.4 m170 -97.1 159.99 14.6 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 169.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 52.8 m -142.74 139.23 30.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.956 1.302 . . . . 0.0 109.937 168.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -94.28 154.7 17.39 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.45 1.1 . . . . 0.0 111.419 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 5.1 mp -128.09 137.34 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 125.558 1.543 . . . . 0.0 108.524 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -138.5 155.24 48.6 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.603 1.161 . . . . 0.0 112.541 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.79 165.38 9.91 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.993 1.317 . . . . 0.0 112.507 177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -86.08 -41.34 0.07 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.896 2.397 . . . . 0.0 115.653 170.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -157.93 169.85 23.66 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.852 2.061 . . . . 0.0 112.435 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -70.37 143.02 52.05 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.74 -155.43 26.73 Favored Glycine 0 CA--C 1.517 0.171 0 CA-C-O 122.175 0.875 . . . . 0.0 114.101 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 51.6 m -105.4 159.26 16.05 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 125.803 1.641 . . . . 0.0 109.038 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 14.9 tt -135.69 134.34 51.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 123.112 0.565 . . . . 0.0 110.114 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.18 -170.99 31.4 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 121.865 0.703 . . . . 0.0 113.754 -169.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.04 129.73 41.61 Favored 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.624 -0.927 . . . . 0.0 110.782 167.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -53.2 146.15 12.31 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.407 171.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 56.0 mt -113.7 1.45 14.89 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.715 1.206 . . . . 0.0 112.355 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -146.85 156.73 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.554 1.942 . . . . 0.0 111.839 -170.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -141.29 169.38 17.71 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.808 2.043 . . . . 0.0 110.443 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -60.44 102.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 126.881 2.072 . . . . 0.0 109.572 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.27 -13.57 16.16 Favored Glycine 0 N--CA 1.467 0.755 0 CA-C-O 119.062 -0.854 . . . . 0.0 112.987 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.04 125.21 24.74 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-N 118.823 1.312 . . . . 0.0 108.112 168.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -70.14 106.92 3.45 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.315 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.5 m -111.98 145.35 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-O 122.637 1.208 . . . . 0.0 114.229 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 t -136.78 143.29 43.13 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.664 1.185 . . . . 0.0 109.98 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.282 . . -36.44 -72.04 0.06 Allowed 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 118.547 2.795 . . . . 0.0 118.547 -164.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.2 p -95.99 -3.45 45.0 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 174.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.6 m -96.01 -13.19 23.95 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -167.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.09 123.96 15.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.916 1.341 . . . . 0.0 108.986 -172.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 125.57 50.31 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.562 -2.108 . . . . 0.0 109.676 -165.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.4 HD12 HG23 ' A' ' 4' ' ' ILE . 12.0 mt -90.5 -36.41 14.53 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -164.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 179.19 174.64 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 129.234 3.014 . . . . 0.0 107.971 -177.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.6 ptt-85 -106.31 141.15 38.12 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 168.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.44 133.79 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 175.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.1 111.91 7.09 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.758 0.79 . . . . 0.0 112.595 -168.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -64.73 135.79 56.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.302 1.041 . . . . 0.0 111.155 -172.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 24.1 mt -64.49 -67.06 0.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.175 0.99 . . . . 0.0 111.873 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -139.15 157.07 71.81 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 125.274 1.43 . . . . 0.0 109.99 169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -86.58 4.82 6.16 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.602 2.868 . . . . 0.0 113.692 -172.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 pt -91.0 6.9 4.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 127.223 2.209 . . . . 0.0 113.295 -176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -101.94 27.7 6.33 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.925 2.09 . . . . 0.0 111.835 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -151.14 159.33 44.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 127.469 2.307 . . . . 0.0 110.988 176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.9 t70 60.99 -19.02 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.686 2.794 . . . . 0.0 118.058 174.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.59 -174.2 43.74 Favored Glycine 0 CA--C 1.537 1.457 0 O-C-N 120.473 -1.392 . . . . 0.0 114.112 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.6 m -132.22 5.74 4.14 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.742 1.217 . . . . 0.0 114.252 -171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -147.02 69.05 1.16 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.655 1.582 . . . . 0.0 110.098 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -61.44 -26.79 68.11 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -172.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -152.47 157.64 41.45 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.411 1.484 . . . . 0.0 111.286 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -75.17 174.55 9.29 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -135.8 11.32 3.4 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.884 1.274 . . . . 0.0 113.748 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 77.1 m80 . . . . . 0 C--O 1.252 1.2 0 C-N-CA 126.119 1.768 . . . . 0.0 113.445 179.667 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.56 0.219 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.7 t -136.15 149.91 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.026 1.73 . . . . 0.0 111.393 -173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.2 94.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 165.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.61 148.15 12.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.483 1.113 . . . . 0.0 109.959 -169.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 71.7 mttt -143.99 153.1 56.61 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.343 1.057 . . . . 0.0 113.566 -177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -81.69 149.0 16.11 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.698 2.266 . . . . 0.0 112.725 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -74.65 -12.42 60.43 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.7 m -143.09 166.33 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.089 1.756 . . . . 0.0 110.978 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 87.2 p -95.02 166.34 11.99 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.866 0.866 . . . . 0.0 112.439 171.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.92 -138.15 9.58 Favored Glycine 0 CA--C 1.482 -2.024 0 N-CA-C 107.824 -2.11 . . . . 0.0 107.824 -169.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 88' ' ' TYR . 41.5 t -144.59 142.86 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-N 112.905 -1.648 . . . . 0.0 109.688 -168.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.4 mm -59.88 142.77 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 O-C-N 123.839 0.712 . . . . 0.0 112.39 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 42.4 t -125.1 -34.87 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 C-N-CA 126.608 1.963 . . . . 0.0 112.501 -178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -148.31 158.35 44.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.366 1.067 . . . . 0.0 110.899 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mmmm -125.74 94.03 4.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 128.501 2.72 . . . . 0.0 107.131 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.55 -42.35 71.26 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.675 0.79 . . . . 0.0 112.1 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -80.38 177.83 8.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.905 1.282 . . . . 0.0 112.019 174.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.9 mttt -132.69 144.3 50.22 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.849 1.259 . . . . 0.0 111.046 171.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.15 110.2 0.64 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.607 0.763 . . . . 0.0 112.209 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.84 -3.33 60.63 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 125.008 1.289 . . . . 0.0 115.184 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -67.88 177.56 2.09 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 119.158 1.479 . . . . 0.0 113.585 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -92.47 161.82 14.47 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.428 1.491 . . . . 0.0 110.032 168.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 m -132.25 134.76 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.046 174.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -72.12 172.33 10.33 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.925 1.29 . . . . 0.0 108.581 166.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -54.96 40.31 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 130.259 3.424 . . . . 0.0 117.101 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.04 1.72 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 125.585 1.564 . . . . 0.0 115.333 -173.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -54.22 150.05 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.655 1.228 . . . . 0.0 113.273 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.7 m -69.84 140.06 53.2 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.792 1.237 . . . . 0.0 111.21 177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 22.6 mt -124.38 -44.94 1.98 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.195 1.798 . . . . 0.0 113.422 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -140.85 168.14 20.51 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 48.4 mt -131.51 144.26 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 126.263 1.825 . . . . 0.0 107.474 170.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.6 mt -125.02 153.43 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 127.094 2.158 . . . . 0.0 111.057 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -116.7 110.81 18.95 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 126.507 1.923 . . . . 0.0 108.823 169.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -64.67 -42.12 95.59 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 -170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -156.02 -6.05 0.12 Allowed 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 117.211 2.3 . . . . 0.0 117.211 -171.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.499 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER 52.26 13.45 0.28 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.01 -46.35 89.57 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.368 0.986 . . . . 0.0 113.08 -170.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.0 m -75.24 -17.0 60.42 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 38.8 ttpt -62.76 -35.81 81.0 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.534 1.061 . . . . 0.0 112.469 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -70.59 -21.62 62.65 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.19 0.996 . . . . 0.0 113.525 172.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -107.42 -40.22 5.42 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -92.91 -38.76 11.53 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.517 1.127 . . . . 0.0 113.963 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -62.86 -22.01 66.37 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -166.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.7 p -69.78 -15.0 63.05 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 172.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.02 -39.18 8.66 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.687 1.195 . . . . 0.0 112.345 171.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.92 -9.86 59.07 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.414 1.086 . . . . 0.0 113.631 173.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . 0.254 4.3 mm? 60.62 159.31 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.887 2.875 . . . . 0.0 114.895 -167.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -74.16 -43.3 57.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 113.352 -1.749 . . . . 0.0 113.477 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 75.7 p -71.63 146.01 48.59 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -169.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.7 mm100 -64.61 -30.01 71.02 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.49 -0.756 . . . . 0.0 112.456 176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.1 m -69.22 -12.83 62.01 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.56 -18.49 65.36 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 68.3 mt -138.58 135.72 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.273 1.429 . . . . 0.0 109.617 -167.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.6 m -77.48 163.16 26.58 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -172.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -58.97 -6.67 0.85 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.891 2.076 . . . . 0.0 116.591 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt -124.51 -1.62 8.02 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.549 -0.719 . . . . 0.0 112.297 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -98.24 -40.76 8.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.691 1.996 . . . . 0.0 112.396 170.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -63.81 -8.9 12.12 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -169.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.97 -22.72 60.74 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.817 -1.177 . . . . 0.0 112.644 168.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.5 m -67.18 -49.09 65.93 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.515 -0.741 . . . . 0.0 110.688 168.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.4 m -60.9 -34.22 74.33 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.43 1.492 . . . . 0.0 113.544 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.69 -15.25 61.11 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.302 1.841 . . . . 0.0 114.317 174.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.52 39.74 1.55 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.845 1.258 . . . . 0.0 112.732 -168.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.521 HG23 ' HG ' ' A' ' 65' ' ' LEU . 3.0 t -147.49 -174.75 4.61 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.894 1.678 . . . . 0.0 110.909 -178.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' HG ' HG23 ' A' ' 64' ' ' THR . 10.0 mt 55.76 25.03 7.87 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 119.572 1.078 . . . . 0.0 112.589 -170.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.255 3.5 t0 58.91 36.65 24.66 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.531 2.332 . . . . 0.0 114.113 -169.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -72.37 144.18 48.32 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.2 m -142.06 145.86 34.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.931 0.892 . . . . 0.0 110.958 175.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' C ' HD12 ' A' ' 70' ' ' ILE . 51.6 mt-10 -103.77 157.41 17.1 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 -175.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 69' ' ' GLU . 3.0 mp -126.89 136.19 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.513 1.525 . . . . 0.0 107.86 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -132.27 150.47 52.15 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.126 1.77 . . . . 0.0 110.823 -172.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.67 163.18 12.87 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 124.159 0.983 . . . . 0.0 113.22 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.79 -42.66 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.848 2.365 . . . . 0.0 114.231 169.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -158.3 173.08 17.22 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.138 1.775 . . . . 0.0 114.026 -167.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -76.05 137.15 40.01 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.294 1.437 . . . . 0.0 112.303 177.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.33 -144.12 9.14 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 121.76 0.644 . . . . 0.0 113.073 -173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 68.1 m -124.77 157.97 34.44 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.182 1.793 . . . . 0.0 109.016 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.2 tt -133.82 128.21 53.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -76.09 -170.11 29.46 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 123.755 0.693 . . . . 0.0 114.61 -167.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.68 125.09 19.7 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.826 0.822 . . . . 0.0 111.389 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.08 148.21 27.14 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.373 1.069 . . . . 0.0 111.102 175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.73 -5.17 17.53 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.698 1.199 . . . . 0.0 112.969 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.74 158.45 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.659 1.583 . . . . 0.0 112.601 -169.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -141.69 168.41 19.83 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.13 2.172 . . . . 0.0 109.922 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.79 103.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 126.569 1.948 . . . . 0.0 109.221 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 116.76 -13.71 14.79 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-O 119.225 -0.764 . . . . 0.0 112.925 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -66.44 124.41 22.67 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 118.733 1.266 . . . . 0.0 108.287 168.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.415 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.0 t80 -71.48 107.24 4.29 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.471 -1.24 . . . . 0.0 109.152 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.2 m -106.31 156.3 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 176.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.9 t -139.85 149.94 44.05 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.194 1.398 . . . . 0.0 110.477 -179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.9 17.36 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 121.277 3.806 . . . . 0.0 121.277 -163.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 86.8 p -136.09 2.5 2.82 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.76 -14.25 22.1 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.233 2.308 . . . . 0.0 117.233 -164.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.0 m -123.28 -28.87 3.92 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -164.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.1 mt-10 60.35 122.93 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 127.321 2.248 . . . . 0.0 112.899 175.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.71 -37.56 11.23 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -166.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.6 p 178.68 179.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 128.914 2.886 . . . . 0.0 108.261 -177.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 97' ' ' VAL . 30.2 ptt-85 -110.98 146.03 37.38 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.185 1.394 . . . . 0.0 114.015 169.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -120.59 133.35 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 119.628 1.104 . . . . 0.0 108.803 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.4 t -141.64 118.88 11.4 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.76 0.79 . . . . 0.0 112.791 -168.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -75.72 152.04 37.53 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.096 -1.002 . . . . 0.0 112.099 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.1 mt -128.88 -62.6 1.0 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.217 1.407 . . . . 0.0 108.606 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -133.25 162.96 54.49 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 126.411 1.884 . . . . 0.0 107.822 165.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.98 13.15 2.79 Favored 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 123.722 2.948 . . . . 0.0 113.704 -173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.8 pt -141.9 21.28 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 127.458 2.303 . . . . 0.0 111.358 -169.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 -11.53 56.4 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.492 -1.38 . . . . 0.0 114.389 -171.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.15 68.19 3.25 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 122.385 1.088 . . . . 0.0 111.331 167.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.35 126.69 28.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.746 0.818 . . . . 0.0 112.431 -174.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.21 -12.37 61.94 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.82 1.2 . . . . 0.0 113.872 -173.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 47.5 m -105.08 15.03 28.31 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.079 1.352 . . . . 0.0 113.095 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -155.11 -179.47 8.1 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.84 2.056 . . . . 0.0 110.912 174.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -142.9 157.08 44.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.873 1.269 . . . . 0.0 111.331 169.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -154.82 172.32 18.18 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.665 1.586 . . . . 0.0 111.292 -174.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -65.47 -19.86 66.11 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.899 -1.126 . . . . 0.0 113.936 170.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 56.03 36.33 27.17 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.623 1.969 . . . . 0.0 113.731 -174.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 30.7 m170 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 127.064 2.146 . . . . 0.0 111.787 179.118 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.94 110.11 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 mp -67.06 98.36 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.183 -1.826 . . . . 0.0 109.85 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.85 147.93 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 127.083 2.153 . . . . 0.0 110.878 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.2 mttt -144.35 153.9 56.37 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 125.743 1.617 . . . . 0.0 113.45 -175.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.62 156.89 40.32 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.069 2.513 . . . . 0.0 112.979 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -95.27 0.46 53.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.12 1.368 . . . . 0.0 113.731 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.7 m -144.05 -178.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 127.751 2.42 . . . . 0.0 110.029 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.9 p -112.37 160.39 17.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.384 1.074 . . . . 0.0 111.409 168.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.74 -128.79 2.8 Favored Glycine 0 CA--C 1.488 -1.623 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -169.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 88' ' ' TYR . 2.5 t -155.76 148.81 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 112.923 -1.638 . . . . 0.0 108.202 -168.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.1 mm -67.53 144.47 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 C-N-CA 123.55 0.74 . . . . 0.0 112.702 176.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.82 -35.13 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 126.907 2.083 . . . . 0.0 112.278 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -150.88 160.65 43.76 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 123.921 0.889 . . . . 0.0 111.059 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -127.42 93.87 3.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 127.828 2.451 . . . . 0.0 107.653 179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -69.54 -47.81 62.49 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.699 0.799 . . . . 0.0 111.291 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.423 ' CE1' ' CZ ' ' A' ' 30' ' ' PHE . 1.8 p90 -70.45 179.03 2.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 111.86 171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -139.95 141.77 36.43 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.908 1.283 . . . . 0.0 110.414 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.6 101.08 0.05 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.332 1.053 . . . . 0.0 112.407 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.34 -11.33 33.52 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 125.73 1.633 . . . . 0.0 115.4 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -70.45 179.06 2.64 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 118.918 1.359 . . . . 0.0 113.658 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -87.8 164.34 15.98 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.557 1.143 . . . . 0.0 111.716 170.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.6 m -137.75 133.95 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 125.236 1.414 . . . . 0.0 110.974 169.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -74.39 153.1 39.39 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.966 1.306 . . . . 0.0 108.634 167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . 0.373 0.0 OUTLIER -49.46 85.27 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.636 1.974 . . . . 0.0 112.513 170.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.6 16.42 24.43 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 126.111 1.815 . . . . 0.0 114.43 171.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.257 0.4 OUTLIER -55.53 143.98 27.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.831 0.824 . . . . 0.0 111.454 169.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 54.8 m -69.28 136.6 52.13 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.946 1.298 . . . . 0.0 110.604 175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 14.4 mt -119.69 -44.41 2.54 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.509 1.924 . . . . 0.0 112.247 -169.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.423 ' CZ ' ' CE1' ' A' ' 17' ' ' PHE . 5.7 m-85 -139.37 163.25 32.98 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.838 0.828 . . . . 0.0 112.322 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 47.7 mt -126.87 145.48 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.522 HD12 HD11 ' A' ' 70' ' ' ILE . 17.3 mt -130.55 156.06 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.647 0 C-N-CA 126.217 1.807 . . . . 0.0 110.668 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -118.28 125.46 50.14 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.792 1.637 . . . . 0.0 108.789 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -74.64 38.75 0.12 Allowed 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.889 1.276 . . . . 0.0 112.612 174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t0 50.86 107.01 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 129.294 3.038 . . . . 0.0 115.881 -175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.493 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -129.09 17.65 6.1 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.352 1.861 . . . . 0.0 113.68 -179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.56 -47.34 82.33 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.2 m -78.16 -14.32 59.51 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 36.8 ttpt -63.84 -44.48 93.07 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.014 0.925 . . . . 0.0 112.3 -171.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -71.84 -46.84 56.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.203 0.601 . . . . 0.0 111.301 170.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -66.11 -32.87 74.58 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -169.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -72.07 -55.66 6.97 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.654 0.781 . . . . 0.0 111.273 169.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -67.92 -29.81 68.97 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -167.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.5 p -50.87 -34.16 26.98 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.064 1.346 . . . . 0.0 113.875 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -73.67 -9.09 58.31 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.22 1.808 . . . . 0.0 114.855 178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 15.21 1.57 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -169.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 85.9 mt -54.74 152.77 6.71 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.059 0.943 . . . . 0.0 113.347 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 62.17 -23.84 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 117.539 2.422 . . . . 0.0 117.539 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -66.42 149.23 50.72 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 119.699 1.136 . . . . 0.0 112.214 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -57.45 -26.63 61.49 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.039 0.936 . . . . 0.0 113.457 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.9 p -59.4 -56.16 25.52 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.669 1.188 . . . . 0.0 112.47 172.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.94 -15.13 63.01 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.3 mm -106.0 -6.8 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.454 1.901 . . . . 0.0 111.912 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -60.46 146.09 45.94 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 120.683 -1.26 . . . . 0.0 112.055 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.416 ' HA ' ' CD2' ' A' ' 58' ' ' TYR 0.328 2.5 tt0 -62.38 -5.94 2.87 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -170.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ptmm? -105.25 -13.93 15.53 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 119.79 -1.819 . . . . 0.0 113.603 172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -98.45 -33.11 11.15 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.101 1.761 . . . . 0.0 114.057 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 55' ' ' GLN . 0.0 OUTLIER -66.12 1.59 1.45 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 118.416 2.747 . . . . 0.0 118.416 -167.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -56.5 -33.4 65.96 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -168.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -67.02 -12.93 61.28 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 175.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m -102.62 -5.6 23.68 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.5 1.52 . . . . 0.0 113.431 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -89.01 -6.28 57.32 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.819 1.648 . . . . 0.0 113.434 177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -150.91 171.25 17.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.247 1.419 . . . . 0.0 112.603 -172.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -65.63 -177.26 0.42 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.244 1.817 . . . . 0.0 112.315 175.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 64' ' ' THR . 59.4 mt -64.97 21.66 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 128.222 2.609 . . . . 0.0 115.427 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.296 4.2 p30 48.66 31.25 2.9 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 127.606 2.363 . . . . 0.0 116.198 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.7 m170 -77.62 161.75 27.58 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 100.0 m -137.39 158.53 44.21 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.517 1.527 . . . . 0.0 109.909 169.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -124.72 152.12 44.16 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.429 1.092 . . . . 0.0 111.386 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.522 HD11 HD12 ' A' ' 32' ' ' ILE . 4.7 mp -127.88 134.9 64.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.982 1.713 . . . . 0.0 108.347 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -136.51 147.46 47.11 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.531 1.532 . . . . 0.0 111.801 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.64 152.51 46.04 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.69 -33.07 4.18 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.315 2.01 . . . . 0.0 112.522 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -165.33 164.19 19.84 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.578 1.551 . . . . 0.0 114.289 -175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -58.28 135.06 57.06 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 127.165 2.186 . . . . 0.0 114.007 174.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 165.9 -139.75 5.97 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-O 122.518 1.066 . . . . 0.0 114.015 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.0 m -122.66 163.32 20.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 127.253 2.221 . . . . 0.0 108.011 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.8 tt -133.33 141.42 44.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 O-C-N 120.944 -1.098 . . . . 0.0 111.49 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.34 -174.55 43.81 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 121.507 0.504 . . . . 0.0 113.525 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -62.2 127.99 33.99 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 121.584 -0.951 . . . . 0.0 111.687 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.74 150.27 13.01 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.564 1.545 . . . . 0.0 111.583 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.4 mt -106.56 -3.22 21.01 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.482 1.513 . . . . 0.0 113.077 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 m -143.2 168.28 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.391 1.477 . . . . 0.0 113.406 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' H ' ' HB2' ' A' ' 87' ' ' ASP . 2.4 p30 -142.01 162.02 36.51 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 127.866 2.467 . . . . 0.0 110.844 -176.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.4 mp -64.74 102.32 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 125.243 1.417 . . . . 0.0 108.672 173.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.78 -15.04 11.39 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 118.46 -1.189 . . . . 0.0 112.038 -172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -60.85 126.95 29.29 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-N 119.588 1.694 . . . . 0.0 109.201 168.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' HA ' HG22 ' A' ' 11' ' ' VAL . 12.6 t80 -77.83 105.38 8.97 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 m -107.28 147.43 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.2 t -136.35 137.98 41.16 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 125.47 1.508 . . . . 0.0 109.126 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.252 . . -27.43 -79.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 117.604 2.446 . . . . 0.0 117.604 -165.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.9 m -95.32 0.19 53.42 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.731 -0.787 . . . . 0.0 112.701 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 m -96.45 -14.4 22.42 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 -162.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 9.3 m -124.35 -28.2 3.68 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 120.899 1.682 . . . . 0.0 115.347 -165.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 3.5 mt-10 62.17 127.16 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.546 2.338 . . . . 0.0 114.012 174.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 30' ' ' PHE . 37.8 mt -99.45 -46.04 5.62 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -167.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.478 HG22 ' N ' ' A' ' 98' ' ' ARG . 8.7 p 178.29 163.47 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 127.64 2.376 . . . . 0.0 109.237 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 97' ' ' VAL . 34.1 ptt-85 -95.6 133.64 39.41 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.335 1.054 . . . . 0.0 112.591 167.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.2 t -94.62 150.61 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -152.04 135.98 16.44 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.001 -1.687 . . . . 0.0 114.576 174.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -69.11 144.55 53.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 26.1 mt -73.59 -72.57 0.26 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.074 1.35 . . . . 0.0 111.819 169.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -135.69 157.56 75.97 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.219 1.408 . . . . 0.0 111.121 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -81.96 0.37 9.87 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.415 2.743 . . . . 0.0 114.46 -169.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 pt -72.79 -2.55 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.305 1.842 . . . . 0.0 114.215 171.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -121.11 -47.2 2.28 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.286 1.834 . . . . 0.0 111.138 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -163.87 143.57 8.13 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.094 2.158 . . . . 0.0 108.807 170.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -84.07 50.03 1.76 Allowed 'General case' 0 CA--C 1.546 0.825 0 O-C-N 120.704 -1.247 . . . . 0.0 112.435 -175.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 54.98 32.89 56.64 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 124.354 0.978 . . . . 0.0 113.236 -171.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 40.4 t -156.92 168.45 27.45 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.487 1.915 . . . . 0.0 110.514 -168.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -67.64 -4.47 12.06 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.538 1.135 . . . . 0.0 113.556 169.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.3 t60 -139.94 172.73 12.34 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.18 2.192 . . . . 0.0 111.368 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -78.41 18.32 0.56 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.285 1.834 . . . . 0.0 113.799 172.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -146.97 159.42 43.58 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.223 1.809 . . . . 0.0 110.902 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -73.54 -4.86 36.58 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.594 1.558 . . . . 0.0 114.756 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 125.772 1.629 . . . . 0.0 112.713 -175.795 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 N--CA 1.484 1.241 0 N-CA-C 110.565 -0.161 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -136.63 141.03 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.843 1.657 . . . . 0.0 110.665 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.75 92.55 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 103.727 -2.694 . . . . 0.0 103.727 164.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -55.36 149.08 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 126.527 1.931 . . . . 0.0 111.182 -168.619 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -144.06 155.48 58.61 Favored Pre-proline 0 N--CA 1.477 0.903 0 C-N-CA 124.983 1.313 . . . . 0.0 114.255 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -79.02 161.63 26.57 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.158 2.572 . . . . 0.0 112.496 -178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -94.4 -5.27 46.77 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.34 171.26 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.545 1.938 . . . . 0.0 110.129 173.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 88.7 p -103.74 164.48 11.65 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.003 0.921 . . . . 0.0 112.278 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.86 -134.47 6.01 Favored Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -170.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.5 t -147.81 144.33 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 CA-C-N 112.961 -1.62 . . . . 0.0 109.606 -168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 32.9 mm -61.86 144.7 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.6 t -126.52 -33.94 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 126.82 2.048 . . . . 0.0 112.121 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -151.55 162.07 41.61 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.209 1.004 . . . . 0.0 111.492 177.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -129.97 93.96 3.61 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 128.406 2.683 . . . . 0.0 107.483 -174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.53 -42.86 41.63 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.887 0.875 . . . . 0.0 112.947 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -78.04 -179.28 6.02 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.308 1.043 . . . . 0.0 112.482 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -126.08 133.8 51.56 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.819 1.248 . . . . 0.0 112.082 175.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 99.56 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.4 1.88 . . . . 0.0 111.892 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 109.13 -6.56 32.43 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.532 1.539 . . . . 0.0 115.832 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -85.22 -150.5 0.13 Allowed 'General case' 0 CA--C 1.554 1.108 0 CA-C-N 119.228 1.514 . . . . 0.0 114.152 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.496 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 72.3 mmtt -115.5 166.54 11.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.764 2.026 . . . . 0.0 111.79 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 m -142.85 133.84 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.707 1.603 . . . . 0.0 111.691 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.8 156.87 38.83 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.301 1.041 . . . . 0.0 108.624 166.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 74' ' ' PHE 0.305 3.9 tptp -51.79 71.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 130.197 3.399 . . . . 0.0 114.058 168.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.48 16.96 8.4 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 126.391 1.948 . . . . 0.0 114.316 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.273 0.6 OUTLIER -55.95 143.23 32.79 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.92 1.36 . . . . 0.0 111.551 168.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 37.2 m -71.51 139.42 49.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.066 1.346 . . . . 0.0 110.211 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.2 mt -122.73 -45.07 2.18 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.052 2.141 . . . . 0.0 112.855 -167.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -143.55 167.98 20.94 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.811 0.815 . . . . 0.0 112.554 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 30.2 mt -130.28 142.94 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 125.812 1.645 . . . . 0.0 107.639 173.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.4 mt -126.39 149.98 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 C-N-CA 126.712 2.005 . . . . 0.0 111.292 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -112.65 114.76 27.52 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.795 1.638 . . . . 0.0 109.65 168.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.78 -43.29 99.18 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.812 1.245 . . . . 0.0 112.805 -178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -170.75 173.36 5.35 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.674 2.389 . . . . 0.0 110.719 -176.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -135.83 16.77 3.3 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.7 73.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.616 -0.678 . . . . 0.0 111.279 169.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.8 m -93.95 -5.43 47.77 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.132 1.373 . . . . 0.0 114.301 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -64.19 -17.71 63.79 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 120.073 1.306 . . . . 0.0 113.937 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -103.11 -40.14 6.58 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.25 1.02 . . . . 0.0 111.896 167.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -74.98 -19.53 60.06 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -170.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -54.88 -28.07 47.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.262 1.425 . . . . 0.0 114.413 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -57.63 -40.88 80.23 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 -166.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 43.9 m -72.33 -27.11 62.22 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -178.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -66.51 -36.12 81.92 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -172.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -7.1 59.65 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.5 mt -74.38 134.28 42.45 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 46.07 -12.79 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.049 1 N-CA-C 122.411 4.226 . . . . 0.0 122.411 161.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.4 t -147.07 -174.9 4.62 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 120.919 1.69 . . . . 0.0 112.694 -169.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.55 -22.57 8.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.025 2.13 . . . . 0.0 114.661 -173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 44.4 m -52.72 -25.17 10.29 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 173.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.05 -18.76 64.67 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.9 tp -137.35 -13.56 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 -173.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 m -58.18 128.55 37.71 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.5 1.12 . . . . 0.0 111.927 170.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -59.69 -6.35 1.15 Allowed 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 117.526 2.417 . . . . 0.0 117.526 -168.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -117.76 -1.71 11.52 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.164 1.386 . . . . 0.0 113.238 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.55 -30.76 3.05 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 114.434 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.0 2.53 0.21 Allowed 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 117.03 2.233 . . . . 0.0 117.03 -174.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -57.87 -28.04 63.81 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.3 m -60.53 -33.71 73.04 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.635 0.774 . . . . 0.0 112.977 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -81.07 -30.23 34.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.543 1.537 . . . . 0.0 112.96 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 43.7 mt -73.67 -40.3 63.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.64 1.176 . . . . 0.0 112.965 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -148.14 87.16 1.59 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.304 1.441 . . . . 0.0 111.405 -169.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.0 m -52.71 129.57 30.0 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.017 0.927 . . . . 0.0 110.769 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 mt 39.53 38.26 0.38 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.448 1.899 . . . . 0.0 114.327 -170.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.43 27.25 16.33 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.347 1.459 . . . . 0.0 113.714 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -92.29 153.56 19.16 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.8 m -136.08 154.88 50.89 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.623 1.569 . . . . 0.0 109.812 171.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -125.15 139.13 54.04 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.035 -1.04 . . . . 0.0 111.249 -172.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mp -108.91 136.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.342 1.457 . . . . 0.0 107.684 -175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -134.05 147.65 50.95 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.016 1.726 . . . . 0.0 110.019 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.68 155.26 31.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 123.714 0.806 . . . . 0.0 112.671 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.13 -41.19 2.05 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 120.686 0.924 . . . . 0.0 111.84 168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 4.8 p90 -158.77 169.14 25.04 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 117.919 2.563 . . . . 0.0 117.919 -168.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' H ' ' HB2' ' A' ' 25' ' ' LYS . 63.8 m-20 -54.77 118.81 4.54 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.166 2.186 . . . . 0.0 111.215 170.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 176.87 -157.77 23.16 Favored Glycine 0 CA--C 1.522 0.522 0 CA-C-O 122.623 1.124 . . . . 0.0 115.519 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.5 m -121.3 152.52 38.83 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.859 2.064 . . . . 0.0 108.669 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 13.9 tt -133.59 139.52 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 123.048 0.539 . . . . 0.0 110.849 -169.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -79.27 -171.8 41.67 Favored Glycine 0 N--CA 1.467 0.703 0 C-N-CA 123.789 0.709 . . . . 0.0 112.756 -171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -66.27 136.49 55.92 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.122 -1.222 . . . . 0.0 111.389 167.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -57.65 148.47 24.34 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.737 174.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 58.4 mt -117.82 2.81 12.24 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.879 1.271 . . . . 0.0 112.483 -177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.7 m -146.58 157.25 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 126.699 2.0 . . . . 0.0 111.289 -172.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -141.84 168.04 20.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 127.313 2.245 . . . . 0.0 110.599 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -59.59 103.73 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.227 1.811 . . . . 0.0 109.634 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.51 -13.36 18.31 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 119.129 -0.817 . . . . 0.0 112.998 -175.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.44 124.77 23.16 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 119.245 1.522 . . . . 0.0 108.065 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -70.47 107.01 3.64 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.451 175.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -108.44 149.03 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.8 t -139.61 147.59 41.3 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.513 1.125 . . . . 0.0 110.756 -176.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.269 . . -52.73 -25.43 11.12 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -162.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.6 t -133.71 -0.06 3.21 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 121.767 0.794 . . . . 0.0 112.594 165.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 m -96.13 -11.63 25.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.264 1.026 . . . . 0.0 113.021 -167.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.84 118.36 9.73 Favored 'General case' 0 CA--C 1.507 -0.694 0 C-N-CA 125.135 1.374 . . . . 0.0 107.962 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.68 124.15 48.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.179 -1.828 . . . . 0.0 109.357 -166.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 4' ' ' ILE . 8.4 mt -85.08 -37.6 20.12 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 -164.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.463 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.5 p 176.98 169.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 C-N-CA 128.873 2.869 . . . . 0.0 108.665 -175.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -103.99 144.65 31.25 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.163 1.347 . . . . 0.0 114.589 168.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.9 t -129.23 129.57 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.248 1.419 . . . . 0.0 109.14 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 t -142.4 140.72 32.11 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -170.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -87.97 138.37 31.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.394 -0.816 . . . . 0.0 112.54 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -126.99 -174.39 3.14 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.248 2.219 . . . . 0.0 109.602 176.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -55.34 155.65 9.31 Favored Pre-proline 0 CA--C 1.557 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 112.039 171.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -81.04 10.27 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.646 2.897 . . . . 0.0 114.719 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.3 pt -62.06 -14.98 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.132 1.773 . . . . 0.0 114.622 -177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.496 ' CE1' ' HE3' ' A' ' 22' ' ' LYS . 28.7 m-85 -89.83 5.39 46.38 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.816 2.046 . . . . 0.0 113.674 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -124.63 15.7 8.79 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.878 1.671 . . . . 0.0 114.131 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -154.7 162.21 41.22 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 0.0 112.066 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -167.72 22.06 0.1 Allowed Glycine 0 CA--C 1.537 1.434 0 C-N-CA 126.76 2.124 . . . . 0.0 113.015 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 48.5 m -61.62 -19.39 62.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.59 1.556 . . . . 0.0 114.639 -173.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -87.54 -0.34 56.7 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.653 1.981 . . . . 0.0 114.114 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 26.9 m80 50.08 29.14 3.35 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.337 1.855 . . . . 0.0 113.768 -172.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.6 t60 56.45 18.53 3.54 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.05 2.14 . . . . 0.0 115.587 -173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -71.04 161.29 31.38 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.152 -0.968 . . . . 0.0 112.048 169.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 p80 -147.72 168.83 21.09 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.304 1.441 . . . . 0.0 111.186 177.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 . . . . . 0 C--O 1.252 1.193 0 C-N-CA 125.596 1.558 . . . . 0.0 112.261 -171.481 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.5 t -132.54 149.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 CA-C-N 120.005 1.275 . . . . 0.0 113.576 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.6 99.47 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 129.65 3.18 . . . . 0.0 104.914 164.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.98 148.98 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 125.97 1.708 . . . . 0.0 110.749 -171.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -144.24 156.19 57.77 Favored Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 125.551 1.54 . . . . 0.0 112.952 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.25 159.18 26.42 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.788 2.325 . . . . 0.0 111.933 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -93.22 -6.58 47.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.4 m -137.23 154.99 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.076 1.75 . . . . 0.0 110.152 171.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.8 p -81.78 155.84 25.24 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 122.196 -0.315 . . . . 0.0 110.821 168.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.79 -151.74 23.13 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 -175.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.48 145.73 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 118.828 1.314 . . . . 0.0 112.485 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 15.5 mm -61.84 146.13 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.311 0.959 . . . . 0.0 112.002 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.61 -35.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.941 2.096 . . . . 0.0 111.498 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -148.55 158.73 44.32 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 123.996 0.918 . . . . 0.0 110.914 178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -125.54 93.9 3.98 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 128.37 2.668 . . . . 0.0 107.494 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -71.93 -45.96 59.28 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.646 0.778 . . . . 0.0 111.918 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -73.0 -175.31 1.74 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.387 1.475 . . . . 0.0 112.715 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -134.77 134.69 41.19 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.103 1.361 . . . . 0.0 111.435 175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 80' ' ' ASP . . . -55.38 108.37 0.42 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.605 1.562 . . . . 0.0 111.554 174.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.27 -9.83 63.21 Favored Glycine 0 CA--C 1.545 1.923 0 C-N-CA 125.056 1.312 . . . . 0.0 116.194 176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.61 -173.17 4.56 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 119.79 1.795 . . . . 0.0 114.888 -173.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -80.24 162.17 24.77 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 120.481 -1.387 . . . . 0.0 112.29 169.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 m -140.0 141.43 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.32 1.848 . . . . 0.0 109.483 171.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 mmmt -70.23 -178.25 1.62 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.936 0.894 . . . . 0.0 111.544 169.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -64.32 35.29 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 128.741 2.816 . . . . 0.0 115.349 -174.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 28.29 1.31 Allowed Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.43 1.014 . . . . 0.0 114.639 -167.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -55.84 148.24 17.3 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 119.016 1.408 . . . . 0.0 111.905 170.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.4 m -65.81 137.33 57.16 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.355 1.062 . . . . 0.0 111.175 175.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.5 mt -122.39 -44.78 2.24 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.835 2.054 . . . . 0.0 113.088 -169.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -141.11 166.2 25.43 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 31.9 mt -131.91 141.15 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 125.989 1.715 . . . . 0.0 106.822 171.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.508 HD12 HD11 ' A' ' 70' ' ' ILE . 19.8 mt -126.16 151.39 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 126.948 2.099 . . . . 0.0 111.695 -178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -113.51 115.04 27.36 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 124.201 0.938 . . . . 0.0 109.461 168.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -58.65 -26.49 63.83 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 167.92 141.6 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 128.229 2.611 . . . . 0.0 109.389 -175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' LYS . 6.8 mp0 -67.93 145.31 54.68 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -170.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.46 -66.32 1.1 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 165.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 m -61.86 -26.56 68.21 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 120.834 -1.166 . . . . 0.0 113.845 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . 5.8 mptt -66.87 -24.75 66.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.387 1.075 . . . . 0.0 111.967 178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.86 -49.23 6.94 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.676 1.19 . . . . 0.0 110.016 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -67.26 -35.34 79.33 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 -167.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -57.61 -38.49 75.04 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.884 0.766 . . . . 0.0 112.186 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 72.4 mtm180 -74.36 -32.07 62.63 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.917 -172.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 69.4 m -62.03 -32.8 73.33 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.454 1.102 . . . . 0.0 113.453 176.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -56.62 -24.63 49.38 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.641 1.176 . . . . 0.0 114.164 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.44 -10.69 59.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.853 1.261 . . . . 0.0 114.327 173.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.89 -49.38 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.508 1.523 . . . . 0.0 113.825 -171.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -160.77 159.67 30.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.309 1.043 . . . . 0.0 113.122 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.8 m -108.23 -7.45 15.98 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.651 1.181 . . . . 0.0 113.493 174.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -60.3 -23.02 63.84 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.683 1.193 . . . . 0.0 113.658 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 13.4 m -56.77 -16.89 7.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.501 1.52 . . . . 0.0 114.09 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.81 -13.88 18.13 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.9 mm -94.82 -16.35 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 126.25 1.82 . . . . 0.0 112.035 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -62.51 140.34 58.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.49 1.116 . . . . 0.0 112.794 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -56.62 -6.01 0.27 Allowed 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 -168.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -130.65 1.42 4.45 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.787 1.635 . . . . 0.0 113.311 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -111.92 -37.37 5.13 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.263 2.225 . . . . 0.0 112.71 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -62.46 -17.76 60.23 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.683 1.364 . . . . 0.0 114.683 -178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.05 7.45 33.96 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.972 2.109 . . . . 0.0 114.021 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.9 m -57.01 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.522 -1.361 . . . . 0.0 113.072 171.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.3 p -73.32 -20.17 60.86 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.955 1.302 . . . . 0.0 114.333 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.4 mt -102.34 -30.61 10.96 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.223 1.809 . . . . 0.0 113.413 -175.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -138.18 6.75 2.61 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.7 m 59.11 -71.31 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 128.322 2.649 . . . . 0.0 115.534 -173.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.2 mt -144.48 8.51 1.35 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 128.773 2.829 . . . . 0.0 113.011 -176.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 t0 59.2 44.85 15.14 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.333 1.453 . . . . 0.0 113.359 -174.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -77.92 151.63 33.65 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.5 m -140.66 148.49 40.91 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.981 0.913 . . . . 0.0 110.37 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -111.67 149.02 32.16 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.395 1.078 . . . . 0.0 111.154 -175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.508 HD11 HD12 ' A' ' 32' ' ' ILE . 5.0 mp -127.11 139.72 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.539 1.536 . . . . 0.0 108.241 -169.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -138.09 154.55 49.23 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.496 1.118 . . . . 0.0 113.631 -171.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.47 162.49 6.2 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.693 1.597 . . . . 0.0 114.038 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.89 -42.36 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.219 2.612 . . . . 0.0 113.406 171.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -163.09 169.0 20.12 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.466 1.906 . . . . 0.0 113.196 -168.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.46 122.76 22.65 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 124.631 1.172 . . . . 0.0 111.186 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -177.98 -157.55 19.01 Favored Glycine 0 C--N 1.318 -0.424 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.491 -168.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.524 ' C ' HG23 ' A' ' 99' ' ' VAL . 8.0 m -128.87 128.47 43.91 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 99' ' ' VAL . 7.8 tt -102.85 153.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 123.786 0.835 . . . . 0.0 109.005 -167.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.31 -170.38 44.99 Favored Glycine 0 CA--C 1.528 0.857 0 O-C-N 121.075 -1.015 . . . . 0.0 112.702 -178.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.403 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 27.3 m-20 -69.17 144.08 53.89 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 121.42 -1.047 . . . . 0.0 110.876 168.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.09 152.14 37.99 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.859 0.463 . . . . 0.0 111.745 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 48.1 mt -118.85 6.65 11.46 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.443 1.497 . . . . 0.0 112.608 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 32.6 m -147.53 157.66 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 127.569 2.348 . . . . 0.0 110.632 -176.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -135.04 167.29 21.22 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.425 1.89 . . . . 0.0 109.586 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.445 ' CD1' ' H ' ' A' ' 85' ' ' ILE . 2.0 mp -55.3 104.01 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.448 1.899 . . . . 0.0 109.839 175.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.92 -7.48 19.42 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 126.074 1.797 . . . . 0.0 113.086 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.25 121.81 17.02 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.04 1.42 . . . . 0.0 111.791 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -64.83 136.4 56.84 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.543 0.737 . . . . 0.0 111.314 169.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.5 m -142.23 156.53 19.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.832 2.053 . . . . 0.0 111.63 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.4 t -133.85 145.83 50.05 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.734 1.614 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.3 -21.69 25.62 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 120.262 3.43 . . . . 0.0 120.262 -165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.1 p -132.71 -2.22 3.36 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 164.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 m -96.67 -14.64 21.95 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -167.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.88 121.36 14.1 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 122.945 1.355 . . . . 0.0 107.86 -170.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 127.9 51.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.874 -1.966 . . . . 0.0 110.387 -165.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 12.1 mt -90.33 -37.46 14.02 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -165.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 98' ' ' ARG . 7.3 p 178.02 163.13 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 128.227 2.611 . . . . 0.0 109.954 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.457 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.6 OUTLIER -97.29 150.71 20.64 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 116.439 -1.743 . . . . 0.0 114.766 172.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 78' ' ' ILE . 7.8 p -136.15 150.47 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 123.367 2.803 . . . . 0.0 110.186 162.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.6 t -141.02 146.21 36.93 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.096 1.358 . . . . 0.0 110.545 -169.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -101.55 110.9 22.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 122.112 0.958 . . . . 0.0 110.619 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 39.9 mt -63.59 174.63 1.28 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.043 1.737 . . . . 0.0 112.904 169.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -55.28 158.59 5.17 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.415 1.086 . . . . 0.0 112.305 177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.86 5.47 3.9 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.533 2.822 . . . . 0.0 115.525 -168.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.4 pt -101.62 -2.5 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 127.133 2.173 . . . . 0.0 112.922 171.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -134.63 -21.69 1.72 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.092 1.757 . . . . 0.0 113.343 -173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -153.86 165.9 34.6 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.976 1.71 . . . . 0.0 111.232 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -109.17 -27.72 9.43 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.67 -166.91 25.99 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.68 1.134 . . . . 0.0 115.411 171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.1 m -69.38 147.01 51.62 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.484 -1.01 . . . . 0.0 109.601 168.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -135.57 178.52 6.98 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 -170.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -141.06 166.16 25.56 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.366 1.867 . . . . 0.0 110.932 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -58.98 -23.24 61.59 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.539 1.536 . . . . 0.0 114.611 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -95.38 8.4 43.32 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.902 1.281 . . . . 0.0 114.071 178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -74.65 65.96 1.38 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.244 1.418 . . . . 0.0 112.567 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 68.8 t60 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 126.76 2.024 . . . . 0.0 111.784 -173.45 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.637 0.256 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 t -139.25 149.68 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 125.969 1.708 . . . . 0.0 111.693 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.5 mp -113.71 94.45 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.98 147.62 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 124.468 1.107 . . . . 0.0 110.402 -169.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.49 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 70.3 mttt -143.88 152.5 55.6 Favored Pre-proline 0 N--CA 1.478 0.97 0 C-N-CA 124.132 0.973 . . . . 0.0 113.32 -176.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.89 147.22 21.24 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.527 2.151 . . . . 0.0 112.972 -174.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -77.53 -6.32 53.19 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.46 176.91 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.546 2.338 . . . . 0.0 110.513 177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 86.3 p -109.18 162.29 14.41 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.226 1.011 . . . . 0.0 111.159 170.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 -137.24 8.0 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 -169.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 41.0 t -145.34 143.36 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.697 0 CA-C-N 113.7 -1.25 . . . . 0.0 110.273 -167.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.1 mm -61.83 143.76 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 O-C-N 123.634 0.584 . . . . 0.0 112.526 176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.7 t -129.34 -32.53 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 126.74 2.016 . . . . 0.0 112.589 -176.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -149.52 158.86 44.55 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.339 1.055 . . . . 0.0 110.834 174.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mmmm -124.84 93.33 3.86 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 127.746 2.418 . . . . 0.0 107.699 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.23 -49.21 58.47 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.816 0.846 . . . . 0.0 111.193 -178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -71.51 -179.7 2.64 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.059 174.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -137.54 138.01 39.18 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.213 1.405 . . . . 0.0 111.36 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 103.0 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.385 1.474 . . . . 0.0 112.197 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.43 -7.6 47.02 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 125.73 1.633 . . . . 0.0 115.446 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -79.97 -150.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 119.504 1.652 . . . . 0.0 113.94 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -123.65 162.93 22.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.88 2.072 . . . . 0.0 111.343 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.64 141.04 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.085 1.754 . . . . 0.0 110.777 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -179.32 2.08 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.435 1.894 . . . . 0.0 110.178 168.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -65.3 39.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 128.039 2.536 . . . . 0.0 115.439 -176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.66 26.73 1.54 Allowed Glycine 0 N--CA 1.467 0.763 0 C-N-CA 124.889 1.233 . . . . 0.0 115.256 -171.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.56 150.96 8.53 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 118.843 1.322 . . . . 0.0 112.595 170.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.7 m -69.4 139.61 54.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.005 0.922 . . . . 0.0 110.764 174.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.3 mt -120.27 -42.99 2.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.206 2.202 . . . . 0.0 112.343 -169.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -139.71 165.44 27.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.151 0.98 . . . . 0.0 112.424 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -125.6 135.05 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 170.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.524 HD12 HD11 ' A' ' 70' ' ' ILE . 30.6 mt -116.22 146.96 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 C-N-CA 125.214 1.405 . . . . 0.0 110.7 174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -100.8 116.88 33.73 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 127.14 2.176 . . . . 0.0 106.638 167.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -63.21 -36.3 83.17 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -167.78 165.15 14.22 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 126.546 1.939 . . . . 0.0 110.895 -178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.43 ' HB2' ' HE2' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -130.47 12.04 5.4 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.597 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.27 -38.47 89.44 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.005 0.922 . . . . 0.0 112.943 -175.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 6.8 m -84.41 -7.43 59.3 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' HE2' ' HB2' ' A' ' 36' ' ' GLN . 33.1 ttpt -62.54 -35.0 78.07 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.302 1.41 . . . . 0.0 113.763 -169.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 -42.44 41.7 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.373 0.669 . . . . 0.0 112.507 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -73.79 -31.56 63.33 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.41 1.084 . . . . 0.0 113.47 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.9 -17.45 64.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.145 1.778 . . . . 0.0 114.217 175.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -58.75 -29.72 66.97 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 114.201 1.185 . . . . 0.0 114.201 -166.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.6 p -60.83 -26.56 67.42 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.482 1.513 . . . . 0.0 114.188 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -97.47 -25.52 15.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.296 1.839 . . . . 0.0 112.233 176.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.41 1.24 6.6 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 125.216 1.406 . . . . 0.0 114.404 171.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.06 154.38 0.78 Allowed 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.126 2.171 . . . . 0.0 116.028 176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 24.1 -68.23 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.031 1 C-N-CA 132.332 4.253 . . . . 0.0 117.342 167.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.4 m -54.86 -33.06 61.39 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 120.291 1.405 . . . . 0.0 113.625 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -99.18 -32.49 11.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.495 1.118 . . . . 0.0 112.702 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.9 m -59.48 -26.01 64.9 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 119.737 1.153 . . . . 0.0 113.797 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.17 -21.96 64.27 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 114.363 1.245 . . . . 0.0 114.363 173.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . 0.287 1.0 OUTLIER 67.26 -52.94 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 128.298 2.639 . . . . 0.0 115.97 177.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.4 m 53.77 103.09 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.459 1.904 . . . . 0.0 113.195 -168.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -56.59 -6.02 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 126.913 2.085 . . . . 0.0 116.378 -175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.6 mtmt -114.43 -2.31 13.26 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.286 1.435 . . . . 0.0 112.764 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -117.75 -34.62 4.15 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.868 2.067 . . . . 0.0 114.164 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -17.26 8.45 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -171.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -67.52 -18.32 64.99 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.314 0.961 . . . . 0.0 113.117 172.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.0 m -73.85 -41.8 61.73 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 167.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 m -60.11 -27.01 66.67 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.87 1.268 . . . . 0.0 113.685 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 31.6 mt -63.58 -15.9 59.37 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.82 1.648 . . . . 0.0 114.461 171.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -147.43 41.62 1.06 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 124.757 1.223 . . . . 0.0 112.301 -168.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.5 m -140.33 -55.39 0.53 Allowed 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -55.39 -41.16 72.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 127.426 2.29 . . . . 0.0 115.527 -165.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -164.02 28.96 0.08 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.494 2.317 . . . . 0.0 110.784 -175.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -112.01 161.14 16.78 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 117.659 2.466 . . . . 0.0 117.659 -165.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 50.5 m -141.33 128.82 21.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.829 167.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -74.67 155.22 37.99 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.577 1.151 . . . . 0.0 112.501 171.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.524 HD11 HD12 ' A' ' 32' ' ' ILE . 4.8 mp -128.28 135.4 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 126.185 1.794 . . . . 0.0 107.468 174.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -135.33 154.54 51.48 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.51 1.124 . . . . 0.0 113.1 -170.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.04 163.22 17.69 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.067 0.947 . . . . 0.0 113.134 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -79.18 -40.87 0.24 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.897 2.398 . . . . 0.0 114.337 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -160.58 171.33 19.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.639 1.976 . . . . 0.0 112.572 -166.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -74.86 135.69 41.56 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.964 0.906 . . . . 0.0 111.882 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 169.44 -160.28 33.45 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.029 0.794 . . . . 0.0 113.549 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.2 m -101.02 159.69 15.01 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 125.75 1.62 . . . . 0.0 109.522 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.5 tt -136.26 131.19 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.339 -174.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.12 -170.88 27.78 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 121.724 0.624 . . . . 0.0 113.889 -169.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -62.31 129.7 41.92 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 121.542 -0.976 . . . . 0.0 111.383 168.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -56.06 143.82 31.26 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.553 1.141 . . . . 0.0 111.26 174.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 93.3 mt -102.93 -5.37 23.55 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.125 1.37 . . . . 0.0 113.109 176.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.5 m -144.58 158.34 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 125.688 1.595 . . . . 0.0 112.497 -168.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -141.6 168.03 20.75 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.853 2.061 . . . . 0.0 109.584 -179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -59.81 103.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 126.116 1.767 . . . . 0.0 109.67 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 115.52 -13.31 18.3 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.96 -175.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.15 124.52 22.36 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-N 118.605 1.203 . . . . 0.0 108.179 167.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -72.64 106.83 4.82 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.17 -1.377 . . . . 0.0 108.956 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.6 m -106.77 154.73 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.0 t -140.14 149.32 42.87 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.754 1.221 . . . . 0.0 110.765 -177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.272 . . -51.82 -24.98 6.82 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 121.27 3.804 . . . . 0.0 121.27 -162.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -136.78 2.77 2.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 165.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -96.37 -12.85 23.77 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 5.2 m -125.31 -29.2 3.28 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -165.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.49 ' HG2' ' HE2' ' A' ' 5' ' ' LYS . 2.9 mt-10 60.02 124.1 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.264 2.226 . . . . 0.0 113.082 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.4 mt -96.7 -36.01 10.82 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -166.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.55 HG22 ' N ' ' A' ' 98' ' ' ARG . 13.1 p 177.12 179.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 129.189 2.995 . . . . 0.0 108.452 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.55 ' N ' HG22 ' A' ' 97' ' ' VAL . 29.1 ptt-85 -111.11 145.07 39.23 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.138 1.375 . . . . 0.0 113.486 168.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.49 131.86 70.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.578 1.081 . . . . 0.0 108.83 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -141.38 118.38 11.22 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -169.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -71.27 1.09 6.58 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.793 1.237 . . . . 0.0 113.394 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 -101.99 0.14 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.099 1.759 . . . . 0.0 110.921 -172.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -131.84 155.6 81.18 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.268 1.027 . . . . 0.0 110.634 169.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -80.27 12.48 2.51 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.291 3.328 . . . . 0.0 113.713 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.5 pt -126.66 -4.56 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 128.11 2.564 . . . . 0.0 112.869 -175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -80.19 -3.26 48.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.203 1.401 . . . . 0.0 113.82 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.37 -26.08 67.59 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -155.78 159.24 39.27 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.514 0.726 . . . . 0.0 112.698 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 161.31 -42.81 0.4 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.472 1.511 . . . . 0.0 112.662 173.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.7 t -159.92 152.79 21.53 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.319 1.848 . . . . 0.0 110.371 170.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -88.67 -21.69 23.81 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.184 1.394 . . . . 0.0 112.819 173.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 38.6 m80 58.2 -1.45 0.09 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 127.914 2.486 . . . . 0.0 117.094 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -135.74 18.74 3.29 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.995 1.718 . . . . 0.0 112.239 177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -151.78 172.92 15.4 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.464 2.306 . . . . 0.0 109.868 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -72.52 46.37 0.15 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 126.649 1.98 . . . . 0.0 113.792 173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 80.0 t60 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.617 1.967 . . . . 0.0 110.746 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 111.188 0.07 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.67 152.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.445 1.498 . . . . 0.0 112.264 174.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.4 mp -120.54 89.64 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 166.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -65.87 149.08 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.008 1.323 . . . . 0.0 111.431 -167.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -144.01 154.51 58.32 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 125.866 1.667 . . . . 0.0 113.516 -176.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.96 160.4 37.02 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.501 2.134 . . . . 0.0 113.364 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -94.1 -6.03 45.97 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.19 -177.76 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 127.103 2.161 . . . . 0.0 110.12 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 80.9 p -113.99 160.3 18.99 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.562 1.145 . . . . 0.0 112.324 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.18 -130.96 4.04 Favored Glycine 0 CA--C 1.483 -1.943 0 C-N-CA 126.43 1.967 . . . . 0.0 108.778 -169.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.0 t -150.14 146.17 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.545 0 CA-C-N 112.824 -1.688 . . . . 0.0 109.658 -167.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.6 mm -62.36 145.14 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.19 -35.97 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 127.315 2.246 . . . . 0.0 112.185 -177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -148.51 159.04 44.45 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.136 0.974 . . . . 0.0 111.339 177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -127.28 94.01 3.88 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 128.015 2.526 . . . . 0.0 106.857 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -70.32 -40.44 74.18 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.088 0.955 . . . . 0.0 112.129 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.85 -177.37 5.78 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.341 1.456 . . . . 0.0 112.218 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -133.17 139.87 47.28 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.698 1.599 . . . . 0.0 112.656 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.48 120.19 6.79 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.09 0.956 . . . . 0.0 112.447 172.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.11 -8.55 73.17 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.725 1.155 . . . . 0.0 115.615 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -75.03 -157.92 0.07 Allowed 'General case' 0 CA--C 1.556 1.186 0 CA-C-N 119.301 1.55 . . . . 0.0 113.382 176.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -117.56 166.16 12.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.798 2.039 . . . . 0.0 111.069 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.1 m -135.1 137.6 50.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 125.791 1.637 . . . . 0.0 110.645 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.6 tptm -72.61 161.86 30.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.838 1.655 . . . . 0.0 109.1 166.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.2 mmmt -41.62 67.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 129.963 3.305 . . . . 0.0 116.898 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.03 26.03 17.76 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 124.211 0.91 . . . . 0.0 114.084 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -50.62 150.66 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -65.78 138.38 57.88 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.232 1.413 . . . . 0.0 111.357 173.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 20.5 mt -124.44 -42.19 2.12 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.617 1.567 . . . . 0.0 113.71 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -141.65 167.28 22.52 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.256 1.022 . . . . 0.0 112.846 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 45.3 mt -132.78 143.93 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.197 1.799 . . . . 0.0 107.132 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 70' ' ' ILE . 37.4 mt -126.47 153.99 35.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.365 0 C-N-CA 127.041 2.136 . . . . 0.0 111.554 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -117.96 117.07 28.24 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.877 1.671 . . . . 0.0 109.618 171.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -65.36 -49.9 67.6 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.266 1.027 . . . . 0.0 112.565 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -166.52 173.39 9.87 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.799 2.44 . . . . 0.0 110.863 172.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.0 13.52 15.93 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 116.117 1.895 . . . . 0.0 116.117 -169.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.16 -43.74 95.56 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 119.814 1.188 . . . . 0.0 112.08 174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.2 m -59.72 -26.91 66.02 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.421 1.088 . . . . 0.0 113.851 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -68.37 -13.34 62.21 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.379 1.071 . . . . 0.0 113.865 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -106.78 -38.24 6.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.623 1.169 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -80.19 -23.36 41.06 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -169.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -49.58 -48.44 48.68 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.295 1.438 . . . . 0.0 114.002 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.0 ttp-105 -62.53 -41.81 99.1 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.623 -169.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.1 m -77.34 -44.26 30.12 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.581 1.152 . . . . 0.0 112.902 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -64.01 -36.36 83.74 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.18 -0.95 . . . . 0.0 112.792 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.89 -10.83 52.82 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.4 mt -65.71 -20.02 66.12 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -159.47 177.55 10.83 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.713 0.805 . . . . 0.0 112.511 -166.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.2 p -54.96 -16.97 3.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.291 1.436 . . . . 0.0 114.395 171.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -57.81 -11.77 2.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 126.078 1.751 . . . . 0.0 115.614 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -60.06 -26.96 66.57 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.38 62.99 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 171.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.5 mt 66.3 -71.57 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 127.664 2.386 . . . . 0.0 112.809 -177.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 m -176.87 154.36 1.13 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.459 2.704 . . . . 0.0 109.394 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -59.29 -4.35 0.54 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -105.23 -14.33 15.4 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.857 1.663 . . . . 0.0 113.025 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -115.02 -29.24 6.74 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.008 2.123 . . . . 0.0 114.513 -176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.05 -10.98 1.3 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.068 2.147 . . . . 0.0 116.483 -171.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -56.6 -26.09 54.59 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 120.712 -1.242 . . . . 0.0 112.762 168.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.7 t -62.06 -26.96 68.57 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.621 1.568 . . . . 0.0 112.775 168.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 m -103.58 -18.68 14.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.475 1.91 . . . . 0.0 114.391 -177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -61.39 -26.24 67.71 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.987 1.315 . . . . 0.0 113.392 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.72 132.79 19.27 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.102 1.361 . . . . 0.0 110.677 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.6 t -60.04 134.24 56.86 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.321 0.649 . . . . 0.0 112.307 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.2 mt 47.28 24.22 0.42 Allowed 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 125.867 1.667 . . . . 0.0 113.833 -176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . 0.257 3.9 t0 46.38 36.27 3.32 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.913 2.085 . . . . 0.0 114.364 -166.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -80.78 149.7 29.52 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.307 1.043 . . . . 0.0 112.646 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.2 m -139.77 137.19 34.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.605 0.762 . . . . 0.0 109.915 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -98.05 152.48 19.26 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.091 0.957 . . . . 0.0 111.922 -176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 32' ' ' ILE . 4.9 mp -127.99 137.52 57.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 125.32 1.448 . . . . 0.0 108.204 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.1 ptmt -137.28 153.41 50.32 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.58 1.152 . . . . 0.0 113.103 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.87 167.25 9.74 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 124.8 1.24 . . . . 0.0 112.168 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.52 -40.59 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.236 2.624 . . . . 0.0 115.706 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -159.21 -175.67 5.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.265 1.826 . . . . 0.0 113.216 -164.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -84.44 135.81 34.1 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.753 1.221 . . . . 0.0 110.734 176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.01 -157.1 26.86 Favored Glycine 0 CA--C 1.523 0.544 0 CA-C-O 122.283 0.935 . . . . 0.0 114.106 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 7.0 m -111.06 157.39 20.03 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 126.383 1.873 . . . . 0.0 109.413 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.5 tt -140.1 133.42 34.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.367 0.603 . . . . 0.0 111.796 -169.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.68 -164.25 22.54 Favored Glycine 0 CA--C 1.528 0.861 0 N-CA-C 115.661 1.024 . . . . 0.0 115.661 -169.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.32 129.63 42.17 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 122.53 1.157 . . . . 0.0 113.006 169.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.54 4.72 2.2 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 120.209 3.411 . . . . 0.0 120.209 -168.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 27.0 mt 38.45 -9.67 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.019 1 C-N-CA 137.065 6.146 . . . . 0.0 118.804 174.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.9 m -146.58 162.26 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 126.179 1.792 . . . . 0.0 111.981 -169.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -141.38 170.11 16.35 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.002 1.721 . . . . 0.0 109.751 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.427 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.7 mp -61.14 101.29 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.328 1.851 . . . . 0.0 109.405 178.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 119.44 -15.64 10.68 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 118.388 -1.229 . . . . 0.0 112.816 -173.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.22 127.14 30.15 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 119.773 1.786 . . . . 0.0 109.045 168.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -72.89 107.2 5.16 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.077 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.4 m -112.04 146.47 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 176.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -136.03 140.97 44.24 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.982 1.313 . . . . 0.0 109.998 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -33.83 -74.6 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 117.731 2.493 . . . . 0.0 117.731 -164.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 m -95.41 -2.91 47.98 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.487 179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.7 m -96.2 -13.31 23.59 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.859 1.664 . . . . 0.0 114.451 -166.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.41 121.32 12.01 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 122.926 1.346 . . . . 0.0 108.047 -170.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.73 125.23 50.06 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.842 -1.981 . . . . 0.0 109.385 -165.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.2 mt -90.94 -37.83 13.26 Favored 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -164.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.543 HG22 ' N ' ' A' ' 98' ' ' ARG . 12.1 p -177.63 176.6 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.801 2.041 . . . . 0.0 107.363 -177.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.543 ' N ' HG22 ' A' ' 97' ' ' VAL . 24.4 ptt-85 -110.59 141.88 43.19 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.497 1.119 . . . . 0.0 112.973 167.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.68 130.45 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 119.342 0.974 . . . . 0.0 108.539 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.49 112.29 7.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.951 0.882 . . . . 0.0 113.171 -168.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -65.53 -15.54 62.79 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.654 -1.279 . . . . 0.0 114.293 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.8 mt 60.54 -89.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.926 1.69 . . . . 0.0 110.615 -169.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -138.31 159.8 66.5 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.677 1.991 . . . . 0.0 109.915 170.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -78.13 -3.2 13.23 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.922 2.415 . . . . 0.0 115.147 -169.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.1 pt -63.58 -13.4 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.594 1.958 . . . . 0.0 114.474 175.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -90.45 -2.32 57.93 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.375 1.47 . . . . 0.0 112.833 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.03 16.28 6.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.386 1.874 . . . . 0.0 113.35 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -156.68 165.08 37.28 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.753 1.221 . . . . 0.0 111.228 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 168.73 13.01 0.02 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 116.85 1.5 . . . . 0.0 116.85 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 45.2 m -55.9 -22.6 26.57 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -168.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -133.19 -18.7 2.26 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.357 1.463 . . . . 0.0 113.298 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -62.54 -20.19 64.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.526 2.33 . . . . 0.0 113.701 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -65.85 -20.97 66.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.112 1.365 . . . . 0.0 114.56 172.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 20.8 m170 45.9 31.2 1.02 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.237 1.815 . . . . 0.0 114.45 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -77.72 -3.04 39.16 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.251 1.82 . . . . 0.0 113.543 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.252 0 C-N-CA 127.892 2.477 . . . . 0.0 114.077 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 99' ' ' VAL . 0.3 OUTLIER -148.86 161.27 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.916 1.286 . . . . 0.0 111.767 -175.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 mm -127.37 115.84 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 126.574 1.949 . . . . 0.0 107.914 167.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.418 HG23 HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -77.08 149.58 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 125.913 1.685 . . . . 0.0 111.311 -177.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.3 mttt -143.89 154.96 59.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.881 1.673 . . . . 0.0 113.067 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -79.41 150.14 22.02 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.473 2.115 . . . . 0.0 112.816 -174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -78.57 -11.19 59.95 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.49 173.58 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 126.254 1.822 . . . . 0.0 110.507 172.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 92.1 p -100.0 165.98 11.27 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.16 0.984 . . . . 0.0 112.749 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.38 -132.77 5.63 Favored Glycine 0 CA--C 1.483 -1.935 0 C-N-CA 126.023 1.773 . . . . 0.0 108.895 -170.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -150.13 144.02 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.797 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.087 -168.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.8 mm -60.98 143.54 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.7 t -124.99 -34.92 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 C-N-CA 126.928 2.091 . . . . 0.0 112.273 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -150.01 161.42 42.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.039 0.936 . . . . 0.0 111.57 177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mmmm -128.34 94.12 3.82 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.837 2.855 . . . . 0.0 107.743 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.25 -41.01 58.39 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.489 0.716 . . . . 0.0 112.856 -176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -80.26 -177.86 6.32 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.567 1.147 . . . . 0.0 112.62 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -126.17 134.34 51.31 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.3 1.44 . . . . 0.0 111.623 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.46 111.26 0.84 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.188 1.395 . . . . 0.0 111.347 172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.66 69.4 Favored Glycine 0 CA--C 1.539 1.544 0 N-CA-C 116.537 1.375 . . . . 0.0 116.537 176.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -92.94 -158.34 0.6 Allowed 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 119.864 1.832 . . . . 0.0 114.241 -171.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -98.15 159.36 14.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.323 1.449 . . . . 0.0 112.116 179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 99' ' ' VAL . 16.5 m -142.81 140.87 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.151 1.78 . . . . 0.0 110.541 174.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -70.27 -176.98 1.3 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.424 1.09 . . . . 0.0 112.494 170.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 mmmt -59.93 31.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 128.492 2.717 . . . . 0.0 116.043 174.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.15 27.54 0.91 Allowed Glycine 0 N--CA 1.465 0.605 0 O-C-N 120.535 -1.353 . . . . 0.0 116.268 -169.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -56.68 150.63 15.48 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 118.94 1.37 . . . . 0.0 112.068 168.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 27.4 m -71.63 138.96 49.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.13 0.972 . . . . 0.0 111.033 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.3 -44.95 2.24 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.14 1.776 . . . . 0.0 113.493 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -142.19 168.87 18.7 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.6 mt -131.05 144.7 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.654 1.982 . . . . 0.0 107.645 172.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 70' ' ' ILE . 22.0 mt -127.75 153.8 37.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 C-N-CA 126.749 2.02 . . . . 0.0 111.582 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.99 118.72 33.7 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 126.032 1.733 . . . . 0.0 109.981 168.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -60.01 -38.15 81.78 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.9 162.45 0.44 Allowed 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 127.776 2.431 . . . . 0.0 108.577 -167.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.65 4.56 4.62 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 171.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.94 -38.76 83.22 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 118.995 0.816 . . . . 0.0 110.822 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.3 m -64.97 -33.54 76.29 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.694 0.798 . . . . 0.0 112.201 170.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -63.57 -42.42 98.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.735 0.814 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -59.75 -44.08 93.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.278 0.631 . . . . 0.0 111.97 171.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -68.37 -38.47 81.42 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.598 0.759 . . . . 0.0 112.927 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.87 -39.47 74.39 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.064 0.946 . . . . 0.0 111.686 174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -65.52 -41.42 93.17 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 52.6 m -68.93 -35.75 77.17 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.011 1.325 . . . . 0.0 113.626 173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -67.02 -39.91 87.13 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.208 1.003 . . . . 0.0 113.059 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.34 -11.29 59.93 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 -175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.5 mt -133.37 158.26 43.44 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.074 1.35 . . . . 0.0 112.538 -170.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 58.32 -52.29 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 128.806 2.843 . . . . 0.0 117.236 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 t -81.82 29.28 0.39 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.478 1.511 . . . . 0.0 113.14 -172.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.3 mm100 -59.73 -31.59 69.77 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.888 1.275 . . . . 0.0 113.486 -168.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.1 m -72.5 -16.0 61.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.033 1.333 . . . . 0.0 114.13 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -94.26 -6.45 44.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.7 tp -136.61 137.54 47.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 118.836 0.743 . . . . 0.0 112.714 -170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.9 m -75.02 149.84 39.11 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.697 -0.627 . . . . 0.0 111.984 176.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -60.92 -0.53 0.31 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.701 2.0 . . . . 0.0 115.052 172.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -113.88 -16.14 12.26 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.343 1.857 . . . . 0.0 112.458 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.45 -37.76 9.46 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.947 1.699 . . . . 0.0 113.306 178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.83 -17.98 63.68 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 -171.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.257 2.3 p30 41.76 2.84 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 131.22 3.808 . . . . 0.0 119.893 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 82.8 p -62.01 -21.62 65.02 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 119.952 -1.717 . . . . 0.0 114.477 177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 80.8 p -85.9 -18.48 32.63 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.15 1.38 . . . . 0.0 114.279 170.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.09 -24.18 13.98 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.206 1.802 . . . . 0.0 113.546 -171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.85 177.11 8.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.077 1.351 . . . . 0.0 112.216 -168.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -136.61 -176.9 4.5 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.018 1.327 . . . . 0.0 111.269 -168.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 64' ' ' THR . 52.4 mt -69.59 45.0 0.06 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 128.338 2.655 . . . . 0.0 114.754 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 60.5 29.38 18.97 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.729 1.612 . . . . 0.0 114.402 169.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -95.13 155.05 16.89 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.1 m -138.5 155.32 48.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.994 1.318 . . . . 0.0 109.66 170.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' C ' HD12 ' A' ' 70' ' ' ILE . 47.1 mt-10 -115.77 155.68 27.38 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 120.961 -1.087 . . . . 0.0 111.624 -176.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 69' ' ' GLU . 2.9 mp -126.48 138.13 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.474 . . . . 0.0 108.282 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -134.8 148.85 50.29 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.283 1.833 . . . . 0.0 110.125 -171.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.6 160.14 10.87 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 124.555 1.142 . . . . 0.0 113.45 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.97 -42.26 0.19 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.1 1.867 . . . . 0.0 112.816 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 p90 -156.2 162.86 40.14 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -168.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -67.97 131.44 45.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.122 1.369 . . . . 0.0 111.601 177.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 171.92 -153.81 20.42 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 122.158 0.865 . . . . 0.0 114.359 -170.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.583 ' C ' HG23 ' A' ' 99' ' ' VAL . 19.7 m -131.07 130.97 43.9 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 -174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.508 HG13 ' HB ' ' A' ' 99' ' ' VAL . 6.2 tt -105.4 158.1 6.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 123.45 0.7 . . . . 0.0 109.25 -167.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -87.29 -172.9 48.28 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 121.073 -1.017 . . . . 0.0 112.368 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.83 139.64 57.78 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.98 0.895 . . . . 0.0 111.62 168.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.15 144.53 40.12 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.544 1.138 . . . . 0.0 111.617 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 54.4 mt -111.89 1.52 16.55 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.798 1.239 . . . . 0.0 112.706 -178.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 m -145.66 158.25 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 126.437 1.895 . . . . 0.0 111.878 -173.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -141.28 168.77 18.98 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 127.051 2.141 . . . . 0.0 110.598 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.6 mp -60.24 103.01 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 126.193 1.797 . . . . 0.0 109.225 -178.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.44 13.82 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.785 -1.008 . . . . 0.0 113.032 -175.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -64.81 125.37 24.61 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-N 118.979 1.39 . . . . 0.0 108.556 168.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -71.58 107.44 4.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.555 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.8 m -111.29 149.46 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.1 t -138.18 147.29 43.67 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.286 1.435 . . . . 0.0 110.983 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . 0.265 . . -54.13 -24.29 17.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 120.953 3.686 . . . . 0.0 120.953 -162.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 83.9 p -133.84 -0.79 3.09 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 165.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 m -96.45 -12.94 23.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.847 1.259 . . . . 0.0 113.529 -167.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.82 120.66 11.95 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 123.234 1.492 . . . . 0.0 107.945 -171.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.87 121.21 42.61 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.543 -166.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 4' ' ' ILE . 10.4 mt -83.92 -38.41 21.1 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -164.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 98' ' ' ARG . 11.9 p 177.9 162.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 128.013 2.525 . . . . 0.0 110.773 -177.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' N ' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -98.9 144.48 28.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.534 1.534 . . . . 0.0 113.458 172.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.583 HG23 ' C ' ' A' ' 77' ' ' THR 0.269 14.8 p -132.4 156.16 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 CA-C-N 121.916 2.144 . . . . 0.0 109.895 162.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.9 t -140.75 134.43 30.24 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.195 -0.941 . . . . 0.0 109.598 -174.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -72.24 134.89 45.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.997 0.919 . . . . 0.0 110.699 -167.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.6 mt -71.77 169.96 14.59 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.067 0.947 . . . . 0.0 113.291 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -65.37 159.8 63.8 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.865 0.866 . . . . 0.0 110.816 169.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.23 4.22 7.17 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.931 2.421 . . . . 0.0 114.724 -169.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 pt -57.73 -18.41 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 127.23 2.212 . . . . 0.0 115.041 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -82.24 -9.15 59.6 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.642 1.577 . . . . 0.0 113.852 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.07 -13.0 0.73 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.04 163.2 39.81 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.036 0.835 . . . . 0.0 112.51 -178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 75.84 -41.86 1.51 Allowed Glycine 0 CA--C 1.537 1.456 0 C-N-CA 126.234 1.873 . . . . 0.0 114.466 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.3 m -70.85 19.0 0.05 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.853 2.461 . . . . 0.0 115.13 -179.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -69.45 176.72 3.25 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.186 1.794 . . . . 0.0 113.359 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -123.14 174.18 7.41 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.408 1.483 . . . . 0.0 111.569 171.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -125.67 -0.84 7.41 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -168.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -159.86 -51.99 0.06 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.754 1.221 . . . . 0.0 111.699 174.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -152.19 167.57 28.12 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.429 1.492 . . . . 0.0 111.811 174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 54.1 t60 . . . . . 0 C--O 1.251 1.167 0 C-N-CA 125.899 1.68 . . . . 0.0 111.695 -179.861 . . . . . . . . 0 0 . 1 stop_ save_